Compound ID,Uniprot ID,Compound Name,Standard inchi key,Max Phase,Target Pref Name,Gene Names,Target Class,Wild type or mutant,Mutation information,PubMed ID,End Point Standard Type,End Point Standard Relation,End Point Standard Value,End Point Standard Units,Endpoint Mode of Action,Assay Format,Assay Type,Assay Sub Type,Inhibitor Type,Detection Technology,Compound concentration value,Compound concentration value units,Substrate type,Substrate Type Standard Relation,Substrate Type Standard Value,Substrate Type Standard Units,Assay cell line,Assay Description,Activity Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation Comments,Assay ID,DTC Tid,DTC Activity ID,DTC Molregno,Record ID,DTC Document ID
CHEMBL100086,P46098,,OSVMSQACZRYAPT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12482441,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,,Development of a presynaptic 5-HT1A antagonist.,Bioorg. Med. Chem. Lett.,2003,13,2,"Mattson RJ, Catt JD, Sloan CP, Gao Q, Carter RB, Gentile A, Mahle CD, Matos FF, McGovern R, VanderMaelen CP, Yocca FD",,3062,DTCT0023221,1489397,DTCC00263953,917398,5847
CHEMBL104700,P46098,,SCDKHPSUXHBJDJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10478126,DTCC00272114,931177,48255
CHEMBL1079079,P46098,,WGIPGQAPFNVWIX-XXFZXMJFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19767206,INHIBITION,<,50,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 (receptor) at 10 uM by scintillation counting,,Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.,Bioorg. Med. Chem. Lett.,2009,19,21,"Donohue SR, Varnäs K, Jia Z, Gulyás B, Pike VW, Halldin C",,619795,DTCT0023221,3267809,DTCC00632772,857661,37697
CHEMBL108,P46098,CARBAMAZEPINE,FFGPTBGBLSHEPO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,<=,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849452,DTCC00144764,229550,34292
CHEMBL1082723,P46098,NITD609,CKLPLPZSUQEDRT-WPCRTTGESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20813948,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant serotonin 5HT3 receptor,,"Spiroindolones, a potent compound class for the treatment of malaria.",Science,2010,329,5996,"Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, Cohen SB, Spencer KR, González-Páez GE, Lakshminarayana SB, Goh A, Suwanarusk R, Jegla T, Schmitt EK, Beck HP, Brun R, Nosten F, Renia L, Dartois V, Keller TH, Fidock DA, Winzeler EA, Diagana TT",,658586,DTCT0023221,3467863,DTCC00031143,1686650,40818
CHEMBL1083485,P46098,,YOCUJVXRRWEPDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345977,DTCC00645978,1654372,39082
CHEMBL1083787,P46098,,LMGUUVWYFJIKCD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345978,DTCC00645979,1395966,39082
CHEMBL1083788,P46098,,DFBQTBNRGSIKHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345979,DTCC00645980,652015,39082
CHEMBL1084363,P46098,,MMXFWZCBTFHARB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345974,DTCC00645913,716354,39082
CHEMBL1084364,P46098,,FWCCJDYYJWWQOS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345975,DTCC00645914,1525122,39082
CHEMBL1084365,P46098,,HCBWAWNFHVHMOV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345976,DTCC00645915,652014,39082
CHEMBL1084631,P46098,,FTPAKCBSUUBRFU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,=,5800,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345972,DTCC00645911,554947,39082
CHEMBL1084876,P46098,,UPVXJFQSDLKQRB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345973,DTCC00645912,1428308,39082
CHEMBL1085379,P46098,,OXIAXPOOKVTTDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,=,5700,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345971,DTCC00645849,1492825,39082
CHEMBL1086332,P46098,,MUIUUGJVKFYPIF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,=,7900,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345969,DTCC00645847,587120,39082
CHEMBL1086333,P46098,,HSWHSJUFDDMBTI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,=,7800,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345970,DTCC00645848,197801,39082
CHEMBL1086577,P46098,,SLMFOVKWAUVQPC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010,53,11,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700,DTCT0023221,3345980,DTCC00645981,1330901,39082
CHEMBL1098230,P46098,,PQPVHIHIJVIEQG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20384344,KI,>,1000,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.,J. Med. Chem.,2010,53,9,"Ishikawa M, Shinei R, Yokoyama F, Yamauchi M, Oyama M, Okuma K, Nagayama T, Kato K, Kakui N, Sato Y",,630142,DTCT0023221,3336761,DTCC00641534,631300,38886
CHEMBL11,P46098,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,>,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849456,DTCC00132703,11935,34292
CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,0.5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553852,DTCC00258915,1310663,41528
CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,-1,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825,DTCT0023221,5035411,DTCC00258915,1316308,42619
CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,2,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638,DTCT0023221,5035400,DTCC00258915,1316308,42619
CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,0.5,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035391,DTCC00258915,1316308,42619
CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,0.5,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709627,DTCC00258915,1301532,58772
CHEMBL1110,P46098,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678639,DTCC00258915,1304123,65052
CHEMBL1112,P46098,ARIPIPRAZOLE,CEUORZQYGODEFX-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1000,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329312,DTCT0023221,13582408,DTCC00106550,1580612,39761
CHEMBL111639,P46098,FLUOROCARAZOLOL,QHLGXPUIUKSADT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11512051,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736677,DTCC00281815,2106040,69642
CHEMBL11608,P46098,TYRAMINE,DZGWFCGJZKJUFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium at 10 uM by calcium imaging assay,Active,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007,450,7169,"Petrascheck M, Ye X, Buck LB",,478754,DTCT0023221,2354067,DTCC00139782,1458834,26306
CHEMBL11608,P46098,TYRAMINE,DZGWFCGJZKJUFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297,EC50,=,26000,NM,,cell_based,,,,,,,,,,,HEK293,Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay,,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007,450,7169,"Petrascheck M, Ye X, Buck LB",,478755,DTCT0023221,2354068,DTCC00139782,1458834,26306
CHEMBL1163015,P46098,,HFOUMBDMIJJHCK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,2800,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114452,DTCC00650396,1232455,36218
CHEMBL116913,P46098,,CEOCEXSTLLSYBV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12540230,KI,=,53.2,NM,,,,,,,,,,,,,,Tested for 5-hydroxytryptamine 3 receptor agonist activity,,5-HT4 receptor ligands: applications and new prospects.,J. Med. Chem.,2003,46,3,"Langlois M, Fischmeister R",,3473,DTCT0023221,1066965,DTCC00290242,1774449,17663
CHEMBL1169707,P46098,,GCWNAFLHJNJVCV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20541425,ACTIVITY,=,-7,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 1 uM by radioligand displacement assay,,"Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.",Bioorg. Med. Chem.,2010,18,14,"Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Kovalenko SM, Mitkin OD, Okun IM, Ravnyeyko IM, Tkachenko SE, Zaremba OV",,642506,DTCT0023221,3393561,DTCC00655086,1536915,39618
CHEMBL1170237,P46098,,DICVBGGIAAPPNV-ZSUDRMHPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296,KI,=,1000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013,21,22,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092,DTCT0023221,12643656,DTCC00655623,481040,56290
CHEMBL1171434,P46098,,XVOYSCVBGLVSOL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14737634,DTCC00655109,2106368,69159
CHEMBL117287,P46098,PRUCALOPRIDE,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,KI,=,3981.07,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428,DTCT0023221,2613773,DTCC00290884,823881,33265
CHEMBL1173578,P46098,,AFEOLFPUJYURJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20541425,ACTIVITY,=,-3,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 1 uM by radioligand displacement assay,,"Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.",Bioorg. Med. Chem.,2010,18,14,"Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Kovalenko SM, Mitkin OD, Okun IM, Ravnyeyko IM, Tkachenko SE, Zaremba OV",,642506,DTCT0023221,3393573,DTCC00656645,1504596,39618
CHEMBL1178,P46098,,UIJIQXGRFSPYQW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14720913,DTCC00292803,2102127,68163
CHEMBL1189234,P46098,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11475977,DTCC00667938,1780157,51935
CHEMBL1189234,P46098,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12600286,DTCC00667938,1780916,55935
CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20724042,KI,=,0.0316,NM,,,,,,,,,,,,,,Binding affinity to 5HT3A receptor,,Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.,Eur. J. Med. Chem.,2010,45,11,"Moura Barbosa AJ, De Rienzo F, Ramos MJ, Menziani MC",,685540,DTCT0023221,3563563,DTCC00668368,1396273,41807
CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,-2,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638,DTCT0023221,5035402,DTCC00668368,1413958,42619
CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,-2,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825,DTCT0023221,5035413,DTCC00668368,1413958,42619
CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128813,IC50,=,0.83,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human wild type 5-HT3A receptor expressed in HEK293 cells assessed as inhibition of 5-HT-induced response after 45 mins by FLIPR assay,,Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.,Bioorg. Med. Chem.,2013,21,23,"Del Cadia M, De Rienzo F, Weston DA, Thompson AJ, Menziani MC, Lummis SC",,1278336,DTCT0023221,12951310,DTCC00668368,1419159,56549
CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128813,KD,=,0.32,NM,,cell_based,,,,,,,,,,,,Binding affinity to human wild type 5-HT3A receptor expressed in HEK293 cells after 24 hrs by liquid scintillation counting analysis,,Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.,Bioorg. Med. Chem.,2013,21,23,"Del Cadia M, De Rienzo F, Weston DA, Thompson AJ, Menziani MC, Lummis SC",,1278482,DTCT0023221,12952197,DTCC00668368,1419159,56549
CHEMBL120055,P46098,,DWSOZYFSYVOVOC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,IC50,>,10000,NM,,,,,,,,,,,,,,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,,Bioorg. Med. Chem. Lett.,1995,5,7,,,3460,DTCT0023221,875262,DTCC00296622,109540,1553
CHEMBL1204203,P46098,,GQQHPWHBHFNFFC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11170628,KI,>,1000,NM,,,,,,,,,,,,,,In vitro binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.,J. Med. Chem.,2001,44,2,"López-Rodríguez ML, Morcillo MJ, Fernández E, Porras E, Orensanz L, Beneytez ME, Manzanares J, Fuentes JA",,3471,DTCT0023221,1564868,DTCC00681707,808331,16410
CHEMBL1208883,P46098,,LMMXCOUUSOBOAF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20638843,ACTIVITY,=,8.4,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human 5HT3 receptor expressed in CHO cells at 10 uM,,Discovery of novel alpha7 nicotinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,16,"Peng Y, Zhang Q, Snyder GL, Zhu H, Yao W, Tomesch J, Papke RL, O'Callaghan JP, Welsh WJ, Wennogle LP",,645017,DTCT0023221,3415698,DTCC00685727,716438,39883
CHEMBL1210154,P46098,,CQUWKHKELQQYRI-KGENOOAVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20591666,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL 43694 from human recombinant 5HT3 receptor expressed in CHO cells,,A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.,Bioorg. Med. Chem. Lett.,2010,20,15,"Gattinoni S, Simone CD, Dallavalle S, Fezza F, Nannei R, Battista N, Minetti P, Quattrociocchi G, Caprioli A, Borsini F, Cabri W, Penco S, Merlini L, Maccarrone M",,643635,DTCT0023221,3413129,DTCC00686944,241890,39814
CHEMBL1210515,P46098,,RPQHJWKLRRXKIS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20591663,IC50,=,7943.28,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor,,Identification of novel alpha7 nAChR positive allosteric modulators with the use of pharmacophore in silico screening methods.,Bioorg. Med. Chem. Lett.,2010,20,15,"Capelli AM, Castelletti L, Salvagno C, Oliosi B, Di Lenarda E, Virginio C, Lightfoot A, Kew JN, Teague S",,643571,DTCT0023221,3412864,DTCC00687304,1557285,35708
CHEMBL1210703,P46098,,AJTVQZWUKUPHIP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20591663,IC50,=,1000,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor,,Identification of novel alpha7 nAChR positive allosteric modulators with the use of pharmacophore in silico screening methods.,Bioorg. Med. Chem. Lett.,2010,20,15,"Capelli AM, Castelletti L, Salvagno C, Oliosi B, Di Lenarda E, Virginio C, Lightfoot A, Kew JN, Teague S",,643571,DTCT0023221,3412900,DTCC00687492,328485,35708
CHEMBL1224034,P46098,,WPNGDOZEXVRNMZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20692833,INHIBITION,=,-8.7,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human 5HT3 receptor at 10 uM,,N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B.,Bioorg. Med. Chem. Lett.,2010,20,18,"Kwon YJ, Saubern S, Macdonald JM, Huang XP, Setola V, Roth BL",,652353,DTCT0023221,3449407,DTCC00692765,716520,40427
CHEMBL1224527,P46098,,FKYWSGYMKJUZEP-ZOBUZTSGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20709559,KI,=,870000,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Facile synthesis of octahydrobenzo[h]isoquinolines: Novel and highly potent D(1) dopamine agonists.,Bioorg. Med. Chem.,2010,18,18,"Bonner LA, Chemel BR, Watts VJ, Nichols DE",,652920,DTCT0023221,3442398,DTCC00693196,1666088,40467
CHEMBL123137,P46098,,HNDAZSYDBSRFST-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,4.68,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422326,DTCC00299255,1656132,51459
CHEMBL1241348,P46098,FALDAPREVIR,LLGDPTDZOVKFDU-XUHJSTDZSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20823284,INHIBITION,=,5,%,,,,,,,,,,,,,,Inhibition of human H3 receptor at 10 uM,,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,2010,54,11,"White PW, Llinàs-Brunet M, Amad M, Bethell RC, Bolger G, Cordingley MG, Duan J, Garneau M, Lagacé L, Thibeault D, Kukolj G",,724392,DTCT0023221,5127076,DTCC00126282,118904,43507
CHEMBL1242923,P46098,,FLGSUSWMWSZVMP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20684563,KI,>=,1000,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659608,DTCT0023221,3460952,DTCC00697046,1200707,40772
CHEMBL1242950,P46098,AC-42,ANTKBACNWQHQJE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20684563,KI,>=,1000,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659608,DTCT0023221,3460953,DTCC00032233,1972874,40772
CHEMBL1258006,P46098,BRADANICLINE,OXKRFEWMSWPKKV-GHTZIAJQSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,EMAX,=,15,%,,,,,,,,,,,,,,Agonist activity at human 5HT3A at 100 uM relative to control,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851022,DTCT0023221,11361502,DTCC00701194,1189842,50968
CHEMBL1258006,P46098,BRADANICLINE,OXKRFEWMSWPKKV-GHTZIAJQSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,INHIBITION,=,25,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851023,DTCT0023221,11361500,DTCC00701194,1189842,50968
CHEMBL1258006,P46098,BRADANICLINE,OXKRFEWMSWPKKV-GHTZIAJQSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365,DTCT0023221,11452775,DTCC00701194,1170043,51687
CHEMBL1258006,P46098,BRADANICLINE,OXKRFEWMSWPKKV-GHTZIAJQSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human 5HT3R,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877364,DTCT0023221,11452733,DTCC00701194,1170043,51687
CHEMBL1258223,P46098,,WKWADEWWLCVVLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20812727,KI,=,1072,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010,53,19,"Xu R, Hong J, Morse CL, Pike VW",,664931,DTCT0023221,3532944,DTCC00701398,1168405,41144
CHEMBL1258452,P46098,,DZZIAERGLDKTBT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20812727,KI,=,3511,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010,53,19,"Xu R, Hong J, Morse CL, Pike VW",,664931,DTCT0023221,3532988,DTCC00701623,716604,41144
CHEMBL1258614,P46098,,IUEKKZWRWOFGRT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20727749,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010,20,19,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664299,DTCT0023221,3527811,DTCC00701782,911256,41064
CHEMBL1258671,P46098,,WLHFUBIRAHRPHA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20812727,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010,53,19,"Xu R, Hong J, Morse CL, Pike VW",,664931,DTCT0023221,3533032,DTCC00701836,911257,41144
CHEMBL1258843,P46098,,VHENJOBTWCOIPN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20727749,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010,20,19,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664299,DTCT0023221,3527894,DTCC00702004,1265966,41064
CHEMBL1270261,P46098,,XILQKEHRYUALQZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5HT3A receptor expressed in Xenopus oocyte,Not Active,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010,53,17,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675557,DTCT0023221,3545611,DTCC00703499,631664,41410
CHEMBL1270261,P46098,,XILQKEHRYUALQZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351,INHIBITION,=,1.7,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte at 20 uM,,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010,53,17,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675555,DTCT0023221,3545610,DTCC00703499,631664,41410
CHEMBL1270361,P46098,,XILQKEHRYUALQZ-SNVBAGLBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351,INHIBITION,=,34,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte at 9 uM,,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010,53,17,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675554,DTCT0023221,3545609,DTCC00703596,1633942,41410
CHEMBL1270457,P46098,,XILQKEHRYUALQZ-JTQLQIEISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351,INHIBITION,=,29,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte at 9 uM,,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010,53,17,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675554,DTCT0023221,3545608,DTCC00703690,1212287,41410
CHEMBL1271520,P46098,,ORJWZBKFHYBQDC-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,165,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553829,DTCC00704734,631676,41528
CHEMBL1271790,P46098,,ABIDZKZAFOTHFB-GRDNDAEWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,6.8,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553838,DTCC00704993,1472476,41528
CHEMBL1272016,P46098,,QZEXFNKCPOFGAE-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,47.3,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553847,DTCC00705207,469940,41528
CHEMBL1272072,P46098,,OUENCNZMGZDHGX-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,32.7,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553849,DTCC00705263,890297,41528
CHEMBL1272121,P46098,,IMXFSNJHDBFECE-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,36.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553856,DTCC00705310,242106,41528
CHEMBL1272122,P46098,,ZCUBEQCDRQOEAQ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,12.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553853,DTCC00705311,1854887,41528
CHEMBL1272123,P46098,,PBZNWDCSSPCDNF-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,66.5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553854,DTCC00705312,1569073,41528
CHEMBL1272176,P46098,,AJOIVAKMJVSBOV-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,18.2,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553855,DTCC00705363,1019144,41528
CHEMBL1272177,P46098,,UYMMSSRZDUEJKE-GFCCVEGCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,36.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553857,DTCC00705364,275022,41528
CHEMBL1272178,P46098,,MNODGVITNFISIZ-LLVKDONJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,13.8,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553858,DTCC00705365,1727628,41528
CHEMBL1272232,P46098,,IATGNHOMUXVGCQ-LLVKDONJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,4.7,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553859,DTCC00705417,502570,41528
CHEMBL1276832,P46098,,VWVPNALHKWLANG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,48.4,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587057,DTCC00706551,1557482,41871
CHEMBL1276833,P46098,,MYBMSIDXODXJBU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,50.5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587058,DTCC00706552,296048,41871
CHEMBL1276834,P46098,,SMZVQCAMELNWOP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,62.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587072,DTCC00706553,555234,41871
CHEMBL1276835,P46098,,LQAYFYWMQKQPPJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,84.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587090,DTCC00126685,490852,41871
CHEMBL1276919,P46098,,YURHTDCTHANLFV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587487,DTCC00706630,133751,41871
CHEMBL1276920,P46098,,YZHWETPHARDZQM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,87.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587094,DTCC00706631,619766,41871
CHEMBL1276921,P46098,,ZNOMCTSKVJJIMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,46.5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587054,DTCC00706632,1072234,41871
CHEMBL1276922,P46098,,MLNBDGCWHJVZAI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,22.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587036,DTCC00706633,878675,41871
CHEMBL1277005,P46098,,MPEGWVZSANJAMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587474,DTCC00706713,780906,41871
CHEMBL1277006,P46098,,OHXKHPFEXVDLQZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,24.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587039,DTCC00706714,1810952,41871
CHEMBL1277007,P46098,,QZHACJCMCCGZRU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,59.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587069,DTCC00706715,1072235,41871
CHEMBL1277098,P46098,,IQKPITCNSNNYNB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587475,DTCC00706802,684307,41871
CHEMBL1277099,P46098,,JIWMRJSKGUAANW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,41.4,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587046,DTCC00706803,133752,41871
CHEMBL1277100,P46098,,LZVLTVPNYIRFTB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587488,DTCC00706804,2005627,41871
CHEMBL1277101,P46098,,ZRMKLDGEAIPBEE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587489,DTCC00706805,1331198,41871
CHEMBL1277186,P46098,,DWCWRMNZCYONIV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587476,DTCC00706886,942829,41871
CHEMBL1277187,P46098,,LLZLRXCVMYYKBH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,44.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587051,DTCC00706887,1493079,41871
CHEMBL1277188,P46098,,VTHVGLORMDHGGF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587490,DTCC00706888,1039843,41871
CHEMBL1277189,P46098,,WOXCQSXEHWXACS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587491,DTCC00706889,652302,41871
CHEMBL1277280,P46098,,HLMKBCUKQMBYDR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,69.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587081,DTCC00706972,1460605,41871
CHEMBL1277281,P46098,,OJNSMLDRVFFVJN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,63.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587076,DTCC00706973,1810956,41871
CHEMBL1277282,P46098,,DQFJTXJCMDYWKL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,52.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587061,DTCC00706974,942831,41871
CHEMBL1277283,P46098,,QCJPMOOSRAYGGE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587492,DTCC00706975,328677,41871
CHEMBL1277371,P46098,,WCGCGRZZPCFDSO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587477,DTCC00707056,1428595,41871
CHEMBL1277372,P46098,,SPBSBKPLXWUEGQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,61,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587071,DTCC00707057,1200798,41871
CHEMBL1277373,P46098,,UGLUCZYCHYWOCD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,55.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587062,DTCC00707058,1525423,41871
CHEMBL1277374,P46098,,HGUUKRWUSHWXTH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,86.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587092,DTCC00707059,780910,41871
CHEMBL1277462,P46098,,YHOYHBANAWEKNE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,64.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587078,DTCC00707139,1493081,41871
CHEMBL1277463,P46098,,MDDLXKDIADSAQA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587112,DTCC00707140,1200799,41871
CHEMBL1277464,P46098,,XYQXSKXZFRFXOW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587493,DTCC00707141,1972994,41871
CHEMBL1277465,P46098,,WCNGVFDLZVYEJL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587494,DTCC00707142,716655,41871
CHEMBL1277558,P46098,,OMACXBJTMXFHCQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,77.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587085,DTCC00707232,1331202,41871
CHEMBL1277559,P46098,,FEPROLQKWGDFKU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,26.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587040,DTCC00707233,1493086,41871
CHEMBL1277560,P46098,,OPVPOKBFTBDGTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587495,DTCC00707234,684313,41871
CHEMBL1277561,P46098,,WXWOIPIEFSEMLN-OYRHEFFESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,INHIBITION,=,19.6,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells at 100 nM by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684898,DTCT0023221,3587034,DTCC00707235,1266030,41871
CHEMBL1277561,P46098,,WXWOIPIEFSEMLN-OYRHEFFESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,INHIBITION,=,87.3,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells at 1000 nM by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684899,DTCT0023221,3587093,DTCC00707235,1266030,41871
CHEMBL1277651,P46098,,GTIKAAJNYPWELX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,45.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587053,DTCC00707320,69163,41871
CHEMBL1277652,P46098,,UFZPJSNEEQOZFZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,50.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587059,DTCC00707321,2070192,41871
CHEMBL1277653,P46098,,WXWOIPIEFSEMLN-MEMLXQNLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,INHIBITION,=,1.4,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells at 100 nM by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684898,DTCT0023221,3586994,DTCC00707322,1972997,41871
CHEMBL1277653,P46098,,WXWOIPIEFSEMLN-MEMLXQNLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,INHIBITION,=,18.4,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells at 1000 nM by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684899,DTCT0023221,3587031,DTCC00707322,1972997,41871
CHEMBL1277745,P46098,,CFOHOEGJDCNBCR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,99.4,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587110,DTCC00707410,133756,41871
CHEMBL1277746,P46098,,PWVBQEUMVVPFJT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587478,DTCC00707411,1810959,41871
CHEMBL1277832,P46098,,ASIIZNZQUBPOJQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587479,DTCC00707495,1746576,41871
CHEMBL1277833,P46098,,TZSHYDBBXRRBCE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587480,DTCC00707496,14899,41871
CHEMBL1277913,P46098,,PYCJRTFNOGPLEL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587481,DTCC00707572,587403,41871
CHEMBL1277914,P46098,,XVBPOYYIPRSULQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,83.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587089,DTCC00707573,101390,41871
CHEMBL1277995,P46098,,RSUQRWJJGYXXCP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587482,DTCC00707651,1007415,41871
CHEMBL1277996,P46098,,GSEARIWHWZTSPV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,45.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587052,DTCC00707652,426610,41871
CHEMBL1278087,P46098,,BSCUUFDNCBQNPG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,15.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587028,DTCC00707741,684323,41871
CHEMBL1278088,P46098,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,8.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587017,DTCC00707742,716661,41871
CHEMBL1278088,P46098,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,8.93,NM,,,,,,,,,,,,,,Displacement of [3H]BRL-43694 from human recombinant 5HT3 receptor,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684926,DTCT0023221,3587018,DTCC00707742,716661,41871
CHEMBL1278088,P46098,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,KI,=,4.72,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684895,DTCT0023221,3587005,DTCC00707742,716661,41871
CHEMBL1278174,P46098,,HOABLJVFGVOCMM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,>,100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587473,DTCC00707823,684327,41871
CHEMBL1278175,P46098,,GERBCOZLRREKHD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,48.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587056,DTCC00707824,2070202,41871
CHEMBL1278176,P46098,,FCQFXDREOPQEAF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963,IC50,=,97.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849,DTCT0023221,3587109,DTCC00707825,166107,41871
CHEMBL128,P46098,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,7752204,IC50,>,10000,NM,,,,,,,,,,,,,,Binding activity radioligand.,,"Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptors.",J. Med. Chem.,1995,38,10,"Street LJ, Baker R, Davey WB, Guiblin AR, Jelley RA, Reeve AJ, Routledge H, Sternfeld F, Watt AP, Beer MS",,3126,DTCT0023221,520894,DTCC00154636,658692,13017
CHEMBL128,P46098,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9357515,IC50,=,9.3,NM,,,,,,,,,,,,,,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,"Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.",J. Med. Chem.,1997,40,22,"MacLeod AM, Street LJ, Reeve AJ, Jelley RA, Sternfeld F, Beer MS, Stanton JA, Watt AP, Rathbone D, Matassa VG",,3459,DTCT0023221,712596,DTCC00154636,659675,14385
CHEMBL1289626,P46098,WMS-1410,KKLZGWQBNXJWGZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20965739,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]-GR-65630 from 5-HT3 receptor at 1 to 3 uM,Not Active,"Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.",Bioorg. Med. Chem.,2010,18,22,"Tewes B, Frehland B, Schepmann D, Schmidtke KU, Winckler T, Wünsch B",,686785,DTCT0023221,3613342,DTCC00032749,40842,41994
CHEMBL133455,P46098,,VVHJUSGIUWQPIT-VIFPVBQESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12954071,KI,>,10000,NM,,,,,,,,,,,,,,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,,"A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.",J. Med. Chem.,2003,46,19,"May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA",,3472,DTCT0023221,1106904,DTCC00315452,2045939,17506
CHEMBL1336,P46098,SORAFENIB,MLDQJTXFUGDVEO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22694093,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor after 1.5 hrs by scintillation counter,Not Active,Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.,J. Med. Chem.,2012,55,12,"Lin X, Huang XP, Chen G, Whaley R, Peng S, Wang Y, Zhang G, Wang SX, Wang S, Roth BL, Huang N",,858212,DTCT0023221,11389507,DTCC00361295,782470,51215
CHEMBL133868,P46098,,VVHJUSGIUWQPIT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12954071,KI,>,10000,NM,,,,,,,,,,,,,,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,,"A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.",J. Med. Chem.,2003,46,19,"May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA",,3472,DTCT0023221,1109511,DTCC00315451,173712,17506
CHEMBL1365455,P46098,,MNJNPLVXBISNSX-PBWFPOADSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26988801,IC50,=,6.9,NM,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human recombinant 5-HT3 receptor expressed in CHO cells,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016,24,8,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559795,DTCT0023221,117199,DTCC00772276,517084,66408
CHEMBL13823,P46098,N-(3-CHLOROPHENYL)GUANIDINE,DWLMIHRZURMFAQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24035337,KI,=,32,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin) expressed in mouse/rat NG108-15 cells after 30 mins by by liquid scintillation counting analysis,,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013,23,21,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988339,DTCT0023221,12618342,DTCC01738849,1877872,56006
CHEMBL1382868,P46098,,BGMSTNYJYPSLHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,1300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14713107,DTCC00788480,2098974,68163
CHEMBL138458,P46098,,IJKYJDDNDXAREJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11784148,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,2002,45,2,"Maier CA, Wünsch B",,3461,DTCT0023221,1330607,DTCC00323189,65365,16958
CHEMBL138809,P46098,,RZZAEVQHACUOGI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11784148,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,2002,45,2,"Maier CA, Wünsch B",,3461,DTCT0023221,1325461,DTCC00323057,1489511,16958
CHEMBL141209,P46098,,POOPPNNSPMKABZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11784148,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,2002,45,2,"Maier CA, Wünsch B",,3461,DTCT0023221,1333323,DTCC00322694,1360188,16958
CHEMBL1417859,P46098,,GEIHZHQRXYKYAE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,9000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14718733,DTCC00821177,2101711,68163
CHEMBL142852,P46098,RS-33800,JKCPJPRSHXMMGA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,3476,DTCT0023221,534954,DTCC01743500,1404383,1973
CHEMBL142852,P46098,RS-33800,JKCPJPRSHXMMGA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,19.95,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,3475,DTCT0023221,534956,DTCC01743500,1404383,1973
CHEMBL14376,P46098,ILOPERIDONE,XMXHEBAFVSFQEX-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11750183,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14732054,DTCC00143788,2104585,69484
CHEMBL1448856,P46098,,XJIAFXBLMMIRJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14714397,DTCC00849945,2099633,68163
CHEMBL145033,P46098,RS-16456,OGXMGJGFLBSEJW-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.138,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,3476,DTCT0023221,525499,DTCC01743499,369324,1973
CHEMBL145033,P46098,RS-16456,OGXMGJGFLBSEJW-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,602.56,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,3475,DTCT0023221,525501,DTCC01743499,369324,1973
CHEMBL145725,P46098,RS-16566,OGXMGJGFLBSEJW-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.145,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,3475,DTCT0023221,528403,DTCC01743488,1883313,1973
CHEMBL145725,P46098,RS-16566,OGXMGJGFLBSEJW-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.537,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,3476,DTCT0023221,528401,DTCC01743488,1883313,1973
CHEMBL148204,P46098,ACRIDIN-3-YLAMINE,GHCKERHPOQWERJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,KI,=,1000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090033,DTCC01743566,296720,45760
CHEMBL148489,P46098,N-(3-PYRIDYLMETHYL)PYRROLIDINE,YFCWBKBNFCDPDF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10337083,DTCC00339052,2026783,48255
CHEMBL15056,P46098,,IBPWGZKZWJYGLA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18181565,KI,=,0.33,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Multi-target-directed ligands to combat neurodegenerative diseases.,J. Med. Chem.,2008,51,3,"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C",,462123,DTCT0023221,2280966,DTCC00144504,585453,25139
CHEMBL1516176,P46098,,PDNJLMZEGXHSCU-VKHMYHEASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14742333,DTCC00912618,2108018,69159
CHEMBL1545368,P46098,,RVXFERDBNJSQDX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14717934,DTCC00939726,2101285,68163
CHEMBL1548,P46098,,VBKOTIVQMCTTAQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17998160,KI,=,172,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor,,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation.,Bioorg. Med. Chem. Lett.,2008,18,1,"Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L",,463654,DTCT0023221,2290840,DTCC00502474,1636476,25254
CHEMBL1586599,P46098,,WHCWGLIMIAJMOY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,12000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14720929,DTCC00978021,2102135,68163
CHEMBL1614664,P46098,PSEUDOHYPERICIN,YXBUQQDFTYOHQI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14739995,DTCC01003548,2107269,69275
CHEMBL1623875,P46098,,UMWDYBZXNCMBRO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14717956,DTCC01011635,2101297,68163
CHEMBL1632158,P46098,,RNXYMZNGMNWKMC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21075638,KI,=,2511.89,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.,Bioorg. Med. Chem.,2010,18,24,"Brudeli B, Moltzau LR, Andressen KW, Krobert KA, Klaveness J, Levy FO",,697187,DTCT0023221,5017352,DTCC01017945,1445751,42157
CHEMBL1632174,P46098,,ODMLUIATXKBXOW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21075638,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.,Bioorg. Med. Chem.,2010,18,24,"Brudeli B, Moltzau LR, Andressen KW, Krobert KA, Klaveness J, Levy FO",,697187,DTCT0023221,5017418,DTCC01017961,1185873,42157
CHEMBL1641625,P46098,,AGVRILRKGQDLBR-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,2.4,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035385,DTCC01020566,604835,42619
CHEMBL1643880,P46098,PUMOSETRAG,AFUWQWYPPZFWCO-LBPRGKRZSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,22,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638,DTCT0023221,5035398,DTCC01020556,798453,42619
CHEMBL1643880,P46098,PUMOSETRAG,AFUWQWYPPZFWCO-LBPRGKRZSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,71,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825,DTCT0023221,5035410,DTCC01020556,798453,42619
CHEMBL1643880,P46098,PUMOSETRAG,AFUWQWYPPZFWCO-LBPRGKRZSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,EC50,=,5.4,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700635,DTCT0023221,5035394,DTCC01020556,798453,42619
CHEMBL1643880,P46098,PUMOSETRAG,AFUWQWYPPZFWCO-LBPRGKRZSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,EC50,=,9.2,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700639,DTCT0023221,5035406,DTCC01020556,798453,42619
CHEMBL1643881,P46098,,PPGYKWQFGNLYIY-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,35,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638,DTCT0023221,5035399,DTCC01020557,313577,42619
CHEMBL1643881,P46098,,PPGYKWQFGNLYIY-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,97,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 1 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700640,DTCT0023221,5035416,DTCC01020557,313577,42619
CHEMBL1643881,P46098,,PPGYKWQFGNLYIY-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,EC50,=,14.5,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700635,DTCT0023221,5035395,DTCC01020557,313577,42619
CHEMBL1643881,P46098,,PPGYKWQFGNLYIY-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,4.4,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035375,DTCC01020557,313577,42619
CHEMBL1643882,P46098,,PPGYKWQFGNLYIY-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 1 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700636,DTCT0023221,5035397,DTCC01020558,960317,42619
CHEMBL1643882,P46098,,PPGYKWQFGNLYIY-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 1 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700636,DTCT0023221,5035408,DTCC01020558,960317,42619
CHEMBL1643882,P46098,,PPGYKWQFGNLYIY-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,84,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 1 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700640,DTCT0023221,5035417,DTCC01020558,960317,42619
CHEMBL1643882,P46098,,PPGYKWQFGNLYIY-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,4.9,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035376,DTCC01020558,960317,42619
CHEMBL1643883,P46098,,FDKJLUOOFWBTDY-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,EC50,=,6.9,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700639,DTCT0023221,5035407,DTCC01020559,215490,42619
CHEMBL1643883,P46098,,FDKJLUOOFWBTDY-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,EC50,=,12.6,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700635,DTCT0023221,5035396,DTCC01020559,215490,42619
CHEMBL1643883,P46098,,FDKJLUOOFWBTDY-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,1.7,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035377,DTCC01020559,215490,42619
CHEMBL1643884,P46098,,FDKJLUOOFWBTDY-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,-2,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 10 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700637,DTCT0023221,5035409,DTCC01020560,2087653,42619
CHEMBL1643884,P46098,,FDKJLUOOFWBTDY-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,-2,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 10 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700641,DTCT0023221,5036540,DTCC01020560,2087653,42619
CHEMBL1643884,P46098,,FDKJLUOOFWBTDY-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,0.7,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035378,DTCC01020560,2087653,42619
CHEMBL1643885,P46098,,ZCOOWPLAEBRGOA-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,2,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035379,DTCC01020561,1024849,42619
CHEMBL1643886,P46098,,JOEZRUWANPRMKY-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,2,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035380,DTCC01020562,183378,42619
CHEMBL1643887,P46098,,JOEZRUWANPRMKY-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,1.6,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035381,DTCC01020563,734130,42619
CHEMBL1643888,P46098,,CKWOZHIVNRGMQI-KRWDZBQOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,3.6,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035382,DTCC01020564,1671980,42619
CHEMBL1643889,P46098,,CKWOZHIVNRGMQI-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,2.3,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035384,DTCC01020565,475832,42619
CHEMBL1643890,P46098,,QOGFHRRNPRRNAI-NRFANRHFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,7.1,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035386,DTCC01020567,378849,42619
CHEMBL1643891,P46098,,JCMOIELRWILJKV-FQEVSTJZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,23.4,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035387,DTCC01020569,798454,42619
CHEMBL1643892,P46098,,JCMOIELRWILJKV-HXUWFJFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,7.9,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035388,DTCC01020570,669627,42619
CHEMBL1643893,P46098,,RZKMGDNFMYZIER-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,0.9,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035389,DTCC01020571,1703834,42619
CHEMBL1643894,P46098,,RZKMGDNFMYZIER-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,0.7,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035390,DTCC01020572,1185896,42619
CHEMBL1643894,P46098,,RZKMGDNFMYZIER-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635613,DTCC01020572,1161836,64307
CHEMBL1643895,P46098,RAMOSETRON,NTHPAPBPFQJABD-LLVKDONJSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,-1,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638,DTCT0023221,5035401,DTCC01020573,540450,42619
CHEMBL1643895,P46098,RAMOSETRON,NTHPAPBPFQJABD-LLVKDONJSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,-1,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825,DTCT0023221,5035412,DTCC01020573,540450,42619
CHEMBL1643895,P46098,RAMOSETRON,NTHPAPBPFQJABD-LLVKDONJSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,KI,=,0.06,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700634,DTCT0023221,5035392,DTCC01020573,540450,42619
CHEMBL1643895,P46098,RAMOSETRON,NTHPAPBPFQJABD-LLVKDONJSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.06,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678640,DTCC01020573,528395,65052
CHEMBL1643899,P46098,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146989,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700885,DTCT0023221,5036630,DTCC01020576,166198,42620
CHEMBL1643899,P46098,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584703,DTCC01020576,168448,55935
CHEMBL1643900,P46098,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146989,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700885,DTCT0023221,5036660,DTCC01020577,942929,42620
CHEMBL1643900,P46098,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584700,DTCC01020577,945255,55935
CHEMBL1643901,P46098,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146989,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700885,DTCT0023221,5036692,DTCC01020578,1460729,42620
CHEMBL1643901,P46098,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584718,DTCC01020578,1463030,55935
CHEMBL1643902,P46098,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146989,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700885,DTCT0023221,5036724,DTCC01020579,619871,42620
CHEMBL1643902,P46098,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584714,DTCC01020579,622243,55935
CHEMBL1651095,P46098,PULICATIN A,ZVWPMYHMXUXIMC-IONNQARKSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21028889,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand displacement assay,Not Active,"Pulicatins A-E, neuroactive thiazoline metabolites from cone snail-associated bacteria.",J. Nat. Prod.,2010,73,11,"Lin Z, Antemano RR, Hughen RW, Tianero MD, Peraud O, Haygood MG, Concepcion GP, Olivera BM, Light A, Schmidt EW",,714929,DTCT0023221,5076871,DTCC01023403,1907820,43120
CHEMBL1651208,P46098,,DWTYHCYVKJONSP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23009245,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human 5HT3 at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012,55,22,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876176,DTCT0023221,11437734,DTCC01023515,317585,51586
CHEMBL1651219,P46098,,ZQBPXBADOJMCRU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23009245,INHIBITION,=,-13,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human 5HT3 at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012,55,22,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876176,DTCT0023221,11437685,DTCC01023526,1675972,51586
CHEMBL1668584,P46098,,YPVOSIDECMYMTD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21333408,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 10 uM by radioligand binding assay,Not Active,"2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,2011,46,4,"Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Mitkin OD, Tkachenko SE, Kysil VM, Okun I",,740251,DTCT0023221,5907271,DTCC01025412,943137,44130
CHEMBL1669669,P46098,RO-5212773,KLFVWQCQUXXLOU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21237643,INHIBITION,=,9,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL 43694 from human recombinant 5HT3 receptor expressed in CHO cells,,Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).,Bioorg. Med. Chem. Lett.,2011,21,4,"Stalder H, Hoener MC, Norcross RD",,716516,DTCT0023221,5105748,DTCC00033580,1557659,43309
CHEMBL1672288,P46098,,LVXAMCKZCLWWTF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21207959,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.,J. Med. Chem.,2011,54,3,"Siméon FG, Wendahl MT, Pike VW",,718858,DTCT0023221,5116559,DTCC01026954,798550,43561
CHEMBL1702607,P46098,,ADVPTQAUNPRNPO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14733126,DTCC01037443,2104825,69159
CHEMBL1738699,P46098,,YVPGZQLRPAGKLA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant 5HT3 receptor at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751207,DTCT0023221,5974923,DTCC01070772,735160,44781
CHEMBL1748,P46098,NORCISAPRIDE,OMLDMGPCWMBPAN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,EC50,=,2300,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598658,DTCT0023221,3115582,DTCC00604523,715932,36218
CHEMBL1748,P46098,NORCISAPRIDE,OMLDMGPCWMBPAN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,1600,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114457,DTCC00604523,715932,36218
CHEMBL1764,P46098,LEVOMEPROMAZINE,VRQVVMDWGGWHTJ-CQSZACIVSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,<=,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849464,DTCC00609202,1745673,34292
CHEMBL1765683,P46098,,ZVRXOXFSMYJETP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21428406,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011,54,8,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743825,DTCT0023221,5918941,DTCC01078226,652599,44302
CHEMBL1765684,P46098,,VCKIDQVWSDVZCZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21428406,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011,54,8,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743825,DTCT0023221,5918942,DTCC01078227,975211,44302
CHEMBL1770373,P46098,PF-3246799,CZWQBSKNHUVZLI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21195614,IC50,=,2300,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor,,"Pyrimido[4,5-d]azepines as potent and selective 5-HT(2C) receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence.",Bioorg. Med. Chem. Lett.,2011,21,9,"Andrews MD, Fish PV, Blagg J, Brabham TK, Brennan PE, Bridgeland A, Brown AD, Bungay PJ, Conlon KM, Edmunds NJ, Af Forselles K, Gibbons CP, Green MP, Hanton G, Holbrook M, Jessiman AS, McIntosh K, McMurray G, Nichols CL, Root JA, Storer RI, Sutton MR, Ward RV, Westbrook D, Whitlock GA",,744884,DTCT0023221,5933236,DTCC00033971,69510,44351
CHEMBL17740,P46098,,GVOCXQUIZNWEMU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,PKI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,Not Active,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090027,DTCC00147787,263506,45760
CHEMBL1774991,P46098,,YTOGOMGUCNEXIR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21520940,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT(1A) Receptor.",J. Med. Chem.,2011,54,10,"Al Hussainy R, Verbeek J, van der Born D, Braker AH, Leysen JE, Knol RJ, Booij J, Herscheid JK",,747437,DTCT0023221,5943668,DTCC01083260,1575851,44583
CHEMBL1774995,P46098,,IUEHDTRLKKNLDW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21520940,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT(1A) Receptor.",J. Med. Chem.,2011,54,10,"Al Hussainy R, Verbeek J, van der Born D, Braker AH, Leysen JE, Knol RJ, Booij J, Herscheid JK",,747437,DTCT0023221,5943667,DTCC01083264,1252166,44583
CHEMBL177611,P46098,PNU-282987,WECKJONDRAUFDD-ZDUSSCGKSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24901260,KI,=,930,NM,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin),,Recent developments in novel antidepressants targeting a4ß2-nicotinic acetylcholine receptors.,J. Med. Chem.,2014,57,20,"Yu LF, Zhang HK, Caldarone BJ, Eaton JB, Lukas RJ, Kozikowski AP",,1454480,DTCT0023221,13901941,DTCC00379668,1846517,60704
CHEMBL1783889,P46098,,DSNALXIKDKGHLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496643,DTCT0023221,14434907,DTCC01087435,1615288,62611
CHEMBL1784671,P46098,,NVCJMYLJSSPEKR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant 5HT3 receptor at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751207,DTCT0023221,5974922,DTCC01088207,184448,44781
CHEMBL1784673,P46098,,CPOQTXKWWFQYCF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant 5HT3 receptor at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751207,DTCT0023221,5974921,DTCC01088209,314586,44781
CHEMBL1784685,P46098,,APARPRRWRUIPGQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant 5HT3 receptor at 10 uM by radioligand binding assay,Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751207,DTCT0023221,5976390,DTCC01088221,1764905,44781
CHEMBL1784694,P46098,,USRJTKDRTOTPRU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant 5HT3 receptor at 10 uM by radioligand binding assay,Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751207,DTCT0023221,5976391,DTCC01088230,347293,44781
CHEMBL180101,P46098,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,>,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849458,DTCC00383453,1362971,34292
CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2145434,KI,=,0.7,NM,,,,,,,,,,,,,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,An initial three-component pharmacophore for specific serotonin-3 receptor ligands.,J. Med. Chem.,1990,33,10,"Rizzi JP, Nagel AA, Rosen T, McLean S, Seeger T",,3470,DTCT0023221,1071794,DTCC00149028,1196464,10392
CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,0.95,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14756850,DTCC00149028,2110980,68446
CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,5.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14756852,DTCC00149028,2110980,68446
CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14756851,DTCC00149028,2110980,68446
CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159,KI,=,0.39,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847,DTCT0023221,12984063,DTCC00149028,1223430,56928
CHEMBL18041,P46098,ZACOPRIDE,FEROPKNOYKURCJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159,KI,=,0.398,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847,DTCT0023221,12984028,DTCC00149028,1223430,56928
CHEMBL1812545,P46098,,JDBSZVDIUIRSDG-DAFODLJHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21726069,INHIBITION,<,10,%,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human 5HT3 receptor at 10 uM relative to control,,"Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.",J. Med. Chem.,2011,54,15,"Dolusic E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R",,762041,DTCT0023221,6053735,DTCC01099864,1959018,45491
CHEMBL1813065,P46098,,DNVBBWNTRFFIHW-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,2.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649960,DTCC01100346,898549,47502
CHEMBL1824046,P46098,,NRJJRVIMKKANAW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,PKI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,Not Active,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090029,DTCC01105796,2006347,45760
CHEMBL1824047,P46098,,WIPPGLNWEIAUEV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,KI,=,794.33,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090034,DTCC01105797,134433,45760
CHEMBL1824048,P46098,,LZFIKFXIHTZOJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,KI,=,1.58,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090040,DTCC01105798,2006348,45760
CHEMBL1824228,P46098,,RWBFCYZFACUBIZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,KI,=,1258.93,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090045,DTCC01105973,166727,45760
CHEMBL1824777,P46098,,ZHHLHBNBIKLLJG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21788137,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767207,DTCT0023221,6091857,DTCC01106515,961498,45468
CHEMBL1824778,P46098,,LPAMOYXJLQSGRI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21788137,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767207,DTCT0023221,6091856,DTCC01106516,1058448,45468
CHEMBL1824784,P46098,,HXOMGUPFBWZKBK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21788137,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767207,DTCT0023221,6091855,DTCC01106522,638709,45468
CHEMBL1824785,P46098,,ZILQWXOKQUVSTI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21788137,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767207,DTCT0023221,6091854,DTCC01106523,1640941,45468
CHEMBL182721,P46098,,XCKMSIBEVNAANY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15261283,KI,=,5248.07,NM,,,,,,,,,,,,,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.,Bioorg. Med. Chem. Lett.,2004,14,16,"Tomic M, Kundakovic M, Butorovic B, Janac B, Andric D, Roglic G, Ignjatovic D, Kostic-Rajacic S",,304007,DTCT0023221,1764678,DTCC00387104,98387,18177
CHEMBL1829335,P46098,IRDABISANT,XUKROCVZGZNGSI-CQSZACIVSA-N,1,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649959,DTCC01107613,1577250,47502
CHEMBL1834350,P46098,,XEWOFIPWWSYNAY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21866910,KI,=,10000,NM,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor,,"N'-(Arylsulfonyl)pyrazoline-1-carboxamidines as Novel, Neutral 5-Hydroxytryptamine 6 Receptor (5-HT(6)R) Antagonists with Unique Structural Features.",J. Med. Chem.,2011,54,20,"van Loevezijn A, Venhorst J, Iwema Bakker WI, de Korte CG, de Looff W, Verhoog S, van Wees JW, van Hoeve M, van de Woestijne RP, van der Neut MA, Borst AJ, van Dongen MJ, de Bruin NM, Keizer HG, Kruse CG",,771214,DTCT0023221,6116220,DTCC01109859,1655306,46048
CHEMBL183776,P46098,,QOTYCLIFPPZNAZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15261283,KI,<,10000,NM,,,,,,,,,,,,,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.,Bioorg. Med. Chem. Lett.,2004,14,16,"Tomic M, Kundakovic M, Butorovic B, Janac B, Andric D, Roglic G, Ignjatovic D, Kostic-Rajacic S",,304007,DTCT0023221,1765138,DTCC00387156,325640,18177
CHEMBL183776,P46098,,QOTYCLIFPPZNAZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,Med Chem Res,2013,22,2,,,932184,DTCT0023221,11740304,DTCC00387156,350771,51606
CHEMBL184238,P46098,URB597,ROFVXGGUISEHAM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16352709,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14740684,DTCC00000860,2107472,69711
CHEMBL184770,P46098,,IOUSMYRYFCYRJU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15261283,KI,<,10000,NM,,,,,,,,,,,,,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.,Bioorg. Med. Chem. Lett.,2004,14,16,"Tomic M, Kundakovic M, Butorovic B, Janac B, Andric D, Roglic G, Ignjatovic D, Kostic-Rajacic S",,304007,DTCT0023221,1764687,DTCC00387182,1036895,18177
CHEMBL184770,P46098,,IOUSMYRYFCYRJU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,Med Chem Res,2013,22,2,,,932184,DTCT0023221,11740306,DTCC00387182,1061574,51606
CHEMBL18772,P46098,QUIPAZINE,XRXDAJYKGWNHTQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,3.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125159,DTCC00149768,905225,23555
CHEMBL18772,P46098,QUIPAZINE,XRXDAJYKGWNHTQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,3.98,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125160,DTCC00149768,905225,23555
CHEMBL1885748,P46098,,JQSJAVBMIMDUFO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23642479,INHIBITION,=,2,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 10 uM relative to control,,Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315.,Bioorg. Med. Chem. Lett.,2013,23,12,"Coombs TC, Tanega C, Shen M, Wang JL, Auld DS, Gerritz SW, Schoenen FJ, Thomas CJ, Aubé J",,965555,DTCT0023221,12471656,DTCC01135294,545285,54833
CHEMBL189676,P46098,SURINABANT,HMXDWDSNPRNUKI-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15131245,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14758281,DTCC00396917,2111237,69827
CHEMBL19215,P46098,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20451398,ACTIVITY,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human cloned 5HT3 receptor,,Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.,Bioorg. Med. Chem.,2010,18,22,"Hooker JM, Kim SW, Reibel AT, Alexoff D, Xu Y, Shea C",,681128,DTCT0023221,3577597,DTCC00150357,296043,41784
CHEMBL1922537,P46098,USABAMYCIN A,VRTIPIUNHQTBEU-JVOXIWMLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22001031,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 25 uM,Not Active,Usabamycins A-C: new anthramycin-type analogues from a marine-derived actinomycete.,Bioorg. Med. Chem. Lett.,2011,21,23,"Sato S, Iwata F, Yamada S, Kawahara H, Katayama M",,791000,DTCT0023221,7549228,DTCC01163372,749872,46551
CHEMBL1922538,P46098,USABAMYCIN B,YZASJELCRXLHII-LFJXOHPOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22001031,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 25 uM,Not Active,Usabamycins A-C: new anthramycin-type analogues from a marine-derived actinomycete.,Bioorg. Med. Chem. Lett.,2011,21,23,"Sato S, Iwata F, Yamada S, Kawahara H, Katayama M",,791000,DTCT0023221,7549229,DTCC01163373,814229,46551
CHEMBL1922539,P46098,USABAMYCIN C,MGYWULAVXWGTIC-JVOXIWMLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22001031,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 25 uM,Not Active,Usabamycins A-C: new anthramycin-type analogues from a marine-derived actinomycete.,Bioorg. Med. Chem. Lett.,2011,21,23,"Sato S, Iwata F, Yamada S, Kawahara H, Katayama M",,791000,DTCT0023221,7549230,DTCC01163374,653111,46551
CHEMBL1922614,P46098,,UKQMQTGGUNTZKM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22029285,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of serotonin 5-HT3 receptor at 1 uM by ligand displacement assay,Not Active,"Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists.",J. Med. Chem.,2011,54,23,"Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Tkachenko SE, Okun IM",,790139,DTCT0023221,7548685,DTCC01163436,1512917,46592
CHEMBL193016,P46098,,TYAGAVRSOFABFO-VIFPVBQESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,INHIBITION,=,2.5,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851023,DTCT0023221,11361592,DTCC00398972,155272,50968
CHEMBL1939222,P46098,,HTSQRRQNKJNSLH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22191331,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of human 5HT3A receptor at 10 uM by radioligand displacement assay,,ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis.,J. Med. Chem.,2012,55,1,"Chen T, Benmohamed R, Kim J, Smith K, Amante D, Morimoto RI, Kirsch DR, Ferrante RJ, Silverman RB",,858163,DTCT0023221,11390346,DTCC01170899,931965,51183
CHEMBL1939782,P46098,,LRBQTFPUUPFJQW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22222034,INHIBITION,=,54,%,,,,,,,,,,,,,,Inhibition of 5HT3 at 10 uM,,"The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia.",Bioorg. Med. Chem. Lett.,2012,22,2,"Ho GD, Yang SW, Smotryski J, Bercovici A, Nechuta T, Smith EM, McElroy W, Tan Z, Tulshian D, McKittrick B, Greenlee WJ, Hruza A, Xiao L, Rindgen D, Mullins D, Guzzi M, Zhang X, Bleickardt C, Hodgson R",,798417,DTCT0023221,7606602,DTCC00129329,1234141,47151
CHEMBL194305,P46098,,ZQZWLJUKYOXRPN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16055331,IC50,>,1000,NM,,cell_based,,,,,,,,,,,,Inhibitory activity against 5-hydroxytryptamine 3 receptor expressed in NG 108 cells,,"2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.",Bioorg. Med. Chem. Lett.,2005,15,19,"Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H",,321408,DTCT0023221,1847927,DTCC00405026,337540,19721
CHEMBL1945843,P46098,,HBDLBTSITBUDIR-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,EC50,=,1.1,NM,,,,,,,,,,,,,,Antagonist activity at human recombinant 5HT3 receptor assessed as inhibition of RAMH-induced [35S]GTPgammaS binding,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805907,DTCT0023221,7650077,DTCC01173747,962719,47502
CHEMBL1945843,P46098,,HBDLBTSITBUDIR-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KB,=,0.3,NM,,,,,,,,,,,,,,Antagonist activity at human recombinant 5HT3 receptor assessed as inhibition of RAMH-induced [35S]GTPgammaS binding,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805907,DTCT0023221,7650079,DTCC01173747,962719,47502
CHEMBL1945843,P46098,,HBDLBTSITBUDIR-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,1.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649971,DTCC01173747,962719,47502
CHEMBL1949930,P46098,,IKXSPLZKOZXPFB-RQBPZYBGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22226656,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human 5HT3 at 10 uM,,"Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test.",Bioorg. Med. Chem. Lett.,2012,22,3,"Tripathy R, McHugh RJ, Bacon ER, Salvino JM, Morton GC, Aimone LD, Huang Z, Mathiasen JR, DiCamillo A, Huffman MJ, McKenna BA, Kopec K, Lu LD, Qian J, Angeles TS, Connors T, Spais C, Holskin B, Duzic E, Schaffhauser H, Rossé GC",,804658,DTCT0023221,7639569,DTCC01175384,653195,47384
CHEMBL195241,P46098,,ACKJXXOVSOCBPX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18181565,KI,=,5.6,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Multi-target-directed ligands to combat neurodegenerative diseases.,J. Med. Chem.,2008,51,3,"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C",,462123,DTCT0023221,2280967,DTCC00400878,1555590,25139
CHEMBL1958132,P46098,,ZSXVTCQOHADCFY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,19,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649961,DTCC01179816,1092624,47502
CHEMBL1958133,P46098,,QJAUWCVZCCDKQC-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,1.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649962,DTCC01179817,444872,47502
CHEMBL1958134,P46098,,IQDHHFRBYSXXIU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,13,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649963,DTCC01179818,1830967,47502
CHEMBL1958135,P46098,,FSIKVHPOLUUBDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,8.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649964,DTCC01179819,2025907,47502
CHEMBL1958322,P46098,,SRWDXYXZNVIWLX-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,2.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649965,DTCC01179982,414258,47502
CHEMBL1958323,P46098,,OVNSLCAMMBQZNV-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,1.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649966,DTCC01179983,315936,47502
CHEMBL1958324,P46098,,ZLVGQXFVHCGGPY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,7.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649967,DTCC01179984,1027328,47502
CHEMBL1958325,P46098,,PNKGJBPTSCNELU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,4.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649968,DTCC01179985,833451,47502
CHEMBL1958326,P46098,,FVBMQXFSNPPRRM-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649969,DTCC01179986,88882,47502
CHEMBL1958327,P46098,,ZDCLGHCQWVFXJS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,8.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649970,DTCC01179987,1734325,47502
CHEMBL1958328,P46098,,HBDLBTSITBUDIR-SFHVURJKSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,11,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649972,DTCC01179988,414259,47502
CHEMBL1958329,P46098,,XBRKSAQXTGMBRJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,7.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649973,DTCC01179989,898552,47502
CHEMBL1958330,P46098,,YNRFAWWXOCTZKF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,5.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649974,DTCC01179990,1513083,47502
CHEMBL1958331,P46098,,ZKBYTERDWDMGKM-LJQANCHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,1.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649975,DTCC01179991,704211,47502
CHEMBL1958332,P46098,,DLAXWULAMBVPFO-LJQANCHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,2.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649976,DTCC01179992,348692,47502
CHEMBL1958333,P46098,,ZROXYPDPKXBHHW-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,1.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649977,DTCC01179993,1253593,47502
CHEMBL1958334,P46098,,DACDBRYFJUJEAA-LJQANCHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22107017,KI,=,3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NAMH from human cloned 5HT3 receptor expressed in CHO cells,,"Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H3 receptor antagonists with potent cognition enhancing activity.",J. Med. Chem.,2012,55,1,"Tao M, Aimone LD, Huang Z, Mathiasen J, Raddatz R, Lyons J, Hudkins RL",,805903,DTCT0023221,7649978,DTCC01179994,1609817,47502
CHEMBL2012728,P46098,,LTQWNQOQFFXHAJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22342142,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM by radioligand displacement assay,Not Active,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,2012,22,6,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ",,811304,DTCT0023221,10426504,DTCC01227134,427664,47711
CHEMBL2012737,P46098,,NFEVAAXMHCVVQF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22342142,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM by radioligand displacement assay,Not Active,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,2012,22,6,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ",,811304,DTCT0023221,10426503,DTCC01227143,620872,47711
CHEMBL2024087,P46098,,FQIJPHXWIONJLF-JKOKRWQUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22171543,INHIBITION,=,38.3,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012,55,2,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815922,DTCT0023221,10457767,DTCC01232472,1365032,48063
CHEMBL2024089,P46098,,HGSHFGWWOPXUPH-WHOFXGATSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22171543,INHIBITION,=,23.5,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012,55,2,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815922,DTCT0023221,10457768,DTCC01232474,102538,48063
CHEMBL2024094,P46098,,NMIIKXFGCKOYRV-WHOFXGATSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22171543,INHIBITION,=,42.4,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012,55,2,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815922,DTCT0023221,10457769,DTCC01232479,1008460,48063
CHEMBL2027925,P46098,CAPESEROD,MDBNTXARNGRHEV-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12130738,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14737750,DTCC01233125,2106409,69654
CHEMBL2030622,P46098,,ITUMTGGIBOPIJQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10477991,DTCC01235111,1610661,48255
CHEMBL2030623,P46098,,HJOLMLNXMCFYQQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10478032,DTCC01235112,382111,48255
CHEMBL2030624,P46098,,MFKYGKXYJBKSQN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10478079,DTCC01235113,218663,48255
CHEMBL2030625,P46098,,JVHYCBRRZUMPEJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818146,DTCT0023221,10478181,DTCC01235114,53054,48255
CHEMBL2030626,P46098,,TWUZJTIHFYRNSV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818146,DTCT0023221,10478230,DTCC01235115,1735130,48255
CHEMBL2030627,P46098,,JJTSIVODPMDGBG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10478269,DTCC01235116,1417143,48255
CHEMBL2030628,P46098,,URNOPSHFIGOPOJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10478609,DTCC01235117,1221331,48255
CHEMBL2030629,P46098,,SRRZEMVAQOSBLB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10478656,DTCC01235118,963513,48255
CHEMBL2030630,P46098,,LCBQDWKMNGEPLD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10471507,DTCC01235119,1961153,48255
CHEMBL2030631,P46098,N-BENZYLPYRROLIDINE,CWEGCQIIDCZZED-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10478728,DTCC00041635,1993939,48255
CHEMBL2030632,P46098,N-(3-FLUOROBENZYL)PYRROLIDINE,PRKCBGIXZFUCEF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10331361,DTCC00041636,1417144,48255
CHEMBL2030633,P46098,"N-(3,4-DIMETHOXYBENZYL)PYRROLIDINE",MIZXZRHARATZMK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10478813,DTCC00041637,801620,48255
CHEMBL2030634,P46098,N-(CYCLOHEXYLMETHYL)PYRROLIDINE,ADGIWWYGVBZYMC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818146,DTCT0023221,10479209,DTCC00041638,769521,48255
CHEMBL2030635,P46098,N-(2-PHENYLETHYL)PYRROLIDINE,KLUCWWVQVUXBSE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10479252,DTCC00041639,995674,48255
CHEMBL2030636,P46098,,PXBKRGXXBYALIH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10479296,DTCC00129963,1156787,48255
CHEMBL2030637,P46098,,VBKWQJLSFFFYLC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10479379,DTCC00129964,834331,48255
CHEMBL2031737,P46098,,GPZMWOXSIRVXQW-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22313227,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012,55,5,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818810,DTCT0023221,10474250,DTCC01236182,1106160,48153
CHEMBL203627,P46098,,PUDDOANNCQNPJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125164,DTCC00417389,1345649,23555
CHEMBL203627,P46098,,PUDDOANNCQNPJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125165,DTCC00417389,1345649,23555
CHEMBL2047561,P46098,,NBIWTPBSAFCSRX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22608762,INHIBITION,=,10.6,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827288,DTCT0023221,10528259,DTCC00130266,167263,48646
CHEMBL2047570,P46098,,QXCOEFGWAUGVTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22608762,INHIBITION,=,8.3,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827288,DTCT0023221,10528278,DTCC00130275,1429720,48646
CHEMBL2047571,P46098,,JYIMWQCCVNSNJW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22608762,INHIBITION,=,0.5,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827288,DTCT0023221,10528297,DTCC01242745,1332453,48646
CHEMBL2047573,P46098,,JZHYJRPFUZJBQH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22608762,INHIBITION,=,14.1,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827288,DTCT0023221,10528316,DTCC01242747,1138570,48646
CHEMBL2047574,P46098,,NQXSFBZVBLPNCG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22608762,INHIBITION,=,25.1,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 60 mins by liquid scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012,54,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827288,DTCT0023221,10528336,DTCC01242748,524316,48646
CHEMBL2058415,P46098,,GBAMAYLRKACPQW-IZZDOVSWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296,KI,=,5916,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013,21,22,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092,DTCT0023221,12643574,DTCC01245405,545513,56290
CHEMBL2058416,P46098,,WNMPRXNFNSOTPV-LFYBBSHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296,KI,=,6178,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013,21,22,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092,DTCT0023221,12643572,DTCC01245406,545514,56290
CHEMBL2058419,P46098,,IQJBDRJDMXGXFH-OSNXYGPASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296,KI,=,656,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013,21,22,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092,DTCT0023221,12643680,DTCC01245409,1062308,56290
CHEMBL2058420,P46098,,MDTKNEDEHYXCRY-OSNXYGPASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296,KI,=,1223,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013,21,22,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092,DTCT0023221,12643652,DTCC01245410,739193,56290
CHEMBL2058426,P46098,,ORMRVPRSUUACQQ-ZLJHMRGVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296,KI,=,591,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013,21,22,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092,DTCT0023221,12643683,DTCC01245413,1963125,56290
CHEMBL2058427,P46098,,ZBFOHUZFNZHQKR-QYRFSWOLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296,KI,=,2624,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013,21,22,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092,DTCT0023221,12643606,DTCC01245414,1354102,56290
CHEMBL2059590,P46098,,ZQMXTDPQEHZTBG-KOUNCHBCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22683222,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor at 10 uM,,"Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.",Bioorg. Med. Chem. Lett.,2012,22,14,"Long DD, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Goldblum AA, Humphrey PP, Marquess DG, Shaw JP, Smith JA, Derek Turner S, Vickery RG",,829453,DTCT0023221,10537716,DTCC01246534,912602,48889
CHEMBL206666,P46098,,OSQNMWDGHFIAOM-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125494,DTCC00417470,1410574,23555
CHEMBL206666,P46098,,OSQNMWDGHFIAOM-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125495,DTCC00417470,1410574,23555
CHEMBL206666,P46098,,OSQNMWDGHFIAOM-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125172,DTCC00417470,1410574,23555
CHEMBL206666,P46098,,OSQNMWDGHFIAOM-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125173,DTCC00417470,1410574,23555
CHEMBL2086404,P46098,,VENCMHFMVFASKV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599866,DTCC01254431,1974296,50457
CHEMBL2086582,P46098,WAY-361789,LKMWIEHGNOUIAH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599886,DTCC00042481,1655940,50457
CHEMBL2086582,P46098,WAY-361789,LKMWIEHGNOUIAH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160,DTCT0023221,10599354,DTCC00042481,1655940,50457
CHEMBL2086583,P46098,,AWJOXQPKTMMFHH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599887,DTCC01253699,1494444,50457
CHEMBL2086584,P46098,,KELGFUJORMNBDM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599888,DTCC01253700,1234562,50457
CHEMBL2086584,P46098,,KELGFUJORMNBDM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160,DTCT0023221,10599355,DTCC01253700,1234562,50457
CHEMBL2086585,P46098,,JJJIVUQWUUXQLP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599889,DTCC01253701,847574,50457
CHEMBL2087337,P46098,VELUSETRAG,HXLOHDZQBKCUCR-WOZUAGRISA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959244,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor at 10 uM,,"Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.",Bioorg. Med. Chem. Lett.,2012,22,19,"Long DD, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Genov D, Goldblum AA, Humphrey PP, Jiang L, Marquess DG, Shaw JP, Smith JA, Turner SD, Vickery RG",,841635,DTCT0023221,10607097,DTCC01254336,154809,49752
CHEMBL2087421,P46098,,TYDKAHFZLFMNQX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22369198,INHIBITION,=,1,%,,cell_based,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 5 uM by cell based assay,,From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.,J. Med. Chem.,2012,55,6,"Barth M, Bondoux M, Luccarini JM, Peyrou V, Dodey P, Pruneau D, Massardier C, Paquet JL",,842013,DTCT0023221,10599265,DTCC01254414,1578316,50456
CHEMBL2087437,P46098,,HSJHANWKJLOWGS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599865,DTCC01254430,1558783,50457
CHEMBL2087438,P46098,,LOEWGPWXHKYVIM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599867,DTCC01254432,1687977,50457
CHEMBL2087439,P46098,,UDNVGXVDJIKQKN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599868,DTCC01254433,1429837,50457
CHEMBL2087440,P46098,,UQHUNGZFFQATJZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599869,DTCC01254434,102739,50457
CHEMBL2087441,P46098,,JWKYJUPITPBTSR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599870,DTCC01254435,1397699,50457
CHEMBL2087442,P46098,,UUULARAVAROYPO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599871,DTCC01254436,847577,50457
CHEMBL2087443,P46098,,BGJJEMSVLGIVLI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599872,DTCC01254437,1202066,50457
CHEMBL2087443,P46098,,BGJJEMSVLGIVLI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160,DTCT0023221,10599346,DTCC01254437,1202066,50457
CHEMBL2087444,P46098,,VAEUZWBERFNXLX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599873,DTCC01254438,297411,50457
CHEMBL2087445,P46098,,YJOREKPBKODAPH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599874,DTCC01254439,1908971,50457
CHEMBL2087445,P46098,,YJOREKPBKODAPH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160,DTCT0023221,10599347,DTCC01254439,1908971,50457
CHEMBL2087446,P46098,,GQCWFDPOTSZPCD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599875,DTCC01254440,1106331,50457
CHEMBL2087447,P46098,,POWHTVORLJYXLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599697,DTCC01254441,1461939,50457
CHEMBL2087447,P46098,,POWHTVORLJYXLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160,DTCT0023221,10599348,DTCC01254441,1461939,50457
CHEMBL2087448,P46098,,MIQNWMJNRQADMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599749,DTCC01254442,362627,50457
CHEMBL2087448,P46098,,MIQNWMJNRQADMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160,DTCT0023221,10599350,DTCC01254442,362627,50457
CHEMBL2087449,P46098,,DWJPLBZSCNLIAR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599698,DTCC01254443,459021,50457
CHEMBL2087450,P46098,,AEZVYNVHNCDBQX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599876,DTCC01254445,1461940,50457
CHEMBL2087451,P46098,,MUFOLRMJGLDINZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599877,DTCC01254446,912667,50457
CHEMBL2087452,P46098,,BRVURYNCYHYNFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599878,DTCC01254447,102740,50457
CHEMBL2087453,P46098,,RPLWNHKGFXWLSL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599879,DTCC01254448,685678,50457
CHEMBL2087453,P46098,,RPLWNHKGFXWLSL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160,DTCT0023221,10599351,DTCC01254448,685678,50457
CHEMBL2087454,P46098,,XJQFQLWVHXSRMJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599880,DTCC01254449,1461941,50457
CHEMBL2087455,P46098,,QENDQZCSFXDDOX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599881,DTCC01254450,1299908,50457
CHEMBL2087456,P46098,,LZQMVVGBOPZASC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599882,DTCC01254451,1106332,50457
CHEMBL2087456,P46098,,LZQMVVGBOPZASC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160,DTCT0023221,10599352,DTCC01254451,1106332,50457
CHEMBL2087457,P46098,,PNHTUMMCJLWVTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599883,DTCC01254452,2071504,50457
CHEMBL2087457,P46098,,PNHTUMMCJLWVTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,IC50,>,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160,DTCT0023221,10599353,DTCC01254452,2071504,50457
CHEMBL2087458,P46098,,UTZCOSNAHHZOGH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599884,DTCC01254453,1138685,50457
CHEMBL2087459,P46098,,VDQDOBJGSUGYMM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells,Not Active,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012,55,10,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842191,DTCT0023221,10599885,DTCC01254454,717999,50457
CHEMBL2104153,P46098,CYAMEMAZINE,SLFGIOIONGJGRT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12527336,KI,=,2943,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14738143,DTCC01257488,2106533,69666
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18588282,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488293,DTCT0023221,2775812,DTCC01260981,175805,30579
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18983139,IC50,=,9.4,NM,,,,,,,,,,,,,,Displacement of radiolabeled MDL 72222 from human 5HT3 receptor,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494485,DTCT0023221,2604410,DTCC01260981,166145,32034
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18983139,KI,=,6.6,NM,,,,,,,,,,,,,,Displacement of radiolabeled MDL 72222 from human 5HT3 receptor,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494485,DTCT0023221,2584078,DTCC01260981,166145,32034
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,770,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2885920,DTCC01260981,176407,34988
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,99.6,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887672,DTCC01260981,176407,34988
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21726069,KI,=,3.9,NM,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human 5HT3 receptor,,"Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.",J. Med. Chem.,2011,54,15,"Dolusic E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R",,761947,DTCT0023221,6053715,DTCC01260981,184540,45491
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23403082,IC50,=,11,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEK293 cells after 60 mins,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013,23,6,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965430,DTCT0023221,12469495,DTCC01260981,188198,54795
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23403082,INHIBITION,=,3,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEK293 cells at 10 uM after 60 mins relative to control,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013,23,6,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965635,DTCT0023221,12469563,DTCC01260981,188198,54795
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23403082,KI,=,2.5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEK293 cells after 60 mins,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013,23,6,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965430,DTCT0023221,12469429,DTCC01260981,188198,54795
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23466604,IC50,=,6.7,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by radioligand displacement assay,,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,2013,63,,"Cappelli A, Manini M, Valenti S, Castriconi F, Giuliani G, Anzini M, Brogi S, Butini S, Gemma S, Campiani G, Giorgi G, Mennuni L, Lanza M, Giordani A, Caselli G, Letari O, Makovec F",,966037,DTCT0023221,12471227,DTCC01260981,188206,54801
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23466604,KI,=,4.7,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by radioligand displacement assay,,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,2013,63,,"Cappelli A, Manini M, Valenti S, Castriconi F, Giuliani G, Anzini M, Brogi S, Butini S, Gemma S, Campiani G, Giorgi G, Mennuni L, Lanza M, Giordani A, Caselli G, Letari O, Makovec F",,966037,DTCT0023221,12471155,DTCC01260981,188206,54801
CHEMBL2107804,P46098,BEMESETRON,MNJNPLVXBISNSX-WDNDVIMCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23582449,IC50,=,4.9,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by radioligand displacement assay,,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,2013,21,10,"Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M",,964168,DTCT0023221,12465310,DTCC01260981,188193,54817
CHEMBL2151437,P46098,AZD0328,OCKIPDMKGPYYJS-ZDUSSCGKSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,12,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851154,DTCT0023221,11361450,DTCC01284531,1514594,50968
CHEMBL2151439,P46098,,TXCYUSKWBHUVEP-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,IC50,=,2.8,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3 receptor expressed in Xenopus oocyte,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851141,DTCT0023221,11361480,DTCC01284532,1546615,50968
CHEMBL2151439,P46098,,TXCYUSKWBHUVEP-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,IC50,=,32.7,NM,,cell_based,,,,,,,,,,,,Antagonist activity at 5HT3 receptor expressed in N1E115 cells,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851140,DTCT0023221,11361481,DTCC01284532,1546615,50968
CHEMBL2151439,P46098,,TXCYUSKWBHUVEP-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,2,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851149,DTCT0023221,11361473,DTCC01284532,1546615,50968
CHEMBL2151440,P46098,,GUUAJKBOCMZUJW-IBGZPJMESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,60,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851135,DTCT0023221,11361487,DTCC01284533,770173,50968
CHEMBL2151441,P46098,,PIEZNFVNSICXLK-FUHWJXTLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,INHIBITION,=,20,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851023,DTCT0023221,11361602,DTCC01284534,1157455,50968
CHEMBL2151441,P46098,,PIEZNFVNSICXLK-FUHWJXTLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365,DTCT0023221,11452778,DTCC01284534,1138922,51687
CHEMBL2151442,P46098,,WIEWCOLOPGXZDJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851023,DTCT0023221,11361606,DTCC01284535,1735816,50968
CHEMBL2151443,P46098,A-582941,GTMRUYCIJSNXGB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,150,NM,,,,,,,,,,,,,,Displacement of [3H]-BRL-43694 from human 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851187,DTCT0023221,11361438,DTCC00045081,1449663,50968
CHEMBL2151570,P46098,ABT-107,LUKNJAQKVPBDSC-SFHVURJKSA-N,1,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,INHIBITION,=,4,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851023,DTCT0023221,11361564,DTCC01284661,1449664,50968
CHEMBL2151572,P46098,ENCENICLINE,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,IC50,=,299,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361601,DTCC01284663,641412,50968
CHEMBL2151572,P46098,ENCENICLINE,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,INHIBITION,=,51,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 nM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877192,DTCT0023221,11452732,DTCC01284663,621376,51687
CHEMBL2164350,P46098,,QJFWBEXGRNKZIY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22738628,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 10 uM by radioligand binding assay,,Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.,Bioorg. Med. Chem. Lett.,2012,22,14,"Mangin F, Dilly S, Joly B, Scuvée-Moreau J, Evans J, Setola V, Roth BL, Liégeois JF",,859967,DTCT0023221,11399011,DTCC01289819,19400,49664
CHEMBL2164354,P46098,,YUOLKUGHNOWKJF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22738628,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 10 uM by radioligand binding assay,,Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.,Bioorg. Med. Chem. Lett.,2012,22,14,"Mangin F, Dilly S, Joly B, Scuvée-Moreau J, Evans J, Setola V, Roth BL, Liégeois JF",,859967,DTCT0023221,11398988,DTCC01289823,1494590,49664
CHEMBL2165447,P46098,,KZONDTNPVHWVKU-NSHDSACASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,EFFICACY,=,-0.1,%,,,,,,,,,,,,,,Displacement of [3H]LY-278584 from human recombinant 5-HT3 receptor at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,880502,DTCT0023221,11472029,DTCC01290805,912917,51811
CHEMBL2169890,P46098,,LDGNYEXMQRXXIW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,7.41,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422341,DTCC01291472,1332760,51459
CHEMBL2169964,P46098,,WWOMJAJTOOLHDS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,46.77,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422329,DTCC01291325,1008870,51459
CHEMBL2169965,P46098,,VMMHKLBVXJNMEM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,2.95,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422327,DTCC01291326,1941466,51459
CHEMBL2169966,P46098,,CFMSRRKPZHTMEX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,1.62,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422324,DTCC01291327,1719485,51459
CHEMBL2169967,P46098,,RSUDGRCQQXSDOO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,407.38,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422323,DTCC01291328,556751,51459
CHEMBL2169968,P46098,,CIBFBHWSAKKIPN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,537.03,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422322,DTCC01291329,1844701,51459
CHEMBL2169969,P46098,,VDFLDQVKOMEZEL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,13.49,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422321,DTCC01291330,1365432,51459
CHEMBL2169970,P46098,,GRQDDYOXJKSBNX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,1.45,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422319,DTCC01291331,135289,51459
CHEMBL2169971,P46098,,WJMAMTPJNQQNJJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,5.89,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422318,DTCC01291332,750463,51459
CHEMBL2169972,P46098,,YMNXOJIOGVVKPL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,218.78,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422317,DTCC01291333,685867,51459
CHEMBL2169973,P46098,,JJKSXCUVAHBTLA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,204.17,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422316,DTCC01291334,880194,51459
CHEMBL2169974,P46098,,GBRCKQVRLPIGIR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,331.13,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422315,DTCC01291335,1397859,51459
CHEMBL2169975,P46098,,FBESFXOTONWCII-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,467.74,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422345,DTCC01291336,395558,51459
CHEMBL2172192,P46098,,CHVVPMVMKPMDFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22664127,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor at 1 uM by radioligand displacement assay,Not Active,"Antagonists of 5-HT(6) receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship.",Bioorg. Med. Chem. Lett.,2012,22,13,"Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Vorobiev AA, Okun I",,863334,DTCT0023221,11411297,DTCC01293389,576450,51365
CHEMBL2177127,P46098,,IRMBVBDXXYXPEW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23098038,INHIBITION,<,20,%,,,,,,,,,,,,,,Inhibition of radioligand binding to 5HT3 at 10 uM,,Identification of Small Molecule Inhibitors of Amyloid ß-Induced Neuronal Apoptosis Acting through the Imidazoline I(2) Receptor.,J. Med. Chem.,2012,55,22,"Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P",,878139,DTCT0023221,11425895,DTCC01296149,2027620,51656
CHEMBL2179217,P46098,,ZPUAIXYROPYWKA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006002,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012,55,21,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875715,DTCT0023221,11435578,DTCC01295975,641546,51583
CHEMBL2179222,P46098,,XRDVQWJPAZZLKN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006002,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012,55,21,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875715,DTCT0023221,11435577,DTCC01295978,1028954,51583
CHEMBL2179392,P46098,,RJIRTFWCWLPHDK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23098038,INHIBITION,<,20,%,,,,,,,,,,,,,,Inhibition of radioligand binding to 5HT3 at 10 uM,,Identification of Small Molecule Inhibitors of Amyloid ß-Induced Neuronal Apoptosis Acting through the Imidazoline I(2) Receptor.,J. Med. Chem.,2012,55,22,"Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P",,878139,DTCT0023221,11425875,DTCC01296145,900186,51656
CHEMBL2179395,P46098,,JXJCCQYPULQIKT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23098038,INHIBITION,<,20,%,,,,,,,,,,,,,,Inhibition of radioligand binding to 5HT3 at 10 uM,,Identification of Small Molecule Inhibitors of Amyloid ß-Induced Neuronal Apoptosis Acting through the Imidazoline I(2) Receptor.,J. Med. Chem.,2012,55,22,"Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P",,878139,DTCT0023221,11425885,DTCC01296148,1385589,51656
CHEMBL2179529,P46098,AZD1446,GTUIQNHJSXQMKW-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22793665,INHIBITION,=,87,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 10 uM,,"Discovery of 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a Novel Highly Selective a4ß2 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,21,"Mazurov AA, Miao L, Bhatti BS, Strachan JP, Akireddy S, Murthy S, Kombo D, Xiao YD, Hammond P, Zhang J, Hauser TA, Jordan KG, Miller CH, Speake JD, Gatto GJ, Yohannes D",,872693,DTCT0023221,11445495,DTCC01296279,1106534,51509
CHEMBL2179529,P46098,AZD1446,GTUIQNHJSXQMKW-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22793665,KI,=,700,NM,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor,,"Discovery of 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a Novel Highly Selective a4ß2 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,21,"Mazurov AA, Miao L, Bhatti BS, Strachan JP, Akireddy S, Murthy S, Kombo D, Xiao YD, Hammond P, Zhang J, Hauser TA, Jordan KG, Miller CH, Speake JD, Gatto GJ, Yohannes D",,872691,DTCT0023221,11445493,DTCC01296279,1106534,51509
CHEMBL2179543,P46098,,AFIZEQKQIKDZQH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22793665,INHIBITION,=,40,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Discovery of 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a Novel Highly Selective a4ß2 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,21,"Mazurov AA, Miao L, Bhatti BS, Strachan JP, Akireddy S, Murthy S, Kombo D, Xiao YD, Hammond P, Zhang J, Hauser TA, Jordan KG, Miller CH, Speake JD, Gatto GJ, Yohannes D",,872690,DTCT0023221,11445491,DTCC01296293,70629,51509
CHEMBL2179707,P46098,,IIDIAHIVYVSCHD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23043420,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human 5HT3 at 100 uM,,"Discovery and Pharmacological Profile of New 1H-Indazole-3-carboxamide and 2H-Pyrrolo[3,4-c]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands.",J. Med. Chem.,2012,55,22,"Furlotti G, Alisi MA, Apicella C, Capezzone de Joannon A, Cazzolla N, Costi R, Cuzzucoli Crucitti G, Garrone B, Iacovo A, Magarò G, Mangano G, Miele G, Ombrato R, Pescatori L, Polenzani L, Rosi F, Vitiello M, Di Santo R",,874294,DTCT0023221,11454329,DTCC01296453,90521,51610
CHEMBL2179839,P46098,,OQFNODATXJBYQO-RBUKOAKNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,INHIBITION,=,15,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365,DTCT0023221,11452781,DTCC01296580,621377,51687
CHEMBL2179862,P46098,,HTBCXNBZJPZOBH-FCHUYYIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,INHIBITION,=,39,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365,DTCT0023221,11452780,DTCC01296603,588999,51687
CHEMBL2179862,P46098,,HTBCXNBZJPZOBH-FCHUYYIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,KI,=,18600,NM,,,,,,,,,,,,,,Inhibition of human 5HT3R,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877364,DTCT0023221,11452773,DTCC01296603,588999,51687
CHEMBL2179866,P46098,,FONCJXWMQYTPRQ-WMLDXEAASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,INHIBITION,=,14,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365,DTCT0023221,11452779,DTCC00131463,1941516,51687
CHEMBL2179877,P46098,,HMBGJHCWZLRYIN-SIKLNZKXSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,INHIBITION,=,12,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365,DTCT0023221,11452777,DTCC00131474,1844742,51687
CHEMBL2179879,P46098,,YQRNOVVTYJEJEA-GHTZIAJQSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,INHIBITION,=,22,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365,DTCT0023221,11452776,DTCC00131476,395618,51687
CHEMBL2180264,P46098,,OXKRFEWMSWPKKV-NQIIRXRSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of human 5HT3R at 10 uM,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877365,DTCT0023221,11452774,DTCC01296948,1202275,51687
CHEMBL2180835,P46098,,OUTWSZAPEGAWEL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093,IC50,>,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012,55,22,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121,DTCT0023221,11442258,DTCC01297487,1832542,51641
CHEMBL2180836,P46098,,KOTAZQOZDGBEDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093,IC50,>,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012,55,22,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121,DTCT0023221,11442257,DTCC01297488,479953,51641
CHEMBL2180837,P46098,,NBIZFEZAYLVEGQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093,PIC50,,,,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,Not Determined,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012,55,22,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121,DTCT0023221,11442215,DTCC01297489,835124,51641
CHEMBL2180838,P46098,,XXYWJJJEDMYQLQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093,PIC50,,,,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,Not Determined,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012,55,22,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121,DTCT0023221,11442214,DTCC01297490,1028975,51641
CHEMBL2180839,P46098,,OGPREQIZGSIMHW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093,PIC50,,,,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,Not Active,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012,55,22,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121,DTCT0023221,11442209,DTCC01297491,1417967,51641
CHEMBL2181166,P46098,,GDRLBCZDGQFDCZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207,KI,=,410,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012,55,22,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523,DTCT0023221,11436254,DTCC01297813,415869,51669
CHEMBL2181168,P46098,,BIAZRDQNRJRCRQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012,55,22,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523,DTCT0023221,11436191,DTCC01297815,479956,51669
CHEMBL2181169,P46098,,UWMNAFXETUEZJZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207,KI,=,1314,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012,55,22,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523,DTCT0023221,11436240,DTCC01297816,802446,51669
CHEMBL2181170,P46098,,JBPBJYKHTQKMKP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207,KI,=,641,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012,55,22,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523,DTCT0023221,11436251,DTCC01297817,1546755,51669
CHEMBL2181171,P46098,,MREMSPSMZSVSJS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207,KI,=,680,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012,55,22,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523,DTCT0023221,11436249,DTCC01297818,251880,51669
CHEMBL2181187,P46098,,OLINRUQQUFMPJJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012,55,22,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523,DTCT0023221,11436192,DTCC01297835,415870,51669
CHEMBL2181188,P46098,,GGQFEMQQQLOYIH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207,KI,=,2470,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012,55,22,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523,DTCT0023221,11436232,DTCC01297836,350378,51669
CHEMBL2181189,P46098,,KMWRABRPTOODHP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23102207,KI,=,710,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 by Cerep protocol based assay,,Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT(4) Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers.,J. Med. Chem.,2012,55,22,"Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F",,878523,DTCT0023221,11436247,DTCC01297837,1028978,51669
CHEMBL2203551,P46098,,JUWUZLUBIRHYMM-LBPRGKRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,EFFICACY,=,7,%,,,,,,,,,,,,,,Displacement of [3H]LY-278584 from human recombinant 5-HT3 receptor at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,880502,DTCT0023221,11472009,DTCC01298943,621402,51811
CHEMBL2203713,P46098,,BLZNLOLTHDUEOL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22840695,INHIBITION,=,9,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL-43694 from human recombinant 5-HT3 receptor expressed in CHO cells at 10 uM after 120 mins,,"Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.",Eur. J. Med. Chem.,2012,55,,"Annedi SC, Maddaford SP, Ramnauth J, Renton P, Rybak T, Silverman S, Rakhit S, Mladenova G, Dove P, Andrews JS, Zhang D, Porreca F",,882748,DTCT0023221,11459348,DTCC00131535,738126,51915
CHEMBL2204355,P46098,,CDEZIFKSLJMFDM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,80,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460328,DTCC01299708,1656222,51828
CHEMBL2204356,P46098,,JTQUHGRGBNXQDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,67,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460327,DTCC01299709,1812500,51828
CHEMBL2204357,P46098,,HHVBUSGGPUQAOP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,29,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460326,DTCC01299710,1202308,51828
CHEMBL2204358,P46098,,ZTLVPNGMZUOVML-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,32,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460325,DTCC01299711,1170077,51828
CHEMBL2204359,P46098,,RJOWFEDJGNNCDF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,26,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460324,DTCC01299712,2007335,51828
CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Agonist activity at human 5HT3A receptor expressed in xenopus oocytes by electrophysiological method in presence of ondansetron,Not Active,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880239,DTCT0023221,11460284,DTCC01299713,1748126,51828
CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,EC50,=,2100,NM,,cell_based,,,,,,,,,,,Oocytes,Agonist activity at human 5HT3A receptor expressed in xenopus oocytes by electrophysiological method,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880243,DTCT0023221,11460191,DTCC01299713,1748126,51828
CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,EFFICACY,=,64,%,,cell_based,,,,,,,,,,,Oocytes,Agonist activity at human 5HT3A receptor expressed in xenopus oocytes by electrophysiological method relative to 5HT,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880242,DTCT0023221,11460190,DTCC01299713,1748126,51828
CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,IC50,=,12,NM,,cell_based,,,,,,,,,,,Oocytes,Antagonist activity at human 5HT3A receptor expressed in xenopus oocytes assessed as inhibition of 5HT-induced effect by electrophysiological method,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880244,DTCT0023221,11460195,DTCC01299713,1748126,51828
CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human 5HT3A receptor at 1 uM,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880225,DTCT0023221,11459023,DTCC01299713,1748126,51828
CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,3.7,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3A receptor,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880262,DTCT0023221,11460287,DTCC01299713,1748126,51828
CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460323,DTCC01299713,1748126,51828
CHEMBL2204361,P46098,,AYFCXRDVVSZQJL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,12,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460322,DTCC01299714,1527000,51828
CHEMBL2204362,P46098,,PQZKTTYJTULMNA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,17,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460321,DTCC01299715,1397958,51828
CHEMBL2204363,P46098,,CAVNQHZFZKMWIY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,7.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460320,DTCC01299716,944409,51828
CHEMBL2204364,P46098,,SCMJERWDLBFTKH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,160,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460184,DTCC01299717,880270,51828
CHEMBL2204365,P46098,,CUKFWEYSWJQRNA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,150,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11459052,DTCC01299718,1300165,51828
CHEMBL2205031,P46098,,JSQWHKSZJJCLBC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,45,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11459051,DTCC01300293,1267718,51828
CHEMBL2205032,P46098,,IJONBIKCSKCKEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,670,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11459050,DTCC01300294,428143,51828
CHEMBL2205033,P46098,,RLFBHQCZNZAQCK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,130,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11459049,DTCC01300295,1430091,51828
CHEMBL2205034,P46098,,HJUJYONTBWEAKN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,27,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11459048,DTCC01300296,2039942,51828
CHEMBL2205035,P46098,,NHOSAEPFSIDHPV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,270,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11459047,DTCC01300297,362885,51828
CHEMBL2205036,P46098,,DGKFZZQCWFNWRZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,310,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460384,DTCC01300298,1267719,51828
CHEMBL2205037,P46098,,OIMAWSBVYIVFBR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,190,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460383,DTCC01300299,589029,51828
CHEMBL2205038,P46098,,QFTFRCOFPNGFPT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460382,DTCC01300300,1559060,51828
CHEMBL2205039,P46098,,MUIUIEFHOZRYHZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,440,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460381,DTCC01300301,847847,51828
CHEMBL2205040,P46098,,BNICWFRCIZHJEK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,260,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460380,DTCC01300302,1365525,51828
CHEMBL2205041,P46098,,RZJQKGRFQHFVDL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,64,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460379,DTCC01300303,944415,51828
CHEMBL2205042,P46098,,AAOXNOFJAOMEGO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,36,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460378,DTCC01300304,135366,51828
CHEMBL2205043,P46098,,XUMDENDMRHWGGR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,36,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460377,DTCC01300305,589030,51828
CHEMBL2205044,P46098,,XJSIHFKFXLFZEG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,53,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460376,DTCC01300306,1909229,51828
CHEMBL2205045,P46098,,TYKBKDLIAKRVRZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,56,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460375,DTCC01300307,330301,51828
CHEMBL2205046,P46098,,YTJNKAUGQNPJTI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,140,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460374,DTCC01300308,1267720,51828
CHEMBL2205047,P46098,,JBYIRSHDOBNQGW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,450,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460373,DTCC01300309,1202316,51828
CHEMBL2205048,P46098,,SIKLZAAJSXLXIN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,62,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460335,DTCC01300310,17960,51828
CHEMBL2205049,P46098,,YTAWEBKOATVAHD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,64,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460334,DTCC00131593,1719575,51828
CHEMBL2205050,P46098,,MLLYZTIIRALMMQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,52,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460333,DTCC00131594,232056,51828
CHEMBL2205051,P46098,,FSPHPGLLPWMVAT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,32,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460332,DTCC01300311,685957,51828
CHEMBL2205052,P46098,,QUHLMVHMAHPVMC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,86,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460331,DTCC01300312,685958,51828
CHEMBL2205053,P46098,,JNDJUERZLVTHAV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,110,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460330,DTCC01300313,589031,51828
CHEMBL2205054,P46098,,VHKBDODTXKHVJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,33,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460329,DTCC01300314,1332854,51828
CHEMBL2205360,P46098,,UGKUXKJKFRZEQP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435,INHIBITION,=,7.3,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor at 10 uM after 1.5 hrs by scintillation counting analysis,,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012,20,23,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884965,DTCT0023221,11458697,DTCC01300594,317632,51993
CHEMBL2205360,P46098,,UGKUXKJKFRZEQP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435,KI,,,,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor after 1.5 hrs by scintillation counting analysis,Not Determined,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012,20,23,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884851,DTCT0023221,11458646,DTCC01300594,317632,51993
CHEMBL2205361,P46098,,CTMDNCSJPPQMLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435,INHIBITION,=,2.9,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor at 10 uM after 1.5 hrs by scintillation counting analysis,,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012,20,23,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884965,DTCT0023221,11458698,DTCC01300595,1449840,51993
CHEMBL2205361,P46098,,CTMDNCSJPPQMLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435,KI,,,,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor after 1.5 hrs by scintillation counting analysis,Not Determined,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012,20,23,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884851,DTCT0023221,11458647,DTCC01300595,1449840,51993
CHEMBL2205362,P46098,,RQJPWNOKFLOHKI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435,INHIBITION,=,64.2,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor at 10 uM after 1.5 hrs by scintillation counting analysis,,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012,20,23,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884965,DTCT0023221,11458677,DTCC01300596,1546783,51993
CHEMBL2205362,P46098,,RQJPWNOKFLOHKI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23084435,KI,=,7612,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor after 1.5 hrs by scintillation counting analysis,,Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors.,Bioorg. Med. Chem.,2012,20,23,"Marriott KS, Morrison AZ, Moore M, Olubajo O, Stewart LE",,884851,DTCT0023221,11458651,DTCC01300596,1546783,51993
CHEMBL2205811,P46098,,ZKOQRCXMSDAJIR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11474528,DTCC01301027,1267730,51935
CHEMBL2205812,P46098,,TWMXGXSGGIIQDM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11474510,DTCC01301028,556858,51935
CHEMBL2205813,P46098,,FOTUXOOYRRRHFQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11474490,DTCC01301029,1688236,51935
CHEMBL2205814,P46098,,KULMFBVVFDTVNX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11474457,DTCC01301030,1623988,51935
CHEMBL2205816,P46098,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11474430,DTCC01301032,880294,51935
CHEMBL2205816,P46098,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584706,DTCC01301032,881049,55935
CHEMBL2205817,P46098,,GFQHCUYWLHSGJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11474406,DTCC01301033,912942,51935
CHEMBL2205823,P46098,,WWXCWTRLUXMAHX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11475950,DTCC01301039,1780156,51935
CHEMBL2205824,P46098,,LIKZWSUAMNZHAE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11475925,DTCC01301040,1688238,51935
CHEMBL2205825,P46098,,GYKFQDQFKGGVKD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11475898,DTCC01301041,750568,51935
CHEMBL2205827,P46098,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11475874,DTCC01301043,1812524,51935
CHEMBL2205827,P46098,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584708,DTCC01301043,1813367,55935
CHEMBL2205829,P46098,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11475850,DTCC01301045,330310,51935
CHEMBL2205829,P46098,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584705,DTCC01301045,331095,55935
CHEMBL2205832,P46098,,ZUHLFYHHSNMSRE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11475822,DTCC01301048,589038,51935
CHEMBL2205833,P46098,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11475784,DTCC01301049,2039955,51935
CHEMBL2205833,P46098,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584707,DTCC01301049,2040747,55935
CHEMBL2205836,P46098,,PSBBAGWMKGXQRW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884079,DTCT0023221,11475753,DTCC01301052,1041425,51935
CHEMBL2206397,P46098,RO-4992479,NIRASHDWADNQJU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22795332,INHIBITION,=,-6,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 10 uM by CEREP assay,,Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012.,Bioorg. Med. Chem. Lett.,2012,22,16,"Galley G, Stalder H, Goergler A, Hoener MC, Norcross RD",,881961,DTCT0023221,11478596,DTCC00045622,835169,51910
CHEMBL2207376,P46098,,MJYQMQCVUXOIFY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23141912,INHIBITION,=,19.92,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012,22,24,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886896,DTCT0023221,11493441,DTCC01302559,750581,52134
CHEMBL2207382,P46098,,MBFLODNVCSXSKE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23141912,INHIBITION,=,8.93,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012,22,24,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886896,DTCT0023221,11493440,DTCC01302565,1041441,52134
CHEMBL2207386,P46098,,AGKMPGSBLMAGAX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23141912,INHIBITION,=,18.82,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012,22,24,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886896,DTCT0023221,11493443,DTCC01302569,718295,52134
CHEMBL2207388,P46098,,CULSPSVPJXBZMJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23141912,INHIBITION,=,6.73,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012,22,24,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886896,DTCT0023221,11493442,DTCC01302571,814971,52134
CHEMBL220808,P46098,SARIZOTAN,HKFMQJUJWSFOLY-OAQYLSRUSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18181565,IC50,<,6,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Multi-target-directed ligands to combat neurodegenerative diseases.,J. Med. Chem.,2008,51,3,"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C",,462123,DTCT0023221,2280978,DTCC00439481,1296638,25139
CHEMBL223331,P46098,KKHT-10608,YKQRXGQZAGVEJY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,2400,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887680,DTCC00002546,1885925,34988
CHEMBL223331,P46098,KKHT-10608,YKQRXGQZAGVEJY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,107.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887655,DTCC00002546,1885925,34988
CHEMBL223387,P46098,,XKRVOMXWYNEPTN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,1400,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887682,DTCC00447015,37738,34988
CHEMBL223387,P46098,,XKRVOMXWYNEPTN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,103.1,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887657,DTCC00447015,37738,34988
CHEMBL223715,P46098,KKHT-10612,RLQXOTMOPGYNGI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,800,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887684,DTCC00002548,1211131,34988
CHEMBL223715,P46098,KKHT-10612,RLQXOTMOPGYNGI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,96.4,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887659,DTCC00002548,1211131,34988
CHEMBL223951,P46098,KKHT-10617,FIJJTIJVCAYUQE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,2100,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887688,DTCC00002553,1536021,34988
CHEMBL223951,P46098,KKHT-10617,FIJJTIJVCAYUQE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,96,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887663,DTCC00002553,1536021,34988
CHEMBL224008,P46098,,ISRIWKVGGLFNBT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,2700,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887683,DTCC00111170,727227,34988
CHEMBL224008,P46098,,ISRIWKVGGLFNBT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,107.4,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887658,DTCC00111170,727227,34988
CHEMBL224159,P46098,KKHT-10109,JXEWFPXPEYRYSN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,19800,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887674,DTCC00002555,1726697,34988
CHEMBL224159,P46098,KKHT-10109,JXEWFPXPEYRYSN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,80,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887649,DTCC00002555,1726697,34988
CHEMBL224160,P46098,KKHT-11118,FXRGLPUKLPILJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,2800,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2885914,DTCC00002557,727237,34988
CHEMBL224160,P46098,KKHT-11118,FXRGLPUKLPILJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,104,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887666,DTCC00002557,727237,34988
CHEMBL224227,P46098,KKHT-20718,YMGCQAHDDYCKLB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,11600,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2885917,DTCC00002561,1950838,34988
CHEMBL224227,P46098,KKHT-20718,YMGCQAHDDYCKLB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,85.7,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887669,DTCC00002561,1950838,34988
CHEMBL224246,P46098,KKHT-20918,IWAHUQRZIUVMSG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,5700,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2885919,DTCC00002563,1697132,34988
CHEMBL224246,P46098,KKHT-20918,IWAHUQRZIUVMSG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,98.2,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887671,DTCC00002563,1697132,34988
CHEMBL224310,P46098,KKHT-20218,WLYLIKBNGQZDFH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,1300,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2885915,DTCC00002556,856886,34988
CHEMBL224310,P46098,KKHT-20218,WLYLIKBNGQZDFH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,52.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887667,DTCC00002556,856886,34988
CHEMBL224389,P46098,KKHT-10603,NVNVERQZWUUANS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,1900,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887677,DTCC00002559,1083040,34988
CHEMBL224389,P46098,KKHT-10603,NVNVERQZWUUANS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,107.9,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887652,DTCC00002559,1083040,34988
CHEMBL224641,P46098,KKHT-20713,CVIIPJUPHIOKNG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,5900,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2885916,DTCC00002564,1950849,34988
CHEMBL224641,P46098,KKHT-20713,CVIIPJUPHIOKNG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,86.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887668,DTCC00002564,1950849,34988
CHEMBL224648,P46098,KKHT-10118,KINBZTGMJRQTER-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,15800,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887675,DTCC00002558,1789145,34988
CHEMBL224648,P46098,KKHT-10118,KINBZTGMJRQTER-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,78.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887650,DTCC00002558,1789145,34988
CHEMBL224701,P46098,KKHT-10606,DPMQWTNICFCLFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,1600,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887678,DTCC00002560,1017971,34988
CHEMBL224701,P46098,KKHT-10606,DPMQWTNICFCLFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,100.6,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887653,DTCC00002560,1017971,34988
CHEMBL224766,P46098,KKHT-10615,DWGFHYJCLFQFTA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,2200,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887687,DTCC00002552,1821673,34988
CHEMBL224766,P46098,KKHT-10615,DWGFHYJCLFQFTA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,103.2,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887662,DTCC00002552,1821673,34988
CHEMBL224778,P46098,KKHT-10609,PYCLIFABZLPONX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,1900,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887681,DTCC00002547,1276680,34988
CHEMBL224778,P46098,KKHT-10609,PYCLIFABZLPONX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,104.6,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887656,DTCC00002547,1276680,34988
CHEMBL225484,P46098,KKHT-10607,JRKIQFPYQPIURM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,2100,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887679,DTCC00002544,823981,34988
CHEMBL225484,P46098,KKHT-10607,JRKIQFPYQPIURM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,100.2,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887654,DTCC00002544,823981,34988
CHEMBL225485,P46098,KKHT-11018,FKCDNDBJVOQPJB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,13600,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887690,DTCC00002545,953339,34988
CHEMBL225485,P46098,KKHT-11018,FKCDNDBJVOQPJB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,104,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887665,DTCC00002545,953339,34988
CHEMBL225543,P46098,KKHT-10613,NNJAFUNKEIDAAF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,2000,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887685,DTCC00002549,339411,34988
CHEMBL225543,P46098,KKHT-10613,NNJAFUNKEIDAAF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,98.8,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887660,DTCC00002549,339411,34988
CHEMBL225600,P46098,KKHT-10614,FALASSBEVXPICK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,2200,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887686,DTCC00002550,791496,34988
CHEMBL225600,P46098,KKHT-10614,FALASSBEVXPICK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,103.7,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887661,DTCC00002550,791496,34988
CHEMBL225601,P46098,KKHT-10618,BKSKSEWIBBBRSQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,3300,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887689,DTCC00002554,1885927,34988
CHEMBL225601,P46098,KKHT-10618,BKSKSEWIBBBRSQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,106.4,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887664,DTCC00002554,1885927,34988
CHEMBL226335,P46098,RUTIN,IKGXIBQEEMLURG-NVPNHPEKSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14750338,DTCC00448737,2109891,69275
CHEMBL22778,P46098,UH-301,FNKBVTBXFLSTPB-LBPRGKRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561,KI,=,2690,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14743178,DTCC01739164,2108309,68785
CHEMBL2298806,P46098,,OTPPYWCIUOIPCN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5248.07,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,Med Chem Res,2013,22,2,,,932184,DTCT0023221,11738843,DTCC01333520,1094659,51606
CHEMBL229998,P46098,,HCPLJHRNFWGIEM-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125510,DTCC00457685,795055,23555
CHEMBL229998,P46098,,HCPLJHRNFWGIEM-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125511,DTCC00457685,795055,23555
CHEMBL229998,P46098,,HCPLJHRNFWGIEM-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,23000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125188,DTCC00457685,795055,23555
CHEMBL229998,P46098,,HCPLJHRNFWGIEM-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,25118.86,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125189,DTCC00457685,795055,23555
CHEMBL229999,P46098,,AKEMSLQKCWUTEN-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125492,DTCC00457692,244448,23555
CHEMBL229999,P46098,,AKEMSLQKCWUTEN-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125493,DTCC00457692,244448,23555
CHEMBL229999,P46098,,AKEMSLQKCWUTEN-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125170,DTCC00457692,244448,23555
CHEMBL229999,P46098,,AKEMSLQKCWUTEN-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125171,DTCC00457692,244448,23555
CHEMBL230951,P46098,L-HOMOCYSTEATE,VBOQYPQEPHKASR-VKHMYHEASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14730879,DTCC00002972,2104237,69159
CHEMBL230952,P46098,,RATRRVRGHOXNQU-USTOHRNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125522,DTCC00457678,2052137,23555
CHEMBL230952,P46098,,RATRRVRGHOXNQU-USTOHRNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125523,DTCC00457678,2052137,23555
CHEMBL230952,P46098,,RATRRVRGHOXNQU-USTOHRNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,15000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125201,DTCC00457678,2052137,23555
CHEMBL230952,P46098,,RATRRVRGHOXNQU-USTOHRNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,15848.93,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125202,DTCC00457678,2052137,23555
CHEMBL2309589,P46098,,GSAVAAKDTVSQKT-MUJYYYPQSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,1.89,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211383,DTCC01334813,1504291,37125
CHEMBL231047,P46098,TOXIFERINE,UAMHUVZCGJSLHZ-ICRMOYGQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125490,DTCC00457693,127806,23555
CHEMBL231047,P46098,TOXIFERINE,UAMHUVZCGJSLHZ-ICRMOYGQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125491,DTCC00457693,127806,23555
CHEMBL231047,P46098,TOXIFERINE,UAMHUVZCGJSLHZ-ICRMOYGQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125168,DTCC00457693,127806,23555
CHEMBL231047,P46098,TOXIFERINE,UAMHUVZCGJSLHZ-ICRMOYGQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125169,DTCC00457693,127806,23555
CHEMBL231056,P46098,,MBYMMLFMGIPHJE-CGYIOGRBSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,3981.07,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125519,DTCC00457680,924516,23555
CHEMBL231056,P46098,,MBYMMLFMGIPHJE-CGYIOGRBSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,4400,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125518,DTCC00457680,924516,23555
CHEMBL231056,P46098,,MBYMMLFMGIPHJE-CGYIOGRBSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,2511.89,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125198,DTCC00457680,924516,23555
CHEMBL231056,P46098,,MBYMMLFMGIPHJE-CGYIOGRBSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,2700,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125197,DTCC00457680,924516,23555
CHEMBL232104,P46098,,BRIVIXLMMUIBJY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17606674,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,Not Active,"Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.",Antimicrob. Agents Chemother.,2007,51,10,"Van Voorhis WC, Rivas KL, Bendale P, Nallan L, Hornéy C, Barrett LK, Bauer KD, Smart BP, Ankala S, Hucke O, Verlinde CL, Chakrabarti D, Strickland C, Yokoyama K, Buckner FS, Hamilton AD, Williams DK, Lombardo LJ, Floyd D, Gelb MH",,498966,DTCT0023221,2717305,DTCC00461356,1166865,34114
CHEMBL2322133,P46098,,FBGLUXQASNAMOM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23265874,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Binding affinity to C-terminal-His6-tagged 5HT3A receptor (unknown origin) expressed in HEK293 cells assessed as decrease in fluorescence at 10 to 500 nM after 2 hrs by fluorimetric analysis in presence of granisetron,Not Active,Near native binding of a fluorescent serotonin conjugate to serotonin type 3 receptors.,Bioorg. Med. Chem. Lett.,2013,23,3,"Silva-Lopez EI, Barden AO, Brozik JA",,940561,DTCT0023221,11790396,DTCC01340489,1656625,53514
CHEMBL2322133,P46098,,FBGLUXQASNAMOM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23265874,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Binding affinity to C-terminal-His6-tagged 5HT3A receptor (unknown origin) expressed in HEK293 cells assessed as decrease in fluorescence at 10 to 500 nM after 2 hrs by fluorimetric analysis,Active,Near native binding of a fluorescent serotonin conjugate to serotonin type 3 receptors.,Bioorg. Med. Chem. Lett.,2013,23,3,"Silva-Lopez EI, Barden AO, Brozik JA",,940562,DTCT0023221,11790397,DTCC01340489,1656625,53514
CHEMBL2322133,P46098,,FBGLUXQASNAMOM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23265874,KD,=,83,NM,,cell_based,,,,,,,,,,,HEK293,Binding affinity to C-terminal-His6-tagged 5HT3A receptor (unknown origin) expressed in HEK293 cells after 2 hrs by fluorimetric analysis,,Near native binding of a fluorescent serotonin conjugate to serotonin type 3 receptors.,Bioorg. Med. Chem. Lett.,2013,23,3,"Silva-Lopez EI, Barden AO, Brozik JA",,940560,DTCT0023221,11790395,DTCC01340489,1656625,53514
CHEMBL2326501,P46098,,KRCLPAGVJVBLJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23237837,INHIBITION,=,7,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5-HT3 receptor expressed in CHO cells at 1 uM,,Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties.,Bioorg. Med. Chem. Lett.,2013,23,2,"Butini S, Gemma S, Brindisi M, Maramai S, Minetti P, Celona D, Napolitano R, Borsini F, Cabri W, Fezza F, Merlini L, Dallavalle S, Campiani G, Maccarrone M",,939655,DTCT0023221,11784459,DTCC01344807,1353507,53501
CHEMBL2332488,P46098,,RQAGIIPBHMAHTO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23414838,IC50,=,19000,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor (unknown origin),,Discovery of a novel series of quinolone a7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2013,23,6,"McDonald IM, Mate RA, Zusi FC, Huang H, Post-Munson DJ, Ferrante MA, Gallagher L, Bertekap RL, Knox RJ, Robertson BJ, Harden DG, Morgan DG, Lodge NJ, Dworetzky SI, Olson RE, Macor JE",,943354,DTCT0023221,11831081,DTCC01346119,1515397,54050
CHEMBL2335706,P46098,MARISTACHONE A,VGUIDVOAJKITDB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23268694,INHIBITION,,,,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) at 10 uM,Not Active,Unprecedented Polyketides from a Marine Sponge-Associated Stachylidium sp.,J. Nat. Prod.,2013,76,3,"Almeida C, Eguereva E, Kehraus S, König GM",,942212,DTCT0023221,11820894,DTCC01349130,964975,53803
CHEMBL238805,P46098,,ZXWKLBTWUHVMTO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17765553,INHIBITION,=,6.8,%,,cell_based,,,,,,,,,,,,Inhibition of human 5HT3 expressed in COS7 cells at 10 uM,,"The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine.",Bioorg. Med. Chem.,2007,15,21,"Welch JT, Lim DS",,449347,DTCT0023221,2188275,DTCC00473634,844044,23869
CHEMBL238806,P46098,,VUYJMSFPKOVHFI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17765553,INHIBITION,=,14.6,%,,cell_based,,,,,,,,,,,,Inhibition of human 5HT3 expressed in COS7 cells at 10 uM,,"The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine.",Bioorg. Med. Chem.,2007,15,21,"Welch JT, Lim DS",,449347,DTCT0023221,2188265,DTCC00473636,1037684,23869
CHEMBL2391147,P46098,,ZTGRWYMPQCQTHD-ONGXEEELSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23582449,INHIBITION,=,-1,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 10 uM by radioligand displacement assay relative to control,,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,2013,21,10,"Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M",,964357,DTCT0023221,12465381,DTCC01378839,220399,54817
CHEMBL2391541,P46098,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23602445,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor expressed in HEK293T cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965131,DTCT0023221,12465428,DTCC01379235,1386484,54821
CHEMBL2392692,P46098,,PVTFEAGMCGMRRS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23664879,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 1 uM relative to control,,"Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase.",Bioorg. Med. Chem. Lett.,2013,23,12,"Thalji RK, McAtee JJ, Belyanskaya S, Brandt M, Brown GD, Costell MH, Ding Y, Dodson JW, Eisennagel SH, Fries RE, Gross JW, Harpel MR, Holt DA, Israel DI, Jolivette LJ, Krosky D, Li H, Lu Q, Mandichak T, Roethke T, Schnackenberg CG, Schwartz B, Shewchuk LM, Xie W, Behm DJ, Douglas SA, Shaw AL, Marino JP",,965581,DTCT0023221,12464859,DTCC01380390,1353885,54882
CHEMBL239434,P46098,,YGBSUVPUXAMOTQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17765553,INHIBITION,=,-6.1,%,,cell_based,,,,,,,,,,,,Inhibition of human 5HT3 expressed in COS7 cells at 10 uM,,"The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine.",Bioorg. Med. Chem.,2007,15,21,"Welch JT, Lim DS",,449347,DTCT0023221,2188291,DTCC00473635,8671,23869
CHEMBL2397268,P46098,,JAKRIQWSQWQJHM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23627311,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of serotonin 5-HT3 receptor (unknown origin) at 5 uM by psychoactive drug screening programme assay,,Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.,J. Med. Chem.,2013,56,13,"Santangelo Freel RM, Ogden KK, Strong KL, Khatri A, Chepiga KM, Jensen HS, Traynelis SF, Liotta DC",,968919,DTCT0023221,12483490,DTCC01381880,1353904,54936
CHEMBL2401750,P46098,,LPYIFDLQYWSXGD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,100000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504356,DTCC01384536,1009644,55103
CHEMBL2402887,P46098,,SMJJKUKILIABKV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,50118.72,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504377,DTCC01384518,2008041,55103
CHEMBL2402888,P46098,,APHNFVMFNAFHIP-SKDQJUDHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,19952.62,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504376,DTCC01384519,1592082,55103
CHEMBL2402889,P46098,,ZMWMLWGNIHSFEN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,63095.73,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504375,DTCC01384520,815642,55103
CHEMBL2402890,P46098,,RGFKOYDSKUBPIE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,79432.82,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504372,DTCC01384521,1202977,55103
CHEMBL2402891,P46098,,XSOUQQFRYGKIGJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,79432.82,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504370,DTCC01384522,622091,55103
CHEMBL2402892,P46098,,GKXVRBQVTDCQMA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,50118.72,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504369,DTCC01384523,718937,55103
CHEMBL2402893,P46098,,RCBBDNFCXSBDIT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,39810.72,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504368,DTCC01384524,103708,55103
CHEMBL2402894,P46098,,RXKLPZCVAQKBQA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,7943.28,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504367,DTCC01384525,622092,55103
CHEMBL2402895,P46098,,OPWPTXBWGBOQAM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,15848.93,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504366,DTCC01384526,1877707,55103
CHEMBL2402896,P46098,,LTNICOZLLWAENB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,1258.93,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504365,DTCC01384527,525389,55103
CHEMBL2402897,P46098,,HXAMYUTYZROIIP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,100000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504364,DTCC01384528,428804,55103
CHEMBL2402898,P46098,,VGWMVWNOQKELRE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,79432.82,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504363,DTCC01384529,718938,55103
CHEMBL2402899,P46098,,JHISKEZJFUUGOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,39810.72,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504362,DTCC01384530,1009643,55103
CHEMBL2402900,P46098,,INMZEMMKDSQLJN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,79432.82,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504361,DTCC01384531,1942199,55103
CHEMBL2402901,P46098,,HKJSZEAARPYKSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,50118.72,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504360,DTCC01384532,1656889,55103
CHEMBL2402902,P46098,,SWAXUQYHWXHRRQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,63095.73,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504359,DTCC01384533,428805,55103
CHEMBL2402903,P46098,,HRBNJCZQEOOCBP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,100000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504358,DTCC01384534,71333,55103
CHEMBL2402904,P46098,,MZOITCJKGUIQEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of serotonin 5-HT3A receptor (unknown origin) at 1 uM,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971577,DTCT0023221,12504308,DTCC01384535,589690,55103
CHEMBL2402904,P46098,,MZOITCJKGUIQEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,100000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504357,DTCC01384535,589690,55103
CHEMBL2413154,P46098,,MEKSQRMXWZHFIP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17221184,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14727705,DTCC01388348,2103458,69253
CHEMBL2418364,P46098,,RIYSYRWQPZAUDK-CAZKFNJPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23932792,INHIBITION,=,90,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor by radioligand binding assay,,"Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1.",Bioorg. Med. Chem. Lett.,2013,23,18,"Manka JT, Rodriguez AL, Morrison RD, Venable DF, Cho HP, Blobaum AL, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Emmitte KA",,979647,DTCT0023221,12546515,DTCC01391044,1644771,55622
CHEMBL2426072,P46098,,ZQRQLCVEOGQBJA-BUHFOSPRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23909910,INHIBITION,=,95,%,,cell_based,,,,,,,,,,,Oocytes,Inhibition of serotonin 5-HT3A receptor (unknown origin) expressed in Xenopus laevis oocytes assessed as inhibition of serotonin-induced current at 3 uM by two-electrode voltage clamp method,,Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists.,J. Med. Chem.,2013,56,16,"Acker TM, Khatri A, Vance KM, Slabber C, Bacsa J, Snyder JP, Traynelis SF, Liotta DC",,983724,DTCT0023221,12584029,DTCC01395097,1909990,55762
CHEMBL2426097,P46098,,PXQFOMCFQUXMBP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23909910,INHIBITION,=,95,%,,cell_based,,,,,,,,,,,Oocytes,Inhibition of serotonin 5-HT3A receptor (unknown origin) expressed in Xenopus laevis oocytes assessed as inhibition of serotonin-induced current at 3 uM by two-electrode voltage clamp method,,Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists.,J. Med. Chem.,2013,56,16,"Acker TM, Khatri A, Vance KM, Slabber C, Bacsa J, Snyder JP, Traynelis SF, Liotta DC",,983724,DTCT0023221,12584192,DTCC01395123,1877816,55762
CHEMBL2429890,P46098,,VGYQUDBPYFLBLJ-PTCVETCVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584697,DTCC01398005,1268545,55935
CHEMBL2431120,P46098,,SWEOAXMICIJCQC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1000,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,ACS Med. Chem. Lett.,2013,4,9,,,986342,DTCT0023221,12586272,DTCC01397077,771298,55848
CHEMBL2432038,P46098,,OKCSFONJDXUZOU-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584696,DTCC01398006,913793,55935
CHEMBL2432039,P46098,,CHZUEGVOEFMIJH-ZKRSMWHSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584695,DTCC01398007,1845582,55935
CHEMBL2432040,P46098,,MPBJQDFYALBXED-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584727,DTCC01398008,1139742,55935
CHEMBL2432041,P46098,,MSTPNDDVMWUDFF-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584726,DTCC01398009,71453,55935
CHEMBL2432042,P46098,,LNTMHZZRTAQEJQ-CPVTZQMHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584725,DTCC01398010,589816,55935
CHEMBL2432043,P46098,,LKFSLMWAVKMONG-KPCGFGSOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584724,DTCC01398011,2040745,55935
CHEMBL2432044,P46098,,IDXFKHDXIHNWAI-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584723,DTCC01398012,2040746,55935
CHEMBL2432045,P46098,,ZWCQZHOWEDKJBN-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584704,DTCC01398013,1657028,55935
CHEMBL2432046,P46098,,KNBHNNRMMAKKFI-SEDVZXITSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584702,DTCC01398014,1009784,55935
CHEMBL2432048,P46098,,KBAKPEFQDPCCTP-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584701,DTCC01398016,1495532,55935
CHEMBL2432049,P46098,,DUZKXKAAUHDBQA-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584699,DTCC01398017,298486,55935
CHEMBL2432051,P46098,,CPLYGLAQLNAQOI-SEDVZXITSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584698,DTCC01398019,71454,55935
CHEMBL2432052,P46098,,SGFPDDMJMPKKTB-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584722,DTCC01398020,783458,55935
CHEMBL2432053,P46098,,DEOOAAFCKARVDM-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584721,DTCC01398021,751332,55935
CHEMBL2432054,P46098,,QQUOSDRKLSIRED-DKSPCFMDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584720,DTCC01398022,945256,55935
CHEMBL2432055,P46098,,VNGQWOKKSKAESQ-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584719,DTCC01398023,2040748,55935
CHEMBL2432056,P46098,,JHFKLSFCMAHSDK-LLOIJXFCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584717,DTCC01398024,103846,55935
CHEMBL2432057,P46098,,QHQJBDOHEUWLBB-CAUKCHDASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584716,DTCC01398025,71455,55935
CHEMBL2432058,P46098,,MJOVYQVAQIHDSE-DKSPCFMDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584715,DTCC01398026,2008169,55935
CHEMBL2432059,P46098,,YLVXPEMITKSDOS-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584713,DTCC01398027,2008170,55935
CHEMBL2432060,P46098,,CKFQOWSPJPMWEK-IINHSQADSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584712,DTCC01398028,1235634,55935
CHEMBL2432061,P46098,,ZFZXJOHWFSRUAO-LLOIJXFCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584711,DTCC01398029,1720366,55935
CHEMBL2432062,P46098,,SSQDVMAIIMMISV-SEDVZXITSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584710,DTCC01398030,1780918,55935
CHEMBL2432063,P46098,,BMHWWKPJPARTBN-RAOGCBAWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985322,DTCT0023221,12584709,DTCC01398031,331096,55935
CHEMBL2436555,P46098,,QFNMPNWOYBWECY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24035337,KI,=,34,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin) expressed in mouse/rat NG108-15 cells after 30 mins by by liquid scintillation counting analysis,,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013,23,21,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988339,DTCT0023221,12618341,DTCC01399574,71471,56006
CHEMBL2436555,P46098,,QFNMPNWOYBWECY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24035337,KI,=,80,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in African green monkey COS cells after 90 mins by scintillation counting analysis,,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013,23,21,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988332,DTCT0023221,12618334,DTCC01399574,71471,56006
CHEMBL2436555,P46098,,QFNMPNWOYBWECY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24035337,PKI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in African green monkey COS cells after 90 mins by scintillation counting analysis,Not Determined,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013,23,21,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988332,DTCT0023221,12618278,DTCC01399574,71471,56006
CHEMBL243712,P46098,AMISULPRIDE,NTJOBXMMWNYJFB-UHFFFAOYSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19337725,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14728346,DTCC00458164,2103595,69290
CHEMBL2440659,P46098,,AXVLPJHYYFHCHK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24074843,INHIBITION,>,35,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]-GR-65630 from human recombinant 5-HT3 receptor expressed in HEK293 cells at 10 uM relative to control,,Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.,Bioorg. Med. Chem. Lett.,2013,23,21,"Felts AS, Rodriguez AL, Morrison RD, Venable DF, Manka JT, Bates BS, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Emmitte KA",,990310,DTCT0023221,12632825,DTCC01401025,1592232,56261
CHEMBL2442940,P46098,,INPPXFAIFVJMMD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050790,INHIBITION,,,,,,,,,,,,,,,,,Binding affinity to human serotonin 5HT3 receptor at 10 uM by radioligand binding assay,Not Active,"Identification of a novel benzoxazolone derivative as a selective, orally active 18 kDa translocator protein (TSPO) ligand.",J. Med. Chem.,2013,56,20,"Fukaya T, Ishiyama T, Baba S, Masumoto S",,991150,DTCT0023221,12640927,DTCC01403311,103900,56238
CHEMBL244561,P46098,,FPNPHDMTUDVXEY-ITAXXUCMSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125526,DTCC00457676,1410573,23555
CHEMBL244561,P46098,,FPNPHDMTUDVXEY-ITAXXUCMSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125527,DTCC00457676,1410573,23555
CHEMBL244561,P46098,,FPNPHDMTUDVXEY-ITAXXUCMSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,19000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125205,DTCC00457676,1410573,23555
CHEMBL244561,P46098,,FPNPHDMTUDVXEY-ITAXXUCMSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,19952.62,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125206,DTCC00457676,1410573,23555
CHEMBL2448556,P46098,,DDHAJFBBJWHSBR-XYYAHUGASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057,INHIBITION,=,96.85,%,,cell_based,,,,,,,,,,,,Inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 0.1 uM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014,78,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337831,DTCT0023221,13611755,DTCC01404267,1030723,57930
CHEMBL244946,P46098,,WIHMMKGUBDZGEG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17867665,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 1 uM,,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,2007,50,21,"Micheli F, Bonanomi G, Blaney FE, Braggio S, Capelli AM, Checchia A, Curcuruto O, Damiani F, Fabio RD, Donati D, Gentile G, Gribble A, Hamprecht D, Tedesco G, Terreni S, Tarsi L, Lightfoot A, Stemp G, Macdonald G, Smith A, Pecoraro M, Petrone M, Perini O, Piner J, Rossi T, Worby A, Pilla M, Valerio E, Griffante C, Mugnaini M, Wood M, Scott C, Andreoli M, Lacroix L, Schwarz A, Gozzi A, Bifone A, Ashby CR, Hagan JJ, Heidbreder C",,446429,DTCT0023221,2158192,DTCC00459015,1312948,23588
CHEMBL246955,P46098,,XYYGFCDTBHAUSN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17127059,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor at 1 uM,Not Active,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,4,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453461,DTCT0023221,2219194,DTCC00477235,1361791,24220
CHEMBL250450,P46098,ISOQUERCETIN,OVSQVDMCBVZWGM-QSOFNFLRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14750916,DTCC00486067,2109951,69275
CHEMBL250699,P46098,A-803467,VHKBTPQDHDSBSP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17483457,IC50,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from 5HT3 receptor,,"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.",Proc. Natl. Acad. Sci. U.S.A.,2007,104,20,"Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, Thomas J, Liu D, Krambis M, Liu Y, McGaraughty S, Chu K, Roeloffs R, Zhong C, Mikusa JP, Hernandez G, Gauvin D, Wade C, Zhu C, Pai M, Scanio M, Shi L, Drizin I, Gregg R, Matulenko M, Hakeem A, Gross M, Johnson M, Marsh K, Wagoner PK, Sullivan JP, Faltynek CR, Krafte DS",,466569,DTCT0023221,2351663,DTCC00003813,310509,25480
CHEMBL251005,P46098,,GKGCLPKLLFABEQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17892934,INHIBITION,<,40,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Discovery of 5-HT6 receptor ligands based on virtual HTS.,Bioorg. Med. Chem. Lett.,2007,17,22,"Tasler S, Kraus J, Wuzik A, Müller O, Aschenbrenner A, Cubero E, Pascual R, Quintana-Ruiz JR, Dordal A, Mercè R, Codony X",,458167,DTCT0023221,2253167,DTCC00482475,1684849,24728
CHEMBL251254,P46098,HYPEROSIDE,OVSQVDMCBVZWGM-DTGCRPNFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14748600,DTCC00487046,2109632,69275
CHEMBL252766,P46098,,WOYCDVDURLTMAW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18078311,ACTIVITY,<,50,%,,,,,,,,,,,,,,Displacement of [3H]PIB from 5HT3 receptor at 10 uM,,"Synthesis and evaluation of N-methyl and S-methyl 11C-labeled 6-methylthio-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridines as radioligands for imaging beta-amyloid plaques in Alzheimer's disease.",J. Med. Chem.,2008,51,1,"Cai L, Liow JS, Zoghbi SS, Cuevas J, Baetas C, Hong J, Shetty HU, Seneca NM, Brown AK, Gladding R, Temme SS, Herman MM, Innis RB, Pike VW",,460342,DTCT0023221,2268443,DTCC00485075,1070293,24989
CHEMBL253597,P46098,,DHZBNHMEIOBPAE-JVVVGQRLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18067245,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to 5HT3 at 10 uM,,Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.,J. Med. Chem.,2008,51,1,"Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW",,460113,DTCT0023221,2267459,DTCC00485513,1458632,24978
CHEMBL254352,P46098,,FVRUVTWIWLDBRH-RGEXLXHISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17470817,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Activity at human 5HT3A receptor expressed in Xenopus oocytes assessed as stimulation of nicotine-induced current at 10 uM by two-electrode voltage-clamp method,Not Active,Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.,Proc. Natl. Acad. Sci. U.S.A.,2007,104,19,"Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW",,466433,DTCT0023221,2351558,DTCC00491379,294152,25479
CHEMBL255898,P46098,BARETTIN,YYFNNPXWRXQUPR-JVXNRYDGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17067154,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [9-methyl-3H]BRL-43694 from human 5HT3A receptor expressed in HEK293 cells,,Brominated cyclodipeptides from the marine sponge Geodia barretti as selective 5-HT ligands.,J. Nat. Prod.,2006,69,10,"Hedner E, Sjögren M, Frändberg PA, Johansson T, Göransson U, Dahlström M, Jonsson P, Nyberg F, Bohlin L",,526858,DTCT0023221,2738959,DTCC00490533,1147126,29670
CHEMBL257155,P46098,,HXRJTORFQVDPEI-LGMDPLHJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17470817,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Activity at human 5HT3A receptor expressed in Xenopus oocytes assessed as stimulation of nicotine-induced current at 10 uM by two-electrode voltage-clamp method,Not Active,Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.,Proc. Natl. Acad. Sci. U.S.A.,2007,104,19,"Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW",,466433,DTCT0023221,2351505,DTCC00492328,326762,25479
CHEMBL257940,P46098,,WZHXVKWOVBWNIB-RHDGDCLCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18160282,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,Discovery of novel orally active ureido NPY Y5 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,3,"Li G, Stamford AW, Huang Y, Cheng KC, Cook J, Farley C, Gao J, Ghibaudi L, Greenlee WJ, Guzzi M, van Heek M, Hwa JJ, Kelly J, Mullins D, Parker EM, Wainhaus S, Zhang X",,468034,DTCT0023221,2301301,DTCC00499075,424837,25590
CHEMBL260374,P46098,THIOPERAMIDE,QKDDJDBFONZGBW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8564266,KI,=,120,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14729293,DTCC00494403,2103825,69351
CHEMBL260565,P46098,,PKWXICSBZZLGCF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,KI,=,251.19,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090036,DTCC00494478,2039045,45760
CHEMBL26533,P46098,,PRZPXKIXNNNNCD-DJICYOIISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,1652026,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand,,Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity.,J. Med. Chem.,1991,34,8,"Raghupathi RK, Rydelek-Fitzgerald L, Teitler M, Glennon RA",,3063,DTCT0023221,1036222,DTCC00162519,1391981,11257
CHEMBL266591,P46098,,WYWNEDARFVJQSG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,10715164,KI,=,1200,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,2000,43,5,"Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK",,3466,DTCT0023221,878057,DTCC00133882,969180,16105
CHEMBL267615,P46098,,ZEYRDXUWJDGTLD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16055331,IC50,>,1000,NM,,cell_based,,,,,,,,,,,,Inhibitory activity against 5-hydroxytryptamine 3 receptor expressed in NG 108 cells,,"2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.",Bioorg. Med. Chem. Lett.,2005,15,19,"Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H",,321408,DTCT0023221,1847909,DTCC00133863,919058,19721
CHEMBL268800,P46098,2-METHYL-5-METHOXYTRYPTAMINE,TYAPSMFCSAKSOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,10715164,KI,>,10000,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,2000,43,5,"Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK",,3467,DTCT0023221,887068,DTCC01738625,1648833,16105
CHEMBL268800,P46098,2-METHYL-5-METHOXYTRYPTAMINE,TYAPSMFCSAKSOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12825922,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor,,"Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).",J. Med. Chem.,2003,46,14,,,3413,DTCT0023221,513854,DTCC01738625,1661576,17380
CHEMBL270595,P46098,,OXEFHEYEQUISKC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,820298,DTCT0023221,10344317,DTCC00502273,1928089,48255
CHEMBL274119,P46098,RACEMETHIONINE,FFEARJCKVFRZRR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14733423,DTCC00135493,2104905,69159
CHEMBL274525,P46098,ABT-418,ILLGYRJAYAAAEW-QMMMGPOBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,7518514,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14746468,DTCC00137246,2107062,69433
CHEMBL27453,P46098,3-(4-CHLOROPHENYL)PYRROLIDINE,MGGZDDQAOZEEDU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,KI,=,794.33,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090031,DTCC01739293,1655267,45760
CHEMBL275528,P46098,PHENCYCLIDINE,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,273,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14737498,DTCC00136780,2106327,68446
CHEMBL275528,P46098,PHENCYCLIDINE,JTJMJGYZQZDUJJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,2671,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14737499,DTCC00136780,2106327,68446
CHEMBL276500,P46098,,HTSNFXAICLXZMA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,2.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14742441,DTCC00135202,2108053,68446
CHEMBL276500,P46098,,HTSNFXAICLXZMA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,398.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14742440,DTCC00135202,2108053,68446
CHEMBL27846,P46098,(R)ZACOPRIDE,FEROPKNOYKURCJ-ZDUSSCGKSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5.01,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,3475,DTCT0023221,528406,DTCC00165567,660106,1973
CHEMBL282433,P46098,DITOLYLGUANIDINE,OPNUROKCUBTKLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,28.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14759465,DTCC00152325,2111536,68446
CHEMBL282433,P46098,DITOLYLGUANIDINE,OPNUROKCUBTKLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,28.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14760114,DTCC00152325,2111536,68446
CHEMBL282433,P46098,DITOLYLGUANIDINE,OPNUROKCUBTKLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,57.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14759466,DTCC00152325,2111536,68446
CHEMBL282433,P46098,DITOLYLGUANIDINE,OPNUROKCUBTKLF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,57.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14760115,DTCC00152325,2111536,68446
CHEMBL287045,P46098,SDZ-205557,FFNWMBDISAYHDC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,KI,=,125.89,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428,DTCT0023221,2613779,DTCC01739544,1726589,33265
CHEMBL288591,P46098,,HOMWNUXPSJQSSU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,0.457,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422325,DTCC00180202,944319,51459
CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,1.45,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211368,DTCC00177095,241562,37125
CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20724042,KI,=,3.98,NM,,,,,,,,,,,,,,Binding affinity to 5HT3A receptor,,Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.,Eur. J. Med. Chem.,2010,45,11,"Moura Barbosa AJ, De Rienzo F, Ramos MJ, Menziani MC",,685540,DTCT0023221,3563562,DTCC00177095,230479,41807
CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,-2,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638,DTCT0023221,5035404,DTCC00177095,247805,42619
CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825,DTCT0023221,5035415,DTCC00177095,247805,42619
CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,1.45,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614109,DTCC00177095,231445,47216
CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128813,EC50,=,320,NM,,cell_based,,,,,,,,,,,,Agonist activity at human wild type 5-HT3A receptor expressed in HEK293 cells by FLIPR assay,,Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.,Bioorg. Med. Chem.,2013,21,23,"Del Cadia M, De Rienzo F, Weston DA, Thompson AJ, Menziani MC, Lummis SC",,1278461,DTCT0023221,12951269,DTCC00177095,253074,56549
CHEMBL289469,P46098,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128813,KD,=,0.53,NM,,cell_based,,,,,,,,,,,,Binding affinity to human wild type 5-HT3A receptor expressed in HEK293 cells after 24 hrs by liquid scintillation counting analysis,,Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.,Bioorg. Med. Chem.,2013,21,23,"Del Cadia M, De Rienzo F, Weston DA, Thompson AJ, Menziani MC, Lummis SC",,1278482,DTCT0023221,12951289,DTCC00177095,253074,56549
CHEMBL28992,P46098,,FEROPKNOYKURCJ-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.182,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,3476,DTCT0023221,537947,DTCC00165493,530906,1973
CHEMBL28992,P46098,,FEROPKNOYKURCJ-CYBMUJFWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5011.87,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,,Bioorg. Med. Chem. Lett.,1996,6,4,,,3475,DTCT0023221,537949,DTCC00165493,530906,1973
CHEMBL290938,P46098,,TZUKARBKFHPFDV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824,KI,=,12,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990,33,10,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465,DTCT0023221,782919,DTCC00181495,1467787,10391
CHEMBL292066,P46098,,NZXGDKLTTHIYTB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154,KI,=,19.21,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001,11,16,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480,DTCT0023221,1260724,DTCC00212687,1034998,4387
CHEMBL292779,P46098,L-775606,ZUTQCPBDRJBADG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9357515,IC50,>,10000,NM,,,,,,,,,,,,,,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,"Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.",J. Med. Chem.,1997,40,22,"MacLeod AM, Street LJ, Reeve AJ, Jelley RA, Sternfeld F, Beer MS, Stanton JA, Watt AP, Rathbone D, Matassa VG",,3459,DTCT0023221,729031,DTCC01740766,1240895,14385
CHEMBL293405,P46098,,SYMHUEFSSMBHJA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14713992,DTCC00215839,2099448,68163
CHEMBL293468,P46098,,RWXRJSRJIITQAK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,2818,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736606,DTCC00216870,2106032,68446
CHEMBL293468,P46098,,RWXRJSRJIITQAK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,6310,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736605,DTCC00216870,2106032,68446
CHEMBL299052,P46098,,VHGCDTVCOLNTBX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12431845,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14731360,DTCC00202425,2104388,68736
CHEMBL3,P46098,NICOTINE,SNICXCGAKADSCV-JTQLQIEISA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125158,DTCC00132283,43212,23555
CHEMBL302743,P46098,,UBXGZTRRRHVEAJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154,KI,=,5.21,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001,11,16,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480,DTCT0023221,1270197,DTCC00218758,2000639,4387
CHEMBL304534,P46098,,RGLVXEXQIZDZCD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154,KI,=,7.96,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001,11,16,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480,DTCT0023221,1255910,DTCC00219214,1617533,4387
CHEMBL305582,P46098,,ADYMTDFOOCWUHC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154,KI,=,7.43,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001,11,16,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480,DTCT0023221,1265601,DTCC00219247,1741821,4387
CHEMBL30713,P46098,ALPHA-METHYLTRYPTAMINE,QSQQQURBVYWZKJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23602445,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]LY278584 from human recombinant 5-HT3 receptor expressed in HEK293T cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965131,DTCT0023221,12465429,DTCC01739501,1995571,54821
CHEMBL3084430,P46098,,CBHIMCIVCXZMRS-DNZQSCRFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,0.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614110,DTCC01407403,1844178,47216
CHEMBL3084431,P46098,,JCHBKINXCIYGSB-MPIKPJSNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,199,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614111,DTCC01407404,1201715,47216
CHEMBL3084432,P46098,,SDFVJNYZXNDMQD-PBROBROCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920,DTCT0023221,7614125,DTCC01407405,943780,47216
CHEMBL3084432,P46098,,SDFVJNYZXNDMQD-PBROBROCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy in presence of 10 uM ondansetron,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800921,DTCT0023221,7614132,DTCC01407405,943780,47216
CHEMBL3084432,P46098,,SDFVJNYZXNDMQD-PBROBROCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,1.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614112,DTCC01407405,943780,47216
CHEMBL3084433,P46098,,WEDXHKBFMNCGFH-PBROBROCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920,DTCT0023221,7614126,DTCC01407406,781918,47216
CHEMBL3084433,P46098,,WEDXHKBFMNCGFH-PBROBROCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,7.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614113,DTCC01407406,781918,47216
CHEMBL3084434,P46098,,MHNNUCFPEURPIX-OJXFFNQFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920,DTCT0023221,7614127,DTCC01407407,17908,47216
CHEMBL3084434,P46098,,MHNNUCFPEURPIX-OJXFFNQFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy in presence of 10 uM ondansetron,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800921,DTCT0023221,7614133,DTCC01407407,17908,47216
CHEMBL3084434,P46098,,MHNNUCFPEURPIX-OJXFFNQFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,1.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614114,DTCC01407407,17908,47216
CHEMBL3084435,P46098,,VJEBGMIAGKMECI-LDLYASANSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614115,DTCC01407408,1169429,47216
CHEMBL3084436,P46098,,QSIGSEDSPXQCKE-CXAYTTCISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,142,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614116,DTCC01407409,749966,47216
CHEMBL3084437,P46098,,MYXOSHHXRWCJCA-HNJRQWSBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,6300,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614117,DTCC01407410,1299535,47216
CHEMBL3084438,P46098,,TXJVVQVHDLOBCQ-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920,DTCT0023221,7614128,DTCC01407411,1267069,47216
CHEMBL3084438,P46098,,TXJVVQVHDLOBCQ-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,8.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614118,DTCC01407411,1267069,47216
CHEMBL3084439,P46098,,XPDKHWGJPIAGSI-BKFWDETESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920,DTCT0023221,7614129,DTCC01407412,1779573,47216
CHEMBL3084439,P46098,,XPDKHWGJPIAGSI-BKFWDETESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,1.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614119,DTCC01407412,1779573,47216
CHEMBL3084440,P46098,,VMAWYVBPAWZAGD-HNJRQWSBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920,DTCT0023221,7614130,DTCC01407413,2039344,47216
CHEMBL3084440,P46098,,VMAWYVBPAWZAGD-HNJRQWSBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy in presence of 10 uM ondansetron,Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800921,DTCT0023221,7614134,DTCC01407413,2039344,47216
CHEMBL3084440,P46098,,VMAWYVBPAWZAGD-HNJRQWSBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,1.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614120,DTCC01407413,2039344,47216
CHEMBL3084441,P46098,,KKQAFQIZABQOOY-JOZNFPNDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human 5HT3A expressed in COS7 cells at 100 nM after 1 hr by fluorescence microscopy,Not Active,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800920,DTCT0023221,7614131,DTCC01407414,17909,47216
CHEMBL3084441,P46098,,KKQAFQIZABQOOY-JOZNFPNDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,1.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614121,DTCC01407414,17909,47216
CHEMBL3084442,P46098,,STOPSEQYAMSLCO-QEIWAGNOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,157,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614122,DTCC01407415,1655595,47216
CHEMBL3084443,P46098,,BWUVAZMPSVZMLB-CXAYTTCISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,1300,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614123,DTCC01407416,263828,47216
CHEMBL3084444,P46098,,KMQUSSWWYBEKHN-PKQPGRETSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22189135,KI,=,208,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A expressed in HEK293 cells after 1 hr by scintillation counting,,High-affinity fluorescent ligands for the 5-HT(3) receptor.,Bioorg. Med. Chem. Lett.,2012,22,2,"Simonin J, Vernekar SK, Thompson AJ, Hothersall JD, Connolly CN, Lummis SC, Lochner M",,800919,DTCT0023221,7614124,DTCC01407417,17916,47216
CHEMBL3084582,P46098,,OBSQXMOZMFTQSH-CNDDSTCGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,KI,=,316.23,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428,DTCT0023221,2613777,DTCC01407558,1950755,33265
CHEMBL3084719,P46098,,MGVAXVSGNNKWEZ-QEIWAGNOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Binding affinity to human 5HT3A receptor in HEK293 cells assessed as cell labeling by confocal microscopy in presence of quipazine,Active,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612616,DTCT0023221,3211384,DTCC01407695,437629,37125
CHEMBL3084719,P46098,,MGVAXVSGNNKWEZ-QEIWAGNOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,2.8,NM,,cell_based,,,,,,,,,,,HEK293,Binding affinity to human 5HT3A receptor in HEK293 cells assessed as cell labeling by confocal microscopy,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612615,DTCT0023221,3211385,DTCC01407695,437629,37125
CHEMBL3084759,P46098,,HMQQYASRCXSQBR-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,73.8,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553826,DTCC01407732,469936,41528
CHEMBL3084760,P46098,,FVAIFXRTWOJMOT-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,58.5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553827,DTCC01407733,1375811,41528
CHEMBL3084761,P46098,,RXDWERDONCYTQT-PHZGNYQRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,40,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553828,DTCC01407734,534677,41528
CHEMBL3084762,P46098,,RBULLMHVZYBTHL-LUKYLMHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,12.9,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553830,DTCC01407735,1019137,41528
CHEMBL3084763,P46098,,RBULLMHVZYBTHL-VQHPVUNQSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,92.6,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553831,DTCC01407736,502564,41528
CHEMBL3084764,P46098,,QFWHMNCBGAIEHD-XLAORIBOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,4.6,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553832,DTCC01407737,1408220,41528
CHEMBL3084765,P46098,,BIKQMUIIBHYLFG-OKYOBFRVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,3.9,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553833,DTCC01407738,1116763,41528
CHEMBL3084766,P46098,,VMTCKBHBISQSTL-FTEYMNFISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553834,DTCC01407739,1504836,41528
CHEMBL3084767,P46098,,SDYKMQKYPRJEJM-HAGHYFMRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,3.5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553835,DTCC01407740,1952039,41528
CHEMBL3084768,P46098,,XLQKCOZKZDBOOM-DCXXXQMHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,2,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553836,DTCC01407741,307828,41528
CHEMBL3084769,P46098,,HHKROCCRVVBZNW-KFGODFMUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,0.6,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553837,DTCC01407742,986896,41528
CHEMBL3084770,P46098,,UIKMHGOYAXJLIA-VPAKFMSCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553839,DTCC01407743,406077,41528
CHEMBL3084771,P46098,,PHTYRUNMQXLWGU-PECIQYQJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,35.3,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553840,DTCC01407744,340534,41528
CHEMBL3084772,P46098,,ZTOYBNWVJQYBOX-PHZGNYQRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,72.2,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553842,DTCC01407745,1472478,41528
CHEMBL3084773,P46098,,QWZXRDUZUQKTLV-LUKYLMHMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,16.5,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553843,DTCC01407746,1375815,41528
CHEMBL3084774,P46098,,BTAHQEQRFWNWKD-PECIQYQJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,37.3,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553844,DTCC01407747,469939,41528
CHEMBL3084775,P46098,,BTAHQEQRFWNWKD-ZKXLYKBJSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,59.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553845,DTCC01407748,502569,41528
CHEMBL3084776,P46098,,BTAHQEQRFWNWKD-KFGODFMUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,2.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553846,DTCC01407749,663789,41528
CHEMBL3084777,P46098,,OZOLNJQERDKPFN-OSYLJGHBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,14.9,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553848,DTCC01407750,1919165,41528
CHEMBL3084778,P46098,,SFVKVHVOODTRCH-QKDCVEJESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,8.3,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553850,DTCC01407751,1440098,41528
CHEMBL3084779,P46098,,ORIFHGMCBRVMDD-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,15.1,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553820,DTCC01407752,1822826,41528
CHEMBL3084780,P46098,,ILEZUEGFQWZUOZ-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,16.3,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553821,DTCC01407753,1019143,41528
CHEMBL3084781,P46098,,GGTVJORIYQKWBH-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,18,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553822,DTCC01407754,792698,41528
CHEMBL3084782,P46098,,VDBKJDOCZOVAPB-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,18.8,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553823,DTCC01407755,566924,41528
CHEMBL3084783,P46098,,ZXDOWRQWHIUDFJ-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,40.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553824,DTCC01407756,1310666,41528
CHEMBL3084784,P46098,,KVRNIHXCXMCIQM-NNZMDNLPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,94.9,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553825,DTCC01407757,858151,41528
CHEMBL3085543,P46098,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125488,DTCC01408495,1987064,23555
CHEMBL3085543,P46098,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125489,DTCC01408495,1987064,23555
CHEMBL3085543,P46098,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125166,DTCC01408495,1987064,23555
CHEMBL3085543,P46098,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125167,DTCC01408495,1987064,23555
CHEMBL3093186,P46098,,RVXJKDQROPYYOF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128816,KI,=,1200,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3,,Design of fluorinated 5-HT(4)R antagonists: influence of the basicity and lipophilicity toward the 5-HT(4)R binding affinities.,Bioorg. Med. Chem.,2013,21,23,"Fontenelle CQ, Wang Z, Fossey C, Cailly T, Linclau B, Fabis F",,1278511,DTCT0023221,12952365,DTCC01412791,363859,56552
CHEMBL3093187,P46098,,YKBQHBXRXWGQIZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128816,KI,=,2600,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3,,Design of fluorinated 5-HT(4)R antagonists: influence of the basicity and lipophilicity toward the 5-HT(4)R binding affinities.,Bioorg. Med. Chem.,2013,21,23,"Fontenelle CQ, Wang Z, Fossey C, Cailly T, Linclau B, Fabis F",,1278511,DTCT0023221,12952364,DTCC01412792,233035,56552
CHEMBL3094311,P46098,,NHUZHVAPAIJQRS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903,INHIBITION,=,23.1,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115,DTCT0023221,12962165,DTCC01413925,1127501,56656
CHEMBL3094312,P46098,,KKYAPAJUTFYVRD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903,INHIBITION,=,10.4,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115,DTCT0023221,12962123,DTCC01413926,351566,56656
CHEMBL3094313,P46098,,XVKBXJCHXRLYAQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903,INHIBITION,=,-10.6,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115,DTCT0023221,12962081,DTCC01413927,933254,56656
CHEMBL3094314,P46098,,NLGKYLSBSOGION-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903,INHIBITION,=,-11.9,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115,DTCT0023221,12962039,DTCC01413928,901389,56656
CHEMBL3094316,P46098,,RSZFCDGHJLBYEB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903,INHIBITION,=,-16.5,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115,DTCT0023221,12963267,DTCC01413930,1708845,56656
CHEMBL3094317,P46098,,VCEAPZBMHGKMHI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903,INHIBITION,=,-17,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115,DTCT0023221,12963225,DTCC01413931,1256448,56656
CHEMBL3094318,P46098,,CYPDLWIUOMSUJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903,INHIBITION,=,-13.8,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115,DTCT0023221,12962292,DTCC01413932,1737126,56656
CHEMBL3094319,P46098,,YYONFKYBFNEIKC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903,INHIBITION,=,-4.2,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115,DTCT0023221,12962250,DTCC01413933,965453,56656
CHEMBL3094320,P46098,,UZVSKGBBGCJIRV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24238903,INHIBITION,=,13.7,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279115,DTCT0023221,12962208,DTCC01413934,1644990,56656
CHEMBL3099899,P46098,,VDWKDBPHAPPUBO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24215892,INHIBITION,=,-3,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 10 uM relative to control,,"Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs).",Bioorg. Med. Chem. Lett.,2013,23,24,"Mercer SP, Roecker AJ, Garson S, Reiss DR, Meacham Harrell C, Murphy KL, Bruno JG, Bednar RA, Lemaire W, Cui D, Cabalu TD, Tang C, Prueksaritanont T, Hartman GD, Young SD, Winrow CJ, Renger JJ, Coleman PJ",,1282878,DTCT0023221,12972963,DTCC01415896,1737150,56711
CHEMBL3104091,P46098,,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847,DTCT0023221,12984227,DTCC01417357,351604,56928
CHEMBL3104092,P46098,,RQBRUGMHSQYCNU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847,DTCT0023221,12984203,DTCC01417358,1030177,56928
CHEMBL3104093,P46098,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159,KI,=,501.19,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847,DTCT0023221,12984162,DTCC01417359,577788,56928
CHEMBL3104093,P46098,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24365159,KI,=,529,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283847,DTCT0023221,12984084,DTCC01417359,577788,56928
CHEMBL310604,P46098,HOMOCYSTEINE,FFFHZYDWPBMWHY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14744009,DTCC00239847,2108578,69159
CHEMBL31354,P46098,"WAY-100,635",SBPRIAGPYFYCRT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14730791,DTCC00166968,2104228,68785
CHEMBL31354,P46098,"WAY-100,635",SBPRIAGPYFYCRT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21520940,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT(1A) Receptor.",J. Med. Chem.,2011,54,10,"Al Hussainy R, Verbeek J, van der Born D, Braker AH, Leysen JE, Knol RJ, Booij J, Herscheid JK",,747437,DTCT0023221,5943669,DTCC00166968,509294,44583
CHEMBL313631,P46098,,YXPIBYSOCFGTHG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12361399,KI,>,10000,NM,,,,,,,,,,,,,,The binding affinity towards 5-hydroxytryptamine 3 receptor; No affinity,,Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding.,J. Med. Chem.,2002,45,21,"Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA",,3474,DTCT0023221,1236399,DTCC00252054,886449,17003
CHEMBL3186763,P46098,,DCAMTBFFNOHDAW-DYTRJAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25244572,INHIBITION,=,1.64,%,,,,,,,,,,,,,,Displacement of [3H]GR-65630 from human 5HT3 receptor at 10 uM,,"Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.",J. Med. Chem.,2014,57,20,"Schroeder CE, Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, Jonsson CB, Chung D, Golden JE",,1439053,DTCT0023221,14011986,DTCC01442275,2029987,59962
CHEMBL3215892,P46098,,MTATYSOUXXNXHF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23141912,INHIBITION,=,17.99,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012,22,24,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886896,DTCT0023221,11493439,DTCC01463309,1041440,52134
CHEMBL3216651,P46098,,KWSJSWCQZPEIPC-LQVXLWKRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9182127,IC50,>,100000,NM,,,,,,,,,,,,,,Displacement of radioligand from 5HT3 receptor by liquid scintillation spectrometry,,"Perhydrogenation of tabersonine, ans Aspidiosperma indole alkaloid.",J. Nat. Prod.,1997,60,4,"Lewin G, Schaeffer C, Dacquet C",,549546,DTCT0023221,2539168,DTCC01464065,1788318,27062
CHEMBL3217984,P46098,,YVENIGOVHPMTDH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,630.96,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329312,DTCT0023221,13582410,DTCC01464882,1030631,39761
CHEMBL3233402,P46098,,QOUMVERMRHELNG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057,INHIBITION,=,36.86,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014,78,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830,DTCT0023221,13611749,DTCC01472420,1030719,57930
CHEMBL3233667,P46098,,IVCAEPYRFIZWLG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057,INHIBITION,=,19.75,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014,78,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830,DTCT0023221,13611750,DTCC01472687,1128021,57930
CHEMBL3233668,P46098,,ILVAWRRDRHCBOI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057,INHIBITION,=,14.28,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014,78,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830,DTCT0023221,13611751,DTCC01472688,1062965,57930
CHEMBL3233675,P46098,,JFMXQIZKNMCOKW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057,INHIBITION,=,17.22,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014,78,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830,DTCT0023221,13611752,DTCC01472695,1613339,57930
CHEMBL3233676,P46098,,WICBFQOIMPMYDE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057,INHIBITION,=,13.75,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014,78,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830,DTCT0023221,13611753,DTCC01472696,1096002,57930
CHEMBL3233679,P46098,,SZNATCJGGOZJDA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24691057,INHIBITION,=,16.56,%,,cell_based,,,,,,,,,,,,Reversible inhibition of human 5-HT3A expressed in xenopus oocytes assessed as decrease in 5-HT-activated chloride current at 30 mM by two-electrode voltage clamp technique,,SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.,Eur. J. Med. Chem.,2014,78,,"Handzlik J, Bojarski AJ, Satala G, Kubacka M, Sadek B, Ashoor A, Siwek A, Wiecek M, Kucwaj K, Filipek B, Kiec-Kononowicz K",,1337830,DTCT0023221,13611754,DTCC01472699,1387348,57930
CHEMBL3235480,P46098,,JIGWWGDIEUWCOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653,KI,=,230,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013,56,19,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278,DTCT0023221,13624528,DTCC01474511,1075182,57970
CHEMBL3235481,P46098,,TYQSTXACTJXVQJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013,56,19,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278,DTCT0023221,13624529,DTCC01474512,200660,57970
CHEMBL3235482,P46098,,RCCDDPHPJBBTOH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653,KI,=,505,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013,56,19,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278,DTCT0023221,13624530,DTCC01474513,622645,57970
CHEMBL3235483,P46098,,BKRDDYIAVADMIJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013,56,19,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278,DTCT0023221,13624531,DTCC01474514,1140168,57970
CHEMBL3235484,P46098,,WITLOMKPGROHOE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013,56,19,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278,DTCT0023221,13624532,DTCC01474515,396907,57970
CHEMBL3235485,P46098,,CTXSDFAIKXRHJK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013,56,19,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278,DTCT0023221,13624533,DTCC01474516,1010204,57970
CHEMBL3235486,P46098,,WBOQGKDOKBETNS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013,56,19,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278,DTCT0023221,13624534,DTCC01474517,881447,57970
CHEMBL3235487,P46098,,BJNBJBFZIZJIQH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013,56,19,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278,DTCT0023221,13624535,DTCC01474518,1495969,57970
CHEMBL3235488,P46098,,FVYGPOGSXRAZEB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24050653,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human 5-HT3 receptor expressed in HEK293 cells,Not Determined,Derivatives of dibenzothiophene for positron emission tomography imaging of a7-nicotinic acetylcholine receptors.,J. Med. Chem.,2013,56,19,"Gao Y, Kellar KJ, Yasuda RP, Tran T, Xiao Y, Dannals RF, Horti AG",,1335278,DTCT0023221,13624536,DTCC01474519,1560308,57970
CHEMBL3261478,P46098,,IYUQYZMILCFRJI-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,67.6,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709617,DTCC01486915,1657540,58772
CHEMBL3261478,P46098,,IYUQYZMILCFRJI-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,74,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678613,DTCC01486915,1659870,65052
CHEMBL3261479,P46098,,IYUQYZMILCFRJI-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,ACTIVITY,=,7,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969,DTCT0023221,13709628,DTCC01486916,233435,58772
CHEMBL3261479,P46098,,IYUQYZMILCFRJI-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,EC50,=,178,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971,DTCT0023221,13709638,DTCC01486916,233435,58772
CHEMBL3261479,P46098,,IYUQYZMILCFRJI-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,3.1,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709618,DTCC01486916,233435,58772
CHEMBL3261479,P46098,,IYUQYZMILCFRJI-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678614,DTCC01486916,235814,65052
CHEMBL3261480,P46098,,VVNHBZRFRXWLFQ-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,0.2,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709619,DTCC01486917,2008702,58772
CHEMBL3261480,P46098,,VVNHBZRFRXWLFQ-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678616,DTCC01486917,2011264,65052
CHEMBL3261481,P46098,,MBYAMJFNDALRJQ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,ACTIVITY,=,19,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969,DTCT0023221,13709629,DTCC01486918,881571,58772
CHEMBL3261481,P46098,,MBYAMJFNDALRJQ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,EC50,=,178,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971,DTCT0023221,13709639,DTCC01486918,881571,58772
CHEMBL3261481,P46098,,MBYAMJFNDALRJQ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,8.1,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709620,DTCC01486918,881571,58772
CHEMBL3261481,P46098,,MBYAMJFNDALRJQ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678619,DTCC01486918,883997,65052
CHEMBL3261482,P46098,,WLINCFBAKQHMPZ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,ACTIVITY,=,30,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969,DTCT0023221,13709630,DTCC01486919,1042780,58772
CHEMBL3261482,P46098,,WLINCFBAKQHMPZ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,EC50,=,178,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971,DTCT0023221,13709640,DTCC01486919,1042780,58772
CHEMBL3261482,P46098,,WLINCFBAKQHMPZ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,6.4,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709621,DTCC01486919,1042780,58772
CHEMBL3261483,P46098,,JBVRKZZSTULWTO-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,ACTIVITY,=,28,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969,DTCT0023221,13709631,DTCC01486920,1625395,58772
CHEMBL3261483,P46098,,JBVRKZZSTULWTO-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,EC50,=,178,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971,DTCT0023221,13709641,DTCC01486920,1625395,58772
CHEMBL3261483,P46098,,JBVRKZZSTULWTO-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,0.5,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709622,DTCC01486920,1625395,58772
CHEMBL3261483,P46098,,JBVRKZZSTULWTO-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678620,DTCC01486920,1627864,65052
CHEMBL3261484,P46098,,RBNIAPFMQOKNBD-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,0.8,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709623,DTCC01486921,622758,58772
CHEMBL3261485,P46098,,XDJFTOOYWJXAAZ-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,ACTIVITY,=,87,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969,DTCT0023221,13709632,DTCC01486922,1496096,58772
CHEMBL3261485,P46098,,XDJFTOOYWJXAAZ-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,EC50,=,178,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971,DTCT0023221,13709643,DTCC01486922,1496096,58772
CHEMBL3261485,P46098,,XDJFTOOYWJXAAZ-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,13.5,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709624,DTCC01486922,1496096,58772
CHEMBL3261486,P46098,,UWHBCOHEASCLEA-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,ACTIVITY,=,83,%,,cell_based,,,,,,,,,,,,Partial agonist activity at human 5-HT3A receptor expressed in HEK293 cells assessed as change in Ca2+ level measured as intrinsic activity at 1 uM relative to 5-HT in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350969,DTCT0023221,13709633,DTCC01486923,1203608,58772
CHEMBL3261486,P46098,,UWHBCOHEASCLEA-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,EC50,=,178,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5-HT3A receptor expressed in HEK293 cells in presence of carbachol,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350971,DTCT0023221,13709644,DTCC01486923,1203608,58772
CHEMBL3261486,P46098,,UWHBCOHEASCLEA-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,5.7,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709625,DTCC01486923,1203608,58772
CHEMBL3261486,P46098,,UWHBCOHEASCLEA-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678629,DTCC01486923,1206052,65052
CHEMBL3261487,P46098,,FOVPMEXFLUOBRL-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24755431,KI,=,701,NM,,,,,,,,,,,,,,Displacement of [9-methyl-3H]BRL-43694 from human 5-HT3A receptor after overnight incubation by scintillation proximity assay,,The discovery of diazepinone-based 5-HT3 receptor partial agonists.,Bioorg. Med. Chem. Lett.,2014,24,11,"Manning DD, Guo C, Zhang Z, Ryan KN, Naginskaya J, Choo SH, Masih L, Earley WG, Wierschke JD, Newman AS, Brady CA, Barnes NM, Guzzo PR",,1350968,DTCT0023221,13709626,DTCC01486924,1592727,58772
CHEMBL3261487,P46098,,FOVPMEXFLUOBRL-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,701,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678630,DTCC01486924,1595242,65052
CHEMBL3262125,P46098,,OIZPYIZBDYGMNM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,95,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710405,DTCC01487568,1930784,58852
CHEMBL3262129,P46098,,DQNDQNJPABVUOS-BTQNPOSSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710406,DTCC01487572,675632,58852
CHEMBL3262132,P46098,,ZWCUBSOPHPGVRD-UTONKHPSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,43,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710407,DTCC01487575,643454,58852
CHEMBL3262135,P46098,,WVUAJTKMQULXHI-BTQNPOSSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,99,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710408,DTCC01487579,902089,58852
CHEMBL3262143,P46098,,ABWJEIIFONCFKT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,99,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710409,DTCC01487587,1159462,58852
CHEMBL3262144,P46098,,MXHSBCKYMYQTPI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,91,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710410,DTCC01487588,319472,58852
CHEMBL3262156,P46098,,CBIFADZHFPXCGB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,39,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710411,DTCC01487600,2029531,58852
CHEMBL3262162,P46098,,GYVJDAOHVCIKJN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,23,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710412,DTCC01487606,1387509,58852
CHEMBL3262164,P46098,,GYVJDAOHVCIKJN-RSAXXLAASA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710413,DTCC01487608,740031,58852
CHEMBL3262168,P46098,,YXVBKPDMQWCFGZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,40,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710414,DTCC01487612,1930785,58852
CHEMBL3262171,P46098,,DSBWLGAVGSZBLW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,80,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710415,DTCC01487615,1709548,58852
CHEMBL3262172,P46098,,GGWDKUQZZHJDPZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,47,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710416,DTCC01487616,869820,58852
CHEMBL3262174,P46098,,ULCUTKYYKKNHQX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24814197,INHIBITION,=,16,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014,57,10,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348019,DTCT0023221,13710417,DTCC01487618,1224063,58852
CHEMBL3262390,P46098,,MRARYZFWVQTTTE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24763360,INHIBITION,=,1,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 1 uM by radioligand displacement assay relative to control,,Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties.,Eur. J. Med. Chem.,2014,80,,"Spadoni G, Bedini A, Bartolucci S, Pala D, Mor M, Riccioni T, Borsini F, Cabri W, Celona D, Marzi M, Tarzia G, Rivara S, Minetti P",,1349437,DTCT0023221,13715641,DTCC01487836,1224067,58782
CHEMBL3262393,P46098,,LGZBUKYZDPMWQV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24763360,INHIBITION,=,15,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 1 uM by radioligand displacement assay relative to control,,Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties.,Eur. J. Med. Chem.,2014,80,,"Spadoni G, Bedini A, Bartolucci S, Pala D, Mor M, Riccioni T, Borsini F, Cabri W, Celona D, Marzi M, Tarzia G, Rivara S, Minetti P",,1349437,DTCT0023221,13715622,DTCC01487839,1709550,58782
CHEMBL3262407,P46098,,DJAHTVFQLSUHKT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24763360,INHIBITION,=,5,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 1 uM by radioligand displacement assay relative to control,,Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties.,Eur. J. Med. Chem.,2014,80,,"Spadoni G, Bedini A, Bartolucci S, Pala D, Mor M, Riccioni T, Borsini F, Cabri W, Celona D, Marzi M, Tarzia G, Rivara S, Minetti P",,1349437,DTCT0023221,13715570,DTCC01487853,1322115,58782
CHEMBL3262432,P46098,,QDZASJHLCZFYMF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24763360,INHIBITION,=,6,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 1 uM by radioligand displacement assay relative to control,,Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties.,Eur. J. Med. Chem.,2014,80,,"Spadoni G, Bedini A, Bartolucci S, Pala D, Mor M, Riccioni T, Borsini F, Cabri W, Celona D, Marzi M, Tarzia G, Rivara S, Minetti P",,1349437,DTCT0023221,13715589,DTCC01487879,92453,58782
CHEMBL3287723,P46098,,AOYJKNKRKBOUAP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24735492,INHIBITION,=,-15.3,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor at 10 uM by radioligand displacement assay,,Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence.,J. Med. Chem.,2014,57,10,"Dhanya RP, Sheffler DJ, Dahl R, Davis M, Lee PS, Yang L, Nickols HH, Cho HP, Smith LH, D'Souza MS, Conn PJ, Der-Avakian A, Markou A, Cosford ND",,1361692,DTCT0023221,13779798,DTCC01498697,200946,59335
CHEMBL329179,P46098,,OJGZHBJNBKIPHW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824,KI,=,1.94,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990,33,10,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465,DTCT0023221,778477,DTCC00255790,1532546,10391
CHEMBL3310035,P46098,,RQPAEAIGXOANQF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human serotonin 5-HT3 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta counting analysis,Not Active,,J. Nat. Prod.,2014,77,5,,,1450763,DTCT0023221,13892096,DTCC01510285,655458,57486
CHEMBL3310802,P46098,,PLIHWCCORFZAAL-WLHGVMLRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24856064,INHIBITION,=,-10,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 3 uM by radioligand binding assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1448341,DTCT0023221,13918399,DTCC01511043,385195,60676
CHEMBL3311308,P46098,,FQUAFMNPXPXOJE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24881566,EC50,>,50118.72,NM,,,,,,,,,,,,,,Agonist activity at human 5-HT3 receptor by FLIPR/summary (Abse5) assay,,Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).,Bioorg. Med. Chem. Lett.,2014,24,14,"Sparks SM, Chen G, Collins JL, Danger D, Dock ST, Jayawickreme C, Jenkinson S, Laudeman C, Leesnitzer MA, Liang X, Maloney P, McCoy DC, Moncol D, Rash V, Rimele T, Vulimiri P, Way JM, Ross S",,1455271,DTCT0023221,13918415,DTCC01511540,558563,60691
CHEMBL3311308,P46098,,FQUAFMNPXPXOJE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24881566,EC50,>,50118.72,NM,,,,,,,,,,,,,,Agonist activity at human 5-HT3 receptor by FLIPR(Abse5) assay,,Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).,Bioorg. Med. Chem. Lett.,2014,24,14,"Sparks SM, Chen G, Collins JL, Danger D, Dock ST, Jayawickreme C, Jenkinson S, Laudeman C, Leesnitzer MA, Liang X, Maloney P, McCoy DC, Moncol D, Rash V, Rimele T, Vulimiri P, Way JM, Ross S",,1455272,DTCT0023221,13918416,DTCC01511540,558563,60691
CHEMBL3326982,P46098,,JUVUVFRLXMQWRG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25127461,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 (unknown origin),,Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression.,Bioorg. Med. Chem.,2014,22,17,"Kim Y, Tae J, Lee K, Rhim H, Choo IH, Cho H, Park WK, Keum G, Choo H",,1453282,DTCT0023221,13967403,DTCC01518856,1593250,61216
CHEMBL3326993,P46098,,IAKYDYYOYGXWAX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25127461,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 (unknown origin),,Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression.,Bioorg. Med. Chem.,2014,22,17,"Kim Y, Tae J, Lee K, Rhim H, Choo IH, Cho H, Park WK, Keum G, Choo H",,1453282,DTCT0023221,13967385,DTCC01518867,590853,61216
CHEMBL3334797,P46098,,KEGBICCDHKITSP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25164761,INHIBITION,=,-5.2,%,,,,,,,,,,,,,,Inhibition of human 5HT3 at 10 uM by [3H]RL43694 binding assay relative to control,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1457920,DTCT0023221,13968464,DTCC01521941,1996944,59781
CHEMBL33884,P46098,GR-113808,MOZPSIXKYJUTKI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428,DTCT0023221,2613764,DTCC01739618,662552,33265
CHEMBL34291,P46098,SC-53116,GAYSOZKZPOVDSB-HZMBPMFUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12540230,KI,=,152,NM,,,,,,,,,,,,,,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,5-HT4 receptor ligands: applications and new prospects.,J. Med. Chem.,2003,46,3,"Langlois M, Fischmeister R",,3468,DTCT0023221,1069306,DTCC01739643,938793,17663
CHEMBL356359,P46098,PIBOSEROD,KVCSJPATKXABRQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428,DTCT0023221,2613769,DTCC00329795,1632627,33265
CHEMBL3577955,P46098,,PWDBREUBRYUEGC-BTJKTKAUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496643,DTCT0023221,14434908,DTCC01646031,903869,62611
CHEMBL3577956,P46098,,ABJWJGMTLYSISP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496643,DTCT0023221,14434909,DTCC01646032,386606,62611
CHEMBL3577957,P46098,,MRTJHEDYFUFHHQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496643,DTCT0023221,14434910,DTCC01646033,1550378,62611
CHEMBL3608450,P46098,,XYYAWEJOUNEPTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,8,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522382,DTCC01659060,2010933,63285
CHEMBL3608451,P46098,,CZFCLBXCYDIEPT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,-2.7,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522383,DTCC01659061,1044967,63285
CHEMBL3609140,P46098,,WMUMDPMAVBGKFH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,0.7,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522384,DTCC01659756,1336478,63285
CHEMBL3609141,P46098,,KZDZYBKXTRADGE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,11.6,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522385,DTCC01659758,366417,63285
CHEMBL3609142,P46098,,FESBEMCDUCWSRS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,0.8,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522386,DTCC01659759,366418,63285
CHEMBL3609143,P46098,,CYJCXWNNMRXTFZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,7.7,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522387,DTCC01659760,1691636,63285
CHEMBL3609144,P46098,,PFRJZRVFRYEUFK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,8.3,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522388,DTCC01659761,1530549,63285
CHEMBL3609145,P46098,,VOXGFSUNUJCBDG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,-7.4,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522389,DTCC01659762,883678,63285
CHEMBL3609146,P46098,,GCHJSHYKQQLMEH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,4.1,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522390,DTCC01659763,171062,63285
CHEMBL3609147,P46098,,IKCBNRBKMJGBBJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,-4.1,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522391,DTCC01659764,1303757,63285
CHEMBL3609148,P46098,,OOEBRLFRLPWAPM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26227772,INHIBITION,=,-13.3,%,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5HT3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512430,DTCT0023221,14522392,DTCC01659765,202966,63285
CHEMBL3613642,P46098,,KORKKQLDGMHNKO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26235950,INHIBITION,=,-3,%,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor assessed as inhibition of control specific binding at 10 uM,,Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.,Bioorg. Med. Chem. Lett.,2015,25,18,"Wei ZL, Nguyen MT, O'Mahony DJ, Acevedo A, Zipfel S, Zhang Q, Liu L, Dourado M, Chi C, Yip V, DeFalco J, Gustafson A, Emerling DE, Kelly MG, Kincaid J, Vincent F, Duncton MA",,1514562,DTCT0023221,14536057,DTCC01662099,495991,63547
CHEMBL363124,P46098,,YQSXXLHEQOZMOT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15261283,KI,<,10000,NM,,,,,,,,,,,,,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.,Bioorg. Med. Chem. Lett.,2004,14,16,"Tomic M, Kundakovic M, Butorovic B, Janac B, Andric D, Roglic G, Ignjatovic D, Kostic-Rajacic S",,304007,DTCT0023221,1764696,DTCC00387183,1295600,18177
CHEMBL363124,P46098,,YQSXXLHEQOZMOT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,Med Chem Res,2013,22,2,,,932184,DTCT0023221,11740305,DTCC00387183,1320700,51606
CHEMBL3633757,P46098,,AJIMVLSQIMXLNV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26475518,KI,>,900,NM,,,,,,,,,,,,,,Displacement of [3H]-LY278584 from recombinant human 5-HT3 receptor after 1.5 hrs by Microbeta scintillation counting analysis,,Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT2A receptor.,Bioorg. Med. Chem. Lett.,2015,25,22,"Ponnala S, Kapadia N, Madapa S, Alberts IL, Harding WW",,1527271,DTCT0023221,14599739,DTCC01670761,1077577,64247
CHEMBL3639782,P46098,,GDMKKRJGHYVUND-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635633,DTCC01712080,2063717,64307
CHEMBL364005,P46098,,BPPGPYJBCVXILI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16055331,IC50,=,34,NM,,cell_based,,,,,,,,,,,,Inhibitory activity against 5-hydroxytryptamine 3 receptor expressed in NG 108 cells,,"2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.",Bioorg. Med. Chem. Lett.,2005,15,19,"Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H",,321408,DTCT0023221,1847955,DTCC00405036,1113810,19721
CHEMBL365323,P46098,,SSOHJAKQLOENEM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23126648,KI,=,49.8,NM,,,,,,,,,,,,,,Inhibition of human 5HT3R,,"Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective a7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders.",J. Med. Chem.,2012,55,22,"Mazurov AA, Kombo DC, Hauser TA, Miao L, Dull G, Genus JF, Fedorov NB, Benson L, Sidach S, Xiao Y, Hammond PS, James JW, Miller CH, Yohannes D",,877364,DTCT0023221,11452772,DTCC00404345,492456,51687
CHEMBL366563,P46098,,LEVWYRKDKASIDU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14727100,DTCC00370225,2103226,69159
CHEMBL3673238,P46098,,UYSKPMCDNLQXLI-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678615,DTCC01705847,980602,65052
CHEMBL3673239,P46098,,ZFBWQZNTQCGSCO-KRWDZBQOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,416,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678617,DTCC01705848,1498536,65052
CHEMBL3673240,P46098,,ZFBWQZNTQCGSCO-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,205,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678618,DTCC01705849,1173788,65052
CHEMBL3673241,P46098,,WLINCFBAKQHMPZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678621,DTCC01705850,592767,65052
CHEMBL3673242,P46098,,CSONPSGXWWHUTD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,14,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678622,DTCC01705851,1945420,65052
CHEMBL3673243,P46098,,RBNIAPFMQOKNBD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,0.8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678623,DTCC01705852,399531,65052
CHEMBL3673244,P46098,,XWUPGTBREYOJFJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678624,DTCC01705853,1401775,65052
CHEMBL3673245,P46098,,YLPZXKURYOEIQJ-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,32,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678625,DTCC01705854,463250,65052
CHEMBL3673246,P46098,,LGLCKEXISVFUDS-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,130,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678626,DTCC01705855,139122,65052
CHEMBL3673247,P46098,,NRGNXBSNUWZEIJ-HXUWFJFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,406,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678627,DTCC01705856,1912946,65052
CHEMBL3673248,P46098,,KACRUIFNMDGLQB-HXUWFJFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,206,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678628,DTCC01705857,235813,65052
CHEMBL3673249,P46098,,HFEFUMDVHZMGPE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678631,DTCC01705858,1271554,65052
CHEMBL3673250,P46098,,FKHIPVXDHNZSRM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,30,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678632,DTCC01705859,657624,65052
CHEMBL3673251,P46098,,DUFOURYPCWYIEE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678633,DTCC01705860,1238778,65052
CHEMBL3673252,P46098,,FQYWZZQVOSFYHI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,24,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678635,DTCC01705861,1498537,65052
CHEMBL3673252,P46098,,FQYWZZQVOSFYHI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,217,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678634,DTCC01705861,1498537,65052
CHEMBL3673253,P46098,,MUFQWBWNQHXWKT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,73,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678636,DTCC01705862,268430,65052
CHEMBL3673254,P46098,,TVQVUCVKRZJIOB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,241,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678638,DTCC01705863,366747,65052
CHEMBL3673254,P46098,,TVQVUCVKRZJIOB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,579,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format. Test compounds were dissolved to 10 mM in 100% DMSO, then serially diluted at 10x assay concentrations in 100% DMSO in 96-well polypropylene plates and further diluted to 4x assay concentrations with the assay buffer. Samples were incubated in 50 mM Tris-HCl, pH 7.5, 3 mM MgCl2, 1 mM EDTA and 10% DMSO with 10 nM [9-methyl-3H]BRL-43694 (Perkin Elmer), 3 ug of human 5-HT3 receptor membranes (Perkin Elmer) and 0.5 mg/mL SPA beads (WGA PVT, Amersham Biosciences) in a final volume of 0.2 mL. Binding reactions were set up in wells of PicoPlates-96 (Perkin Elmer) by adding consecutively 50 uL of each competing compound or buffer, SPA beads, the radioligand and 5-HT3 receptor membranes. After an overnight incubation at room temperature on a Nutator mixer, plates were centrifuged for 15 min at 1,500 rpm.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2015,,,,,1528463,DTCT0023221,14678637,DTCC01705863,366747,65052
CHEMBL3679390,P46098,,ZTVHPOWKVOPISB-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635621,DTCC01712061,645857,64307
CHEMBL3679391,P46098,,ATTAPIQZQXPNMZ-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635625,DTCC01712062,968400,64307
CHEMBL3679392,P46098,,ATTAPIQZQXPNMZ-CQSZACIVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635620,DTCC01712063,774425,64307
CHEMBL3679393,P46098,,ZTVHPOWKVOPISB-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635615,DTCC01712064,710068,64307
CHEMBL3679394,P46098,,WTFBVGQGFZBITI-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635622,DTCC01712065,742387,64307
CHEMBL3679395,P46098,,UCBSZTBOXRRYMN-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635623,DTCC01712066,872180,64307
CHEMBL3679396,P46098,,UCBSZTBOXRRYMN-MRXNPFEDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635617,DTCC01712067,516578,64307
CHEMBL3679397,P46098,,WTASBJPDMWMMEL-KRWDZBQOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635624,DTCC01712068,710069,64307
CHEMBL3679398,P46098,,WTASBJPDMWMMEL-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635616,DTCC01712069,420116,64307
CHEMBL3679399,P46098,,HPMOOCNWTGBYIG-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635618,DTCC01712070,223888,64307
CHEMBL3679400,P46098,,NJXILISOPRFRLR-NRFANRHFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635626,DTCC01712071,159693,64307
CHEMBL3679401,P46098,,YKQUIJWABGQLEP-FQEVSTJZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,29,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635627,DTCC01712072,1680207,64307
CHEMBL3679402,P46098,,YKQUIJWABGQLEP-HXUWFJFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635619,DTCC01712073,1966340,64307
CHEMBL3679403,P46098,,LNCMYWGGZAEHIK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,13,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635614,DTCC01712074,127073,64307
CHEMBL3679404,P46098,,NXSYJBVNYHBHHG-FQEVSTJZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,68,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635628,DTCC01712075,1804500,64307
CHEMBL3679405,P46098,,GTOVOFHFJNASEM-NRFANRHFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,57,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635629,DTCC01712076,94858,64307
CHEMBL3679406,P46098,,PBZWPISSKGJWPR-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635630,DTCC01712077,1130572,64307
CHEMBL3679407,P46098,,BZPUAHCKXAJNIM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,34,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635631,DTCC01712078,516579,64307
CHEMBL3679408,P46098,,WHLXDRXTKZLGFK-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635638,DTCC01712079,1771944,64307
CHEMBL3679408,P46098,,WHLXDRXTKZLGFK-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635632,DTCC01712079,1771942,64307
CHEMBL3679409,P46098,,USMXSRUHBDFPEM-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635634,DTCC01712081,1486619,64307
CHEMBL3679410,P46098,,ZAHAKXSHZSSPOF-GOSISDBHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635635,DTCC01712082,1771943,64307
CHEMBL3679411,P46098,,MEYSSICNMCKUSB-JOCHJYFZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635636,DTCC01712083,1868817,64307
CHEMBL3679412,P46098,,WHLXDRXTKZLGFK-HNNXBMFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,108,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635637,DTCC01712084,1583093,64307
CHEMBL3679413,P46098,,IANJVKHDSMUIRT-QGZVFWFLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635640,DTCC01712085,1130573,64307
CHEMBL3679414,P46098,,RBGMTAOTVOHILH-HSZRJFAPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635641,DTCC01712086,256099,64307
CHEMBL3679415,P46098,,WHVZPNITVJSAMC-INIZCTEOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,49,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635642,DTCC01712087,904452,64307
CHEMBL3679416,P46098,,IANJVKHDSMUIRT-KRWDZBQOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,8,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635643,DTCC01712088,1740132,64307
CHEMBL3679417,P46098,,RBGMTAOTVOHILH-QHCPKHFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,13,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635644,DTCC01712089,1868818,64307
CHEMBL3679418,P46098,,LSNUXVIISZOERE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,267,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635645,DTCC01712090,159694,64307
CHEMBL3679419,P46098,,JTKYQKMRKDHHPR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,59,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635646,DTCC01712091,1161837,64307
CHEMBL3679420,P46098,,IQMIOVIDFWQLDA-JOCHJYFZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,25,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proximity assay (SPA) format.",,"5-HT3 receptor modulators, methods of making, and use thereof",,2013,,,,,1527764,DTCT0023221,14635639,DTCC01712092,548620,64307
CHEMBL3740472,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26363507,INHIBITION,<,50,%,,,,,,,,,,,,,,Agonist activity at human recombinant 5HT3 receptor expressed in CHO cells assessed as cAMP level at 10 uM after 4 hrs by luciferase reporter gene assay,,"Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.",Eur. J. Med. Chem.,2015,103,,"Nirogi R, Mohammed AR, Shinde AK, Bogaraju N, Gagginapalli SR, Ravella SR, Kota L, Bhyrapuneni G, Muddana NR, Benade V, Palacharla RC, Jayarajan P, Subramanian R, Goyal VK.",,1540913,DTCT0023221,16676,DTCC00065101,1648360,65482
CHEMBL3740472,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26363507,INHIBITION,<,50,%,,,,,,,,,,,,,,Antagonist activity at human recombinant 5HT3 receptor expressed in CHO cells assessed as cAMP level at 10 uM after 4 hrs by luciferase reporter gene assay,,"Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.",Eur. J. Med. Chem.,2015,103,,"Nirogi R, Mohammed AR, Shinde AK, Bogaraju N, Gagginapalli SR, Ravella SR, Kota L, Bhyrapuneni G, Muddana NR, Benade V, Palacharla RC, Jayarajan P, Subramanian R, Goyal VK.",,1540933,DTCT0023221,16696,DTCC00065101,1648360,65482
CHEMBL3741992,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26460788,INHIBITION,<,30,%,,,,,,,,,,,,,,Inhibition of human 5-HT3 receptor at 10 uM,,Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.,J. Med. Chem.,2015,58,21,"Lopez-Tapia F, Walker KA, Brotherton-Pleiss C, Caroon J, Nitzan D, Lowrie L, Gleason S, Zhao SH, Berger J, Cockayne D, Phippard D, Suttmann R, Fitch WL, Bourdet D, Rege P, Huang X, Broadbent S, Dvorak C, Zhu J, Wagner P, Padilla F, Loe B, Jahangir A, Alker A.",,1541658,DTCT0023221,20304,DTCC00065423,1804813,65488
CHEMBL374351,P46098,KKHT-10103,WHHXYDWPIRKEHF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,57000,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887673,DTCC00002551,921018,34988
CHEMBL374351,P46098,KKHT-10103,WHHXYDWPIRKEHF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,34.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887648,DTCC00002551,921018,34988
CHEMBL3746146,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26580980,KI,=,3,NM,,,,,,,,,,,,,,Displacement of [3H]BRL 43694 from human 5-HT3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"Design of 7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.",Eur. J. Med. Chem.,2016,107,,"Ouach A, Pin F, Bertrand E, Vercouillie J, Gulhan Z, Mothes C, Deloye JB, Guilloteau D, Suzenet F, Chalon S, Routier S.",,1546368,DTCT0023221,33154,DTCC00068812,1013253,65644
CHEMBL3746799,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26580980,KI,=,52,NM,,,,,,,,,,,,,,Displacement of [3H]BRL 43694 from human 5-HT3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"Design of 7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.",Eur. J. Med. Chem.,2016,107,,"Ouach A, Pin F, Bertrand E, Vercouillie J, Gulhan Z, Mothes C, Deloye JB, Guilloteau D, Suzenet F, Chalon S, Routier S.",,1546368,DTCT0023221,33156,DTCC00069049,884371,65644
CHEMBL3747344,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26580980,KI,=,3,NM,,,,,,,,,,,,,,Displacement of [3H]BRL 43694 from human 5-HT3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"Design of 7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.",Eur. J. Med. Chem.,2016,107,,"Ouach A, Pin F, Bertrand E, Vercouillie J, Gulhan Z, Mothes C, Deloye JB, Guilloteau D, Suzenet F, Chalon S, Routier S.",,1546368,DTCT0023221,33155,DTCC00069041,915885,65644
CHEMBL3759860,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26761776,INHIBITION,=,50,%,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin) at 1 to 2 uM by radioligand binding assay,,Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.,Eur. J. Med. Chem.,2016,109,,"Park JS, Im W, Choi S, Park SJ, Jung JM, Baek KS, Son HP, Sharma S, Kim IS, Jung YH.",,1552730,DTCT0023221,69217,DTCC00074937,432317,66015
CHEMBL3763166,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26653033,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor (unknown origin) at 10 uM,,"Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.",J. Med. Chem.,2016,59,1,"Lin SY, Yeh TK, Kuo CC, Song JS, Cheng MF, Liao FY, Chao MW, Huang HL, Chen YL, Yang CY, Wu MH, Hsieh CL, Hsiao W, Peng YH, Wu JS, Lin LM, Sun M, Chao YS, Shih C, Wu SY, Pan SL, Hung MS, Ueng SH.",,1553775,DTCT0023221,91902,DTCC00075195,807224,66086
CHEMBL376324,P46098,,BJPAAUARTYANJL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16971122,IC50,=,275,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Inhibitors of unactivated p38 MAP kinase.,Bioorg. Med. Chem. Lett.,2006,16,23,"Bullington J, Argentieri D, Averill K, Carter D, Cavender D, Fahmy B, Fan X, Hall D, Heintzelman G, Jackson P, Leung WP, Li X, Ling P, Olini G, Razler T, Reuman M, Rupert K, Russell R, Siekierka J, Wadsworth S, Wolff R, Xiang B, Zhang YM",,424582,DTCT0023221,2013813,DTCC00440693,1102639,21793
CHEMBL3763779,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26852005,INHIBITION,=,24,%,,,,,,,,,,,,,,Binding affinity to recombinant 5-HT3 receptor (unknown origin) at 10 uM after 1.5 hrs by radioligand displacement assay,,Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.,Eur. J. Med. Chem.,2016,110,,"Kim Y, Yeom M, Tae J, Rhim H, Choo H.",,1554571,DTCT0023221,81424,DTCC00075509,74889,66201
CHEMBL3764133,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26852005,INHIBITION,=,41,%,,,,,,,,,,,,,,Binding affinity to recombinant 5-HT3 receptor (unknown origin) at 10 uM after 1.5 hrs by radioligand displacement assay,,Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.,Eur. J. Med. Chem.,2016,110,,"Kim Y, Yeom M, Tae J, Rhim H, Choo H.",,1554571,DTCT0023221,81344,DTCC00075511,1752263,66201
CHEMBL3764335,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26852005,INHIBITION,=,41,%,,,,,,,,,,,,,,Binding affinity to recombinant 5-HT3 receptor (unknown origin) at 10 uM after 1.5 hrs by radioligand displacement assay,,Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.,Eur. J. Med. Chem.,2016,110,,"Kim Y, Yeom M, Tae J, Rhim H, Choo H.",,1554571,DTCT0023221,81434,DTCC00075512,658061,66201
CHEMBL3764650,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26852005,INHIBITION,=,18,%,,,,,,,,,,,,,,Binding affinity to recombinant 5-HT3 receptor (unknown origin) at 10 uM after 1.5 hrs by radioligand displacement assay,,Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.,Eur. J. Med. Chem.,2016,110,,"Kim Y, Yeom M, Tae J, Rhim H, Choo H.",,1554571,DTCT0023221,81425,DTCC00075510,367196,66201
CHEMBL376596,P46098,KKHT-20818,PRICKWSOIKQPFF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,4800,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2885918,DTCC00002562,1983565,34988
CHEMBL376596,P46098,KKHT-20818,PRICKWSOIKQPFF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,99.5,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887670,DTCC00002562,1983565,34988
CHEMBL3770106,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26700945,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) after 1.5 hrs by microbeta scintillation counting method,,Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.,J. Med. Chem.,2016,59,2,"Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.",,1557239,DTCT0023221,99386,DTCC00078103,256545,66255
CHEMBL3770342,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26700945,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) after 1.5 hrs by microbeta scintillation counting method,,Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.,J. Med. Chem.,2016,59,2,"Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.",,1557239,DTCT0023221,99388,DTCC00078107,678484,66255
CHEMBL3770981,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26700945,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) after 1.5 hrs by microbeta scintillation counting method,,Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.,J. Med. Chem.,2016,59,2,"Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.",,1557239,DTCT0023221,99387,DTCC00078106,1519401,66255
CHEMBL3771331,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26700945,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) after 1.5 hrs by microbeta scintillation counting method,,Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.,J. Med. Chem.,2016,59,2,"Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.",,1557239,DTCT0023221,99389,DTCC00078113,1837319,66255
CHEMBL3775436,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26988801,INHIBITION,=,29.4,%,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human recombinant 5-HT3 receptor expressed in CHO cells at 10'-5 M,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016,24,8,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559533,DTCT0023221,118987,DTCC00081018,517082,66408
CHEMBL3775769,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26988801,INHIBITION,=,12.3,%,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human recombinant 5-HT3 receptor expressed in CHO cells at 10'-5 M,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016,24,8,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559533,DTCT0023221,119852,DTCC00081020,774921,66408
CHEMBL378349,P46098,,AFLJKKMTBWNZFE-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,IC50,=,188,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851149,DTCT0023221,11361460,DTCC00427657,835012,50968
CHEMBL378349,P46098,,AFLJKKMTBWNZFE-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,174,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361459,DTCC00427657,835012,50968
CHEMBL378471,P46098,,CXDMUUBLDHSHNL-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,IC50,=,580,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851149,DTCT0023221,11361470,DTCC00427682,1800122,50968
CHEMBL378471,P46098,,CXDMUUBLDHSHNL-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,663,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361469,DTCC00427682,1800122,50968
CHEMBL379302,P46098,,LGWFAAILRNJWJB-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,IC50,=,962,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851149,DTCT0023221,11361465,DTCC00427560,931900,50968
CHEMBL379302,P46098,,LGWFAAILRNJWJB-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,310,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361464,DTCC00427560,931900,50968
CHEMBL382243,P46098,,YUIBGCSVGUWIHQ-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125496,DTCC00417396,730707,23555
CHEMBL382243,P46098,,YUIBGCSVGUWIHQ-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125497,DTCC00417396,730707,23555
CHEMBL382243,P46098,,YUIBGCSVGUWIHQ-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125174,DTCC00417396,730707,23555
CHEMBL382243,P46098,,YUIBGCSVGUWIHQ-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125175,DTCC00417396,730707,23555
CHEMBL3823832,P46098,,,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,INHIBITION,=,64,%,,,,,,,,,,,,,,Displacement of [3H]BRL 43694 from human recombinant 5-HT3 receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting analysis,,In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents,MedChemComm,2016,7,6,"Shao L, Campbell UC, Fang QK, Powell NA, Campbell JE, Jones PG, Hanania T, Alexandrov V, Morganstern I, Sabath E, Zhong HM, Large TH, Spear KL",,1586709,DTCT0023221,303633,DTCC00099681,1722211,67430
CHEMBL38288,P46098,WAY-100135,UMTDAKAAYOXIKU-HXUWFJFHSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14744737,DTCC01739668,2108809,68785
CHEMBL38465,P46098,,SDWUPSHVUBKGKN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824,KI,=,1.8,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990,33,10,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465,DTCT0023221,773157,DTCC00181296,140856,10391
CHEMBL388046,P46098,,PYVYQZKNFYHFNG-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125512,DTCC00457684,1247690,23555
CHEMBL388046,P46098,,PYVYQZKNFYHFNG-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125513,DTCC00457684,1247690,23555
CHEMBL388046,P46098,,PYVYQZKNFYHFNG-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,5700,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125190,DTCC00457684,1247690,23555
CHEMBL388046,P46098,,PYVYQZKNFYHFNG-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,6309.57,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125191,DTCC00457684,1247690,23555
CHEMBL388047,P46098,,NPZKVFNHJRDGHI-SQHUXFNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125186,DTCC00457686,342835,23555
CHEMBL388048,P46098,,VVWIDIIMLHNFOH-SBUQLOQDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,2500,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125507,DTCC00457687,244447,23555
CHEMBL388048,P46098,,VVWIDIIMLHNFOH-SBUQLOQDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,2511.89,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125508,DTCC00457687,244447,23555
CHEMBL388048,P46098,,VVWIDIIMLHNFOH-SBUQLOQDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,1900,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125184,DTCC00457687,244447,23555
CHEMBL388048,P46098,,VVWIDIIMLHNFOH-SBUQLOQDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,1995.26,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125185,DTCC00457687,244447,23555
CHEMBL388049,P46098,,SSDBSZARTBSRRD-KTQKYGKGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125501,DTCC00457690,537046,23555
CHEMBL388049,P46098,,SSDBSZARTBSRRD-KTQKYGKGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125502,DTCC00457690,537046,23555
CHEMBL388049,P46098,,SSDBSZARTBSRRD-KTQKYGKGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125178,DTCC00457690,537046,23555
CHEMBL388049,P46098,,SSDBSZARTBSRRD-KTQKYGKGSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125179,DTCC00457690,537046,23555
CHEMBL388212,P46098,,VDEOWAISRHKINC-MPCDFULNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,11000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125301,DTCC00457674,795054,23555
CHEMBL388212,P46098,,VDEOWAISRHKINC-MPCDFULNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,12589.25,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125302,DTCC00457674,795054,23555
CHEMBL388212,P46098,,VDEOWAISRHKINC-MPCDFULNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,3100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125162,DTCC00457674,795054,23555
CHEMBL388212,P46098,,VDEOWAISRHKINC-MPCDFULNSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,3162.28,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125163,DTCC00457674,795054,23555
CHEMBL388401,P46098,KKHT-10318,VJRGAGPCQUZOLU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,IC50,=,7500,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446,DTCT0023221,2887676,DTCC00002566,1276678,34988
CHEMBL388401,P46098,KKHT-10318,VJRGAGPCQUZOLU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040,VMAX,=,103.2,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte relative to bemesetron,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009,17,13,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578445,DTCT0023221,2887651,DTCC00002566,1276678,34988
CHEMBL389120,P46098,,MMIPHEFKLSFNNB-MWGLOKQDSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125514,DTCC00457683,892666,23555
CHEMBL389120,P46098,,MMIPHEFKLSFNNB-MWGLOKQDSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125515,DTCC00457683,892666,23555
CHEMBL389120,P46098,,MMIPHEFKLSFNNB-MWGLOKQDSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,25118.86,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125193,DTCC00457683,892666,23555
CHEMBL389120,P46098,,MMIPHEFKLSFNNB-MWGLOKQDSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,28000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125192,DTCC00457683,892666,23555
CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,495,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14729698,DTCC00134069,2103971,68446
CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14729699,DTCC00134069,2103971,68446
CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,EC50,=,457.09,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2126082,DTCC00134069,43214,23555
CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,EC50,=,500,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2126080,DTCC00134069,43214,23555
CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,EC50,=,141,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700639,DTCT0023221,5035405,DTCC00134069,47560,42619
CHEMBL39,P46098,SEROTONIN,QZAYGJVTTNCVMB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,EC50,=,178,NM,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700635,DTCT0023221,5035393,DTCC00134069,47560,42619
CHEMBL390135,P46098,,FUSIITLPTACWMA-XYRKINJJSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125524,DTCC00457677,1760292,23555
CHEMBL390135,P46098,,FUSIITLPTACWMA-XYRKINJJSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125525,DTCC00457677,1760292,23555
CHEMBL390135,P46098,,FUSIITLPTACWMA-XYRKINJJSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125203,DTCC00457677,1760292,23555
CHEMBL390135,P46098,,FUSIITLPTACWMA-XYRKINJJSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125204,DTCC00457677,1760292,23555
CHEMBL392760,P46098,WAY-181187,RYBOXBBYCVOYNO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17948978,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,CHO,Inhibition of human 5HT3 receptor expressed in CHO cells at 100 nM,,"Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.",J. Med. Chem.,2007,50,23,"Cole DC, Stock JR, Lennox WJ, Bernotas RC, Ellingboe JW, Boikess S, Coupet J, Smith DL, Leung L, Zhang GM, Feng X, Kelly MF, Galante R, Huang P, Dawson LA, Marquis K, Rosenzweig-Lipson S, Beyer CE, Schechter LE",,451126,DTCT0023221,2203115,DTCC00003286,2020054,24044
CHEMBL395368,P46098,,ZYALYWXELCWDBL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17127059,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor at 1 uM,Not Active,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,4,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453461,DTCT0023221,2219138,DTCC00477229,67033,24220
CHEMBL395609,P46098,,DIMAAAZZSSXDEH-DFBJGRDBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17127059,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor at 1 uM,Not Active,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,4,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453461,DTCT0023221,2219193,DTCC00477237,682203,24220
CHEMBL395727,P46098,,VJSCAPXAYUYCDD-MBOLQDAKSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125528,DTCC00457675,147879,23555
CHEMBL395727,P46098,,VJSCAPXAYUYCDD-MBOLQDAKSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125529,DTCC00457675,147879,23555
CHEMBL395727,P46098,,VJSCAPXAYUYCDD-MBOLQDAKSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125208,DTCC00457675,147879,23555
CHEMBL395727,P46098,,VJSCAPXAYUYCDD-MBOLQDAKSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,11000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125207,DTCC00457675,147879,23555
CHEMBL395960,P46098,,UKZPDTRKIBHQLP-JKBBQUHLSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125520,DTCC00457679,1889425,23555
CHEMBL395960,P46098,,UKZPDTRKIBHQLP-JKBBQUHLSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125521,DTCC00457679,1889425,23555
CHEMBL395960,P46098,,UKZPDTRKIBHQLP-JKBBQUHLSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125199,DTCC00457679,1889425,23555
CHEMBL395960,P46098,,UKZPDTRKIBHQLP-JKBBQUHLSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,>,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125200,DTCC00457679,1889425,23555
CHEMBL396705,P46098,,RYIMMAUZEHWVRP-JJDXUFKPSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125516,DTCC00457681,601373,23555
CHEMBL396705,P46098,,RYIMMAUZEHWVRP-JJDXUFKPSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125517,DTCC00457681,601373,23555
CHEMBL396705,P46098,,RYIMMAUZEHWVRP-JJDXUFKPSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125195,DTCC00457681,601373,23555
CHEMBL396705,P46098,,RYIMMAUZEHWVRP-JJDXUFKPSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125196,DTCC00457681,601373,23555
CHEMBL39677,P46098,ACRIDINE,DZBUGLKDJFMEHC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,<=,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849459,DTCC00181372,1717187,34292
CHEMBL397434,P46098,,ULIQGBPQLPCTAJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,30000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14718823,DTCC00455328,2101764,68163
CHEMBL399045,P46098,,AKKGFQRBBVGLEB-KRXBUXKQSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17869105,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 1 uM,Not Active,Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.,Bioorg. Med. Chem. Lett.,2007,17,21,"Xia M, Hou C, Pollack S, Brackley J, DeMong D, Pan M, Singer M, Matheis M, Olini G, Cavender D, Wachter M",,457775,DTCT0023221,2249928,DTCC00483460,115518,24680
CHEMBL401541,P46098,,UDUQYNVUNNDSEJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17998160,KI,=,1051,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor,,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation.,Bioorg. Med. Chem. Lett.,2008,18,1,"Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L",,463654,DTCT0023221,2290837,DTCC00502473,1378416,25254
CHEMBL402143,P46098,,QCFZUTYIUYQTPW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490,DTCT0023221,2622640,DTCC00501513,1588595,33115
CHEMBL402540,P46098,,FOBJQZLFHNQSAX-UYRXBGFRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17470817,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Activity at human 5HT3A receptor expressed in Xenopus oocytes assessed as stimulation of nicotine-induced current at 10 uM by two-electrode voltage-clamp method,Not Active,Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.,Proc. Natl. Acad. Sci. U.S.A.,2007,104,19,"Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW",,466433,DTCT0023221,2351557,DTCC00491376,747050,25479
CHEMBL40260,P46098,,ATBPRFXCCZLQCU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2145434,KI,=,3.3,NM,,,,,,,,,,,,,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,An initial three-component pharmacophore for specific serotonin-3 receptor ligands.,J. Med. Chem.,1990,33,10,"Rizzi JP, Nagel AA, Rosen T, McLean S, Seeger T",,3470,DTCT0023221,1056369,DTCC00181522,712139,10392
CHEMBL402757,P46098,,NSEUBONDLOTDLU-XLNRJJMWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17470817,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Activity at human 5HT3A receptor expressed in Xenopus oocytes assessed as stimulation of nicotine-induced current at 10 uM by two-electrode voltage-clamp method,Not Active,Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.,Proc. Natl. Acad. Sci. U.S.A.,2007,104,19,"Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW",,466433,DTCT0023221,2351559,DTCC00491378,1523527,25479
CHEMBL404232,P46098,APLYSINOPSIN,AZGOVLGMSGAOMP-FZYUQVBKSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296,KI,=,3029,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013,21,22,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092,DTCT0023221,12643600,DTCC00490517,836269,56290
CHEMBL404372,P46098,,XFMPGBXLGWZMQP-YFKPBYRVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18023344,KI,=,1062.3,NM,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor,,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration.,Bioorg. Med. Chem. Lett.,2008,18,1,"Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L",,464433,DTCT0023221,2291676,DTCC00502372,779086,25312
CHEMBL407391,P46098,DIMETHYLADENINE,BVIAOQMSVZHOJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14718000,DTCC00494965,2101324,68163
CHEMBL41,P46098,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,>,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849461,DTCC00134078,1588862,34292
CHEMBL414183,P46098,,FKFNPTZCZKTCNF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,KI,=,12.59,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090038,DTCC00133197,1908320,45760
CHEMBL41543,P46098,,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,<=,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849451,DTCC00180007,845294,34292
CHEMBL415568,P46098,,SJGFHXJCUGAPEE-FSEYQHDASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,3981.07,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125506,DTCC00457688,1889427,23555
CHEMBL415568,P46098,,SJGFHXJCUGAPEE-FSEYQHDASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,4200,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125505,DTCC00457688,1889427,23555
CHEMBL415568,P46098,,SJGFHXJCUGAPEE-FSEYQHDASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,5900,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125182,DTCC00457688,1889427,23555
CHEMBL415568,P46098,,SJGFHXJCUGAPEE-FSEYQHDASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,6309.57,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125183,DTCC00457688,1889427,23555
CHEMBL415569,P46098,,HIKALAMHAXPLDW-RCCNGQCQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125503,DTCC00457689,1474801,23555
CHEMBL415569,P46098,,HIKALAMHAXPLDW-RCCNGQCQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125504,DTCC00457689,1474801,23555
CHEMBL415569,P46098,,HIKALAMHAXPLDW-RCCNGQCQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,39810.72,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125181,DTCC00457689,1474801,23555
CHEMBL415569,P46098,,HIKALAMHAXPLDW-RCCNGQCQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,40000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125180,DTCC00457689,1474801,23555
CHEMBL415570,P46098,,JKQCYYLFNPUCJQ-WZHDNETFSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,30000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125499,DTCC00457691,1857141,23555
CHEMBL415570,P46098,,JKQCYYLFNPUCJQ-WZHDNETFSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125500,DTCC00457691,1857141,23555
CHEMBL415570,P46098,,JKQCYYLFNPUCJQ-WZHDNETFSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125176,DTCC00457691,1857141,23555
CHEMBL415570,P46098,,JKQCYYLFNPUCJQ-WZHDNETFSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,=,100000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125177,DTCC00457691,1857141,23555
CHEMBL418854,P46098,,QHLRKDSRGUZHSH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,10464021,KI,>,1000,NM,,,,,,,,,,,,,,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor,,"N-Substituted (2,3-dihydro-1,4-benzodioxin-2-yl)methylamine derivatives as D(2) antagonists/5-HT(1A) partial agonists with potential as atypical antipsychotic agents.",J. Med. Chem.,1999,42,17,"Birch AM, Bradley PA, Gill JC, Kerrigan F, Needham PL",,3125,DTCT0023221,1102501,DTCC00287129,1456479,15336
CHEMBL419496,P46098,,NYNPDVHTKWVOLU-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361455,DTCC00251734,900076,50968
CHEMBL42,P46098,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15261283,KI,=,186.21,NM,,,,,,,,,,,,,,Binding affinity against 5-Hydroxytryptamine 3 receptor,,Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.,Bioorg. Med. Chem. Lett.,2004,14,16,"Tomic M, Kundakovic M, Butorovic B, Janac B, Andric D, Roglic G, Ignjatovic D, Kostic-Rajacic S",,304007,DTCT0023221,1765154,DTCC00134115,6984,18177
CHEMBL42,P46098,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,186.21,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor (unknown origin),,,Med Chem Res,2013,22,2,,,932184,DTCT0023221,11738831,DTCC00134115,55750,51606
CHEMBL42,P46098,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1000,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329312,DTCT0023221,13582405,DTCC00134115,58495,39761
CHEMBL42055,P46098,E-FLUPENTIXOL,NJMYODHXAKYRHW-BLLMUTORSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,>,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849454,DTCC00185842,618780,34292
CHEMBL421747,P46098,,DVTRMRRJKIYJHT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990,33,10,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465,DTCT0023221,791253,DTCC00255789,1980183,10391
CHEMBL429317,P46098,AVL-3288,VMAKIACTLSBBIY-BOPFTXTBSA-N,1,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17470817,ACTIVITY,,,,,cell_based,,,,,,,,,,,Oocytes,Activity at human 5HT3A receptor expressed in Xenopus oocytes assessed as stimulation of nicotine-induced current at 10 uM by two-electrode voltage-clamp method,Not Active,Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.,Proc. Natl. Acad. Sci. U.S.A.,2007,104,19,"Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW",,466433,DTCT0023221,2351560,DTCC00492329,1523526,25479
CHEMBL43048,P46098,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12761331,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14730587,DTCC00186878,2104160,68767
CHEMBL443764,P46098,VUF-10249,QPKAPAVYCGEURE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,1.35,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422330,DTCC00004197,1073800,51459
CHEMBL444985,P46098,,ZINGRQZUIVEPKX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19282174,KI,=,404,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3 receptor expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564831,DTCT0023221,2620132,DTCC00570244,586439,33285
CHEMBL445332,P46098,SALVINORIN A,OBSYBRPAKCASQB-AGQYDFLVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12192085,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14728234,DTCC00395210,2103589,69286
CHEMBL453023,P46098,,IAORVHGBICJISE-STYPWORHSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9182127,IC50,>,100000,NM,,,,,,,,,,,,,,Displacement of radioligand from 5HT3 receptor by liquid scintillation spectrometry,,"Perhydrogenation of tabersonine, ans Aspidiosperma indole alkaloid.",J. Nat. Prod.,1997,60,4,"Lewin G, Schaeffer C, Dacquet C",,549546,DTCT0023221,2539167,DTCC00113358,597145,27062
CHEMBL453996,P46098,,MUOXAGUZMVATIC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19282174,KI,=,311,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3 receptor expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564831,DTCT0023221,2620029,DTCC00570174,1653671,33285
CHEMBL454407,P46098,,VKXYLXZLODSKCD-QZTJIDSGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472,IC50,=,251188.64,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009,19,5,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267,DTCT0023221,2473366,DTCC00517737,1841786,32916
CHEMBL454890,P46098,VUF-10499,VCADIWSEVTZZOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,2.82,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422331,DTCC00005478,524648,51459
CHEMBL459689,P46098,,NBYYGODJBZAJJF-WOJBJXKFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472,IC50,=,25118.86,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009,19,5,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267,DTCT0023221,2473367,DTCC00517852,941322,32916
CHEMBL459730,P46098,,OQIBXTHHXDTIBJ-OAQYLSRUSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18754613,INHIBITION,<,50,%,,,,,,,,,,,,,,"Displacement of [3H]LY278,584 from human cloned 5HT3 receptor",,"Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.",J. Med. Chem.,2008,51,18,"Donohue SR, Pike VW, Finnema SJ, Truong P, Andersson J, Gulyás B, Halldin C",,512507,DTCT0023221,2562803,DTCC00529017,2036926,31906
CHEMBL459900,P46098,,KNSUADXKFTZSIZ-RTBURBONSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472,IC50,=,100000,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009,19,5,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267,DTCT0023221,2473368,DTCC00517853,164502,32916
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2145434,KI,=,16,NM,,,,,,,,,,,,,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,An initial three-component pharmacophore for specific serotonin-3 receptor ligands.,J. Med. Chem.,1990,33,10,"Rizzi JP, Nagel AA, Rosen T, McLean S, Seeger T",,3470,DTCT0023221,1075266,DTCC00134875,291514,10392
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824,KI,=,16.2,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990,33,10,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465,DTCT0023221,784312,DTCC00134875,303211,10391
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,9.62,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14735558,DTCC00134875,2105680,68446
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,6383,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14735559,DTCC00134875,2105680,68446
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14735560,DTCC00134875,2105680,68446
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20889341,KI,=,3.4,NM,,,,,,,,,,,,,,Binding affinity to human HT3A receptor,,Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2010,20,22,"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C, Isaacson S, Fitzpatrick K, DeOrazio RJ, Chen J, Harding JP, Isherwood M, Dobritsa S, Christensen KL, Wierschke JD, Bliss BI, Peterson LH, Beer CM, Cioffi C, Lynch M, Rennells WM, Richards JJ, Rust T, Khmelnitsky YL, Cohen ML, Manning DD",,674333,DTCT0023221,3553851,DTCC00134875,307832,41528
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,-1,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells at 3 uM relative to 5HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700638,DTCT0023221,5035403,DTCC00134875,313578,42619
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21146988,ACTIVITY,=,0,%,,cell_based,,,,,,,,,,,HEK293,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 100 uM 5-chloroindole-induced increase in intracellular calcium release at 3 uM relative to 5-HT,,Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.,Bioorg. Med. Chem. Lett.,2011,21,1,"Manning DD, Cioffi CL, Usyatinsky A, Fitzpatrick K, Masih L, Guo C, Zhang Z, Choo SH, Sikkander MI, Ryan KN, Naginskaya J, Hassler C, Dobritsa S, Wierschke JD, Earley WG, Butler AS, Brady CA, Barnes NM, Cohen ML, Guzzo PR",,700825,DTCT0023221,5035414,DTCC00134875,313578,42619
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,IC50,=,0.09,NM,,cell_based,,,,,,,,,,,Oocytes,Antagonist activity at human 5HT3A receptor expressed in xenopus oocytes assessed as inhibition of 5HT-induced effect by electrophysiological method,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880244,DTCT0023221,11460193,DTCC00134875,297651,51828
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,=,2.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460370,DTCC00134875,297651,51828
CHEMBL461360,P46098,,CMOWYBWYCJHODO-VIFPVBQESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,2344.23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422344,DTCC00515317,1300093,51459
CHEMBL461729,P46098,,PCXDWBYAWMJZSM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,3548.13,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422343,DTCC00515254,264389,51459
CHEMBL462417,P46098,,OICQCECVOFFRAG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,11748.98,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422342,DTCC00515381,135290,51459
CHEMBL464099,P46098,N-METHYLLAUROTETANINE,ZFLRVRLYWHNAEC-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,25695425,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5-HT3 receptor expressed in HEKT cell membranes by radioligand binding assay,,Semisynthetic Studies on and Biological Evaluation of N-Methyllaurotetanine Analogues as Ligands for 5-HT Receptors.,J. Nat. Prod.,2015,78,4,"Madapa S, Harding WW",,1499640,DTCT0023221,14438671,DTCC00005857,624816,62678
CHEMBL467094,P46098,NANTENINE,WSVWKHTVFGTTKJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19963380,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from human 5HT3 receptor,,Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.,Bioorg. Med. Chem. Lett.,2010,20,2,"Legendre O, Pecic S, Chaudhary S, Zimmerman SM, Fantegrossi WE, Harding WW",,604273,DTCT0023221,3169930,DTCC00115128,663129,36881
CHEMBL470432,P46098,,FZGWDCDUMFWUEO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,ACTIVITY,,,,,cell_based,,,,,,,,,,,NG108-15,Antagonist activity at 5HT3 receptor in hybrid NG108-15 cells assessed as inhibition of 5HT-induced current treated 1 min prior to agonist treatment by electrophysiology,Not Active,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564576,DTCT0023221,2613018,DTCC00570224,1082935,33265
CHEMBL470432,P46098,,FZGWDCDUMFWUEO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,IC50,=,6.92,NM,,,,,,,,,,,,,,Displacement of [3H]granisetron from human recombinant 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564583,DTCT0023221,2613037,DTCC00570224,1082935,33265
CHEMBL470432,P46098,,FZGWDCDUMFWUEO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,IC50,=,385,NM,,cell_based,,,,,,,,,,,NG108-15,Antagonist activity at 5HT3 receptor in hybrid NG108-15 cells assessed as inhibition of 5HT-induced current by electrophysiology,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564575,DTCT0023221,2613019,DTCC00570224,1082935,33265
CHEMBL471035,P46098,,IMESNXOOQNBNMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19282174,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3 receptor expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009,19,8,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564831,DTCT0023221,2620133,DTCC00570245,2004653,33285
CHEMBL471663,P46098,,CZPMNOSNQHHGTD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,IC50,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]granisetron from human recombinant 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564583,DTCT0023221,2613734,DTCC00569998,371836,33265
CHEMBL471712,P46098,VUF-10331,BNASSGFQLMOZKG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,575.44,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422340,DTCC00005442,912852,51459
CHEMBL472219,P46098,SC-53606,UVEYNCQCHBIENE-GTNSWQLSSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,KI,=,251.19,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428,DTCT0023221,2613781,DTCC00009156,208469,33265
CHEMBL473186,P46098,RS-127445,ZZZQXCUPAJFVBN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,10455251,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736443,DTCC00005674,2105972,69444
CHEMBL473302,P46098,VUF-10351,PELIXYXPUAFHOR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,12.02,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422339,DTCC00005441,1656134,51459
CHEMBL475331,P46098,VUF-10147,KJVGBWURWKYDCH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,0.0513,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422328,DTCC00005440,2007250,51459
CHEMBL475965,P46098,,IFWGJAXMPXZADJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19146417,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 1 uM,,"The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.",J. Med. Chem.,2009,52,3,"Wroblowski B, Wigglesworth MJ, Szekeres PG, Smith GD, Rahman SS, Nicholson NH, Muir AI, Hall A, Heer JP, Garland SL, Coates WJ",,516660,DTCT0023221,2696301,DTCC00550152,1567645,32399
CHEMBL476838,P46098,,CFYAUZPZSBAQNA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490,DTCT0023221,2622643,DTCC00551714,100166,33115
CHEMBL476839,P46098,,MJKRYUCQHJLOIV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490,DTCT0023221,2622644,DTCC00551715,1103808,33115
CHEMBL479,P46098,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,>,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849467,DTCC00137035,165159,34292
CHEMBL479383,P46098,,IJHSPFFWIXGDBB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18588282,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488430,DTCT0023221,2775990,DTCC00525641,1756334,30579
CHEMBL479683,P46098,,OLLHYYCQHNBTQC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24582985,INHIBITION,=,61.7,%,,,,,,,,,,,,,,Inhibition of 5-HT3 receptor (unknown origin) at 10 uM by radioligand binding assay relative to control,,5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.,Bioorg. Med. Chem. Lett.,2014,24,6,"Williams DA, Zaidi SA, Zhang Y",,1297171,DTCT0023221,13068455,DTCC00537969,1127642,57600
CHEMBL479683,P46098,,OLLHYYCQHNBTQC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24582985,KI,=,2511.89,NM,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5-HT3 receptor (unknown origin),,5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.,Bioorg. Med. Chem. Lett.,2014,24,6,"Williams DA, Zaidi SA, Zhang Y",,1296927,DTCT0023221,13068431,DTCC00537969,1127642,57600
CHEMBL481153,P46098,,CJGNMVAAMQAWEF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23707254,KI,=,1900,NM,,,,,,,,,,,,,,Antagonist activity at serotonin 5HT3 receptor (unknown origin) by PDSP assay,,Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.,Bioorg. Med. Chem. Lett.,2013,23,13,"Darvesh S, Macdonald IR, Martin E",,969177,DTCT0023221,12499004,DTCC00526518,1624676,55086
CHEMBL481280,P46098,,BUZBVOKDNAZIIM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18588282,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488430,DTCT0023221,2775982,DTCC00525642,1756335,30579
CHEMBL481425,P46098,,LTMXOVNSECYFSK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19119012,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents.",Bioorg. Med. Chem.,2009,17,3,"Chu W, Xu J, Zhou D, Zhang F, Jones LA, Wheeler KT, Mach RH",,515866,DTCT0023221,2694584,DTCC00532302,1243524,32320
CHEMBL481863,P46098,JNJ-10392980,ZIQGASWXUSSORV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18588282,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488314,DTCT0023221,2775753,DTCC00006309,207957,30579
CHEMBL482496,P46098,,ZFUOLNAKPBFDIJ-VQBNBCTGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18468904,KI,>,500,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand.",Bioorg. Med. Chem.,2008,16,11,"Nichols DE, Frescas SP, Chemel BR, Rehder KS, Zhong D, Lewin AH",,556751,DTCT0023221,2543046,DTCC00559644,1906611,28891
CHEMBL483749,P46098,,QPUXUSUONDVIKY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19338356,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009,52,7,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497693,DTCT0023221,2727994,DTCC00569050,273669,34004
CHEMBL484952,P46098,,MTEFLXYKMHWTNG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19338356,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009,52,7,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497693,DTCT0023221,2727995,DTCC00569111,759316,34004
CHEMBL489060,P46098,VUF-10350,GLWWAUFFFXRHOL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,6.61,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422338,DTCC00005452,556753,51459
CHEMBL489061,P46098,VUF-10508,YLCLVZULHOQJRR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,16595.87,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422336,DTCC00005453,1748050,51459
CHEMBL489062,P46098,VUF-10349,GNITVWLUINGTBR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,1.12,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422346,DTCC00005454,1106489,51459
CHEMBL489271,P46098,VUF-10509,YTLUXTFQLXDBJU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,2.69,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422333,DTCC00005457,1494619,51459
CHEMBL489408,P46098,,GWHHZSAHAOWCRM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490,DTCT0023221,2623612,DTCC00551776,1297360,33115
CHEMBL489664,P46098,VUF-10455,BQFFJFYYLYTLCC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,14.79,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422332,DTCC00005471,1462113,51459
CHEMBL49,P46098,BUSPIRONE,QWCRAEMEVRGPNT-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460371,DTCC00135177,102981,51828
CHEMBL490071,P46098,VUF-10329,CBXQAAQVKDTXJJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,13.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422335,DTCC00005448,1909144,51459
CHEMBL490072,P46098,VUF-10453,LCGYRMCRRGNDFQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,79.43,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422334,DTCC00005449,1494618,51459
CHEMBL490073,P46098,VUF-10452,GGBKKIVDGBAYTK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,165.96,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422337,DTCC00005450,880196,51459
CHEMBL490632,P46098,,PPXOTGGYVKBLCQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490,DTCT0023221,2623609,DTCC00551773,1906510,33115
CHEMBL490633,P46098,,YTQJBBJHLKKOLR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490,DTCT0023221,2623610,DTCC00551774,1427399,33115
CHEMBL490634,P46098,,VSDLSICGFMFZRC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490,DTCT0023221,2623611,DTCC00551775,1685574,33115
CHEMBL490843,P46098,,BADPXOSJBUEVTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19331415,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human 5HT3A receptor,Active,"Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.",J. Med. Chem.,2009,52,8,"Ulens C, Akdemir A, Jongejan A, van Elk R, Bertrand S, Perrakis A, Leurs R, Smit AB, Sixma TK, Bertrand D, de Esch IJ",,563563,DTCT0023221,2625327,DTCC00552222,1071069,33123
CHEMBL491861,P46098,,DZOFIEFQFCWGIY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19331415,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human 5HT3A receptor,Active,"Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.",J. Med. Chem.,2009,52,8,"Ulens C, Akdemir A, Jongejan A, van Elk R, Bertrand S, Perrakis A, Leurs R, Smit AB, Sixma TK, Bertrand D, de Esch IJ",,563563,DTCT0023221,2625335,DTCC00552280,1556319,33123
CHEMBL492884,P46098,,NIJGWJIOMPHDBP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,KI,=,1258.93,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090043,DTCC00528056,588048,45760
CHEMBL498770,P46098,IODOPHENPROPIT,UBHYDQAARZKHEZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8564266,KI,=,11,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14743399,DTCC00541500,2108370,69351
CHEMBL499536,P46098,,HQYLURGLNKLOQJ-XHDPSFHLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472,IC50,=,19952.62,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009,19,5,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267,DTCT0023221,2473370,DTCC00517855,1555907,32916
CHEMBL499536,P46098,,HQYLURGLNKLOQJ-XHDPSFHLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KD,=,13000,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361605,DTCC00517855,1578796,50968
CHEMBL50,P46098,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14729987,DTCC00135230,2104025,69275
CHEMBL500,P46098,PINDOLOL,JZQKKSLKJUAGIC-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561,KI,=,6610,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14744125,DTCC00139321,2108612,68785
CHEMBL503427,P46098,,BSAYMXGAHRLDCA-RTBURBONSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472,IC50,=,50118.72,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009,19,5,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267,DTCT0023221,2473369,DTCC00517854,132100,32916
CHEMBL509387,P46098,(-)-TABERSONINE HCL,BFVXDLZRORZNHX-OCIDDWSYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9182127,IC50,>,100000,NM,,,,,,,,,,,,,,Displacement of radioligand from 5HT3 receptor by liquid scintillation spectrometry,,"Perhydrogenation of tabersonine, ans Aspidiosperma indole alkaloid.",J. Nat. Prod.,1997,60,4,"Lewin G, Schaeffer C, Dacquet C",,549546,DTCT0023221,2539166,DTCC00004852,1406207,27062
CHEMBL509540,P46098,A-940894,KUZRWWLVBUPCRK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,INHIBITION,=,98,%,,,,,,,,,,,,,,Inhibition of 5-HT3AR at 10 uM,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766549,DTCT0023221,6090049,DTCC00006426,1908323,45760
CHEMBL510275,P46098,METHYLLYCACONITINE,XLTANAWLDBYGFU-BVFBBISOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2125300,DTCC00538707,1021384,23555
CHEMBL510275,P46098,METHYLLYCACONITINE,XLTANAWLDBYGFU-BVFBBISOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5HT3A receptor in HEK293 cells,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445992,DTCT0023221,2125161,DTCC00538707,1021384,23555
CHEMBL511312,P46098,,RZFPSYUVZCCIFI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,IC50,>,1000,NM,,,,,,,,,,,,,,Displacement of [3H]granisetron from human recombinant 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564583,DTCT0023221,2613740,DTCC00569996,371835,33265
CHEMBL511609,P46098,,HVWYYWIRLPBRTO-JSGCOSHPSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17067154,KI,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [9-methyl-3H]BRL-43694 from human 5HT3A receptor expressed in HEK293 cells,,Brominated cyclodipeptides from the marine sponge Geodia barretti as selective 5-HT ligands.,J. Nat. Prod.,2006,69,10,"Hedner E, Sjögren M, Frändberg PA, Johansson T, Göransson U, Dahlström M, Jonsson P, Nyberg F, Bohlin L",,526858,DTCT0023221,2738950,DTCC00506515,920108,29670
CHEMBL511699,P46098,,XFBXGLNGAUZHSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006041,KI,=,18.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from 5HT3A receptor expressed in HEK293 cells after 24 hrs by scintillation counting in presence of quipazine,,"Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT(3) Receptor Ligands.",J. Med. Chem.,2012,55,20,"Verheij MH, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,864726,DTCT0023221,11422347,DTCC00515257,1300092,51459
CHEMBL512332,P46098,METHYLAPLYSINOPSIN,GXBMTEAMDOVNLO-TVSYJCFYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24084296,KI,=,1511,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells,,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,2013,21,22,"Lewellyn K, Bialonska D, Loria MJ, White SW, Sufka KJ, Zjawiony JK",,989092,DTCT0023221,12643633,DTCC00507844,1095374,56290
CHEMBL515472,P46098,,QCFZUTYIUYQTPW-JOCHJYFZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490,DTCT0023221,2622641,DTCC00551712,554033,33115
CHEMBL516088,P46098,,HVJOIRMQZXEGPW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19329329,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human cloned 5HT3 receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563490,DTCT0023221,2622642,DTCC00551713,1264819,33115
CHEMBL519240,P46098,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18983139,ACTIVITY,=,2.2,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM relative to control,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494267,DTCT0023221,2604325,DTCC00008943,1621329,32034
CHEMBL519240,P46098,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18983139,INHIBITION,=,98,%,,,,,,,,,,,,,,Inhibition of human 5HT3 receptor at 10 uM,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494189,DTCT0023221,2604246,DTCC00008943,1621329,32034
CHEMBL519240,P46098,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,INHIBITION,=,98,%,,,,,,,,,,,,,,Inhibition of 5-HT3AR at 10 uM,,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766549,DTCT0023221,6090047,DTCC00008943,1623090,45760
CHEMBL519609,P46098,,FPUKGJMTLUQGFZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23707254,KI,=,3900,NM,,,,,,,,,,,,,,Antagonist activity at serotonin 5HT3 receptor (unknown origin) by PDSP assay,,Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.,Bioorg. Med. Chem. Lett.,2013,23,13,"Darvesh S, Macdonald IR, Martin E",,969177,DTCT0023221,12499021,DTCC00526517,1235500,55086
CHEMBL520349,P46098,,OHOQFGDSEWQDAX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19338356,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009,52,7,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497693,DTCT0023221,2727996,DTCC00569166,1178835,34004
CHEMBL526307,P46098,,AATPYXMXFBBKFO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19231180,KI,=,100000000,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,"Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.",Bioorg. Med. Chem. Lett.,2009,19,6,"Carter DS, Alam M, Cai H, Dillon MP, Ford AP, Gever JR, Jahangir A, Lin C, Moore AG, Wagner PJ, Zhai Y",,565951,DTCT0023221,2475726,DTCC00534803,726731,32941
CHEMBL53929,P46098,OCTOPAMINE,QHGUCRYDKWKLMG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium at 10 nM by calcium imaging assay,Active,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007,450,7169,"Petrascheck M, Ye X, Buck LB",,478753,DTCT0023221,2354066,DTCC00196284,1426856,26306
CHEMBL53929,P46098,OCTOPAMINE,QHGUCRYDKWKLMG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297,EC50,=,24,NM,,cell_based,,,,,,,,,,,HEK293,Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay,,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007,450,7169,"Petrascheck M, Ye X, Buck LB",,478755,DTCT0023221,2354069,DTCC00196284,1426856,26306
CHEMBL54,P46098,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,0.56,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14727266,DTCC00135385,2103354,68446
CHEMBL54,P46098,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,15.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14727265,DTCC00135385,2103354,68446
CHEMBL54,P46098,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,<=,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849455,DTCC00135385,11934,34292
CHEMBL541018,P46098,,RKGYJVASTMCSHZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,<=,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849469,DTCC00582611,1717191,34292
CHEMBL541993,P46098,,JDPGHZDOBUGUDU-LURJTMIESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18023344,KI,,,,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor,Not Determined,Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration.,Bioorg. Med. Chem. Lett.,2008,18,1,"Peters JU, Lübbers T, Alanine A, Kolczewski S, Blasco F, Steward L",,464433,DTCT0023221,2291693,DTCC00502334,228570,25312
CHEMBL54720,P46098,,QYWDOJXSLBBWLE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,IC50,=,1.41,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]granisetron form 5HT3 receptor in hybrid NG180-15 cells,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564556,DTCT0023221,2613762,DTCC00197722,240858,33265
CHEMBL549,P46098,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038,KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by filter binding assay,Not Determined,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011,54,9,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880265,DTCT0023221,11460372,DTCC00144121,428144,51828
CHEMBL54943,P46098,CYSTEINE,XUJNEKJLAYXESH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14732676,DTCC00201307,2103464,69159
CHEMBL555146,P46098,,VGSYEFOBFMUWGO-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22313227,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012,55,5,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818810,DTCT0023221,10474249,DTCC00380469,1106159,48153
CHEMBL558226,P46098,SC-52491,DHGXYMAJZPNYQQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1.2,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,,Bioorg. Med. Chem. Lett.,1997,7,17,,,3469,DTCT0023221,1022050,DTCC00022374,1196056,2213
CHEMBL559456,P46098,,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19359175,INHIBITION,<,15,%,,,,,,,,,,,,,,Inhibition of 5HT3R at 200 nM,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009,19,10,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575313,DTCT0023221,2876718,DTCC00582984,339382,34589
CHEMBL559478,P46098,SSR180711,RXLOZRCLQMJJLC-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19576766,IC50,>,3160,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]LY278584 from human 5HT3 receptor expressed in HEK293 cells,,"Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2009,19,16,"O'Donnell CJ, Peng L, O'Neill BT, Arnold EP, Mather RJ, Sands SB, Shrikhande A, Lebel LA, Spracklin DK, Nedza FM",,582492,DTCT0023221,2914150,DTCC00583548,985720,35190
CHEMBL559478,P46098,SSR180711,RXLOZRCLQMJJLC-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to human 5HT3 receptor at 10 uM by radioligand binding assay,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851023,DTCT0023221,11361603,DTCC00583548,996351,50968
CHEMBL560,P46098,PENTAZOCINE,VOKSWYLNZZRQPF-GDIGMMSISA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,15.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736560,DTCC00145614,2106015,68446
CHEMBL560,P46098,PENTAZOCINE,VOKSWYLNZZRQPF-GDIGMMSISA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,195,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736559,DTCC00145614,2106015,68446
CHEMBL560,P46098,PENTAZOCINE,VOKSWYLNZZRQPF-GDIGMMSISA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,857.7,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736558,DTCC00145614,2106015,68446
CHEMBL563848,P46098,,XWTAQEXSIBGWRM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,3993,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361541,DTCC00585061,2059386,50968
CHEMBL564180,P46098,,PJQCANLCUDUPRF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,<=,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849453,DTCC00584171,910364,34292
CHEMBL564850,P46098,,MQZFLDZRBIKMGM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19576766,IC50,>,3160,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]LY278584 from human 5HT3 receptor expressed in HEK293 cells,,"Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2009,19,16,"O'Donnell CJ, Peng L, O'Neill BT, Arnold EP, Mather RJ, Sands SB, Shrikhande A, Lebel LA, Spracklin DK, Nedza FM",,582492,DTCT0023221,2914151,DTCC00586605,79685,35190
CHEMBL565540,P46098,SEN-12333,GBMDUJQQSGOIFW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19515567,SELECTIVITY RATIO,,,,,cell_based,,,,,,,,,,,HEK293,Activity at human 5HT3 receptor expressed in human HEK293 cells assessed as effect on membrane potential by FLIPR assay,Not Active,SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist.,Bioorg. Med. Chem.,2009,17,14,"Haydar SN, Ghiron C, Bettinetti L, Bothmann H, Comery TA, Dunlop J, La Rosa S, Micco I, Pollastrini M, Quinn J, Roncarati R, Scali C, Valacchi M, Varrone M, Zanaletti R",,598743,DTCT0023221,3090598,DTCC00023271,1363188,36012
CHEMBL565547,P46098,,QGJVXXSJZAPJME-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19646865,KI,=,3700,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.,Bioorg. Med. Chem. Lett.,2009,19,17,"Brennan PE, Whitlock GA, Ho DK, Conlon K, McMurray G",,599284,DTCT0023221,3109451,DTCC00602399,208957,36131
CHEMBL56564,P46098,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2145434,KI,=,2.7,NM,,,,,,,,,,,,,,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,An initial three-component pharmacophore for specific serotonin-3 receptor ligands.,J. Med. Chem.,1990,33,10,"Rizzi JP, Nagel AA, Rosen T, McLean S, Seeger T",,3470,DTCT0023221,1056367,DTCC00204705,712138,10392
CHEMBL56564,P46098,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824,KI,=,2.7,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990,33,10,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465,DTCT0023221,813759,DTCC00204705,723753,10391
CHEMBL56564,P46098,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,KI,=,2.82,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428,DTCT0023221,2613775,DTCC00204705,727129,33265
CHEMBL56564,P46098,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,5.3,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851149,DTCT0023221,11361609,DTCC00204705,737976,50968
CHEMBL56900,P46098,LERISETRON,PWWDCRQZITYKDV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154,KI,=,0.36,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001,11,16,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480,DTCT0023221,1255908,DTCC00204700,1423851,4387
CHEMBL569270,P46098,,UTPGRZGMQVAYAA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24147864,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human 5-HT3 receptor by PDSP assay,,Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1).,J. Med. Chem.,2013,56,22,"Xu R, Zanotti-Fregonara P, Zoghbi SS, Gladding RL, Woock AE, Innis RB, Pike VW",,1274798,DTCT0023221,12941488,DTCC00606473,1333771,56413
CHEMBL569357,P46098,,HFOUMBDMIJJHCK-OSPHWJPCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,3100,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114455,DTCC00604510,1039093,36218
CHEMBL569585,P46098,,POJMJIIKSJRQPV-OZJYBUQCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,790,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114460,DTCC00604518,1589099,36218
CHEMBL570487,P46098,,POJMJIIKSJRQPV-UBMARQKXSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,1700,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114462,DTCC00604561,619033,36218
CHEMBL570710,P46098,,SOEFWQWHKHCTLH-BIIVWMMYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,1600,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114459,DTCC00604500,1874707,36218
CHEMBL571799,P46098,,POJMJIIKSJRQPV-QZOFJNMOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,EC50,>,10000,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598658,DTCT0023221,3115583,DTCC00604612,133045,36218
CHEMBL571799,P46098,,POJMJIIKSJRQPV-QZOFJNMOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,159,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114464,DTCC00604612,133045,36218
CHEMBL572038,P46098,,OHGAQBAXUOYIOB-CJAUYULYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,3500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114453,DTCC00604452,165404,36218
CHEMBL572248,P46098,,HFOUMBDMIJJHCK-BXKMTCNYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,2500,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114456,DTCC00604517,229795,36218
CHEMBL572249,P46098,,SOEFWQWHKHCTLH-QJTHLVPVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,1400,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114465,DTCC00604453,812625,36218
CHEMBL582877,P46098,,ODCAEXNEGXTNBY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26700945,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]LY278584 from 5-HT3 receptor (unknown origin) after 1.5 hrs by microbeta scintillation counting method,,Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome.,J. Med. Chem.,2016,59,2,"Zhou Y, Ma J, Lin X, Huang XP, Wu K, Huang N.",,1557239,DTCT0023221,99385,DTCC00599156,1226952,66255
CHEMBL583681,P46098,,POJMJIIKSJRQPV-JQKXIHIISA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,2800,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114458,DTCC00604591,327966,36218
CHEMBL584743,P46098,,OHGAQBAXUOYIOB-AVRWGWEMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,4900,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114454,DTCC00604451,1810259,36218
CHEMBL585567,P46098,,SOEFWQWHKHCTLH-YUXJLSHCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,18,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114463,DTCC00604574,393299,36218
CHEMBL585925,P46098,,SOEFWQWHKHCTLH-ZSKASMGYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325,IC50,=,390,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009,19,19,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654,DTCT0023221,3114461,DTCC00604524,1363220,36218
CHEMBL590615,P46098,,CWYDYWFZPBTTIM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19954972,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010,20,1,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603538,DTCT0023221,3163675,DTCC00609878,176896,36082
CHEMBL595449,P46098,,ILPANLYEJQKXKY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19646882,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.,Bioorg. Med. Chem.,2009,17,17,"Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S, Wannemacher KM, Howells RD, Welsh WJ",,601696,DTCT0023221,3163162,DTCC00612138,1136637,36541
CHEMBL596758,P46098,,HKZXJCJPMIJTDL-KBPBESRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,237,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211377,DTCC00622307,372592,37125
CHEMBL596951,P46098,,CGNLROWYSDSBMN-STQMWFEESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,0.17,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211369,DTCC00622184,1789798,37125
CHEMBL596952,P46098,,OIVVFYLMLVRCHQ-KBPBESRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,26.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211370,DTCC00622185,241563,37125
CHEMBL597241,P46098,,XJNOJISWTROLSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678,IC50,=,484,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010,53,3,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801,DTCT0023221,3181593,DTCC00618948,910774,37429
CHEMBL597241,P46098,,XJNOJISWTROLSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,IC50,=,484,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851149,DTCT0023221,11361553,DTCC00618948,931901,50968
CHEMBL597241,P46098,,XJNOJISWTROLSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,1370,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361551,DTCC00618948,931901,50968
CHEMBL597276,P46098,,KZCFXYPUJPOLMF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678,IC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,Not Determined,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010,53,3,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801,DTCT0023221,3181596,DTCC00619021,1330645,37429
CHEMBL597440,P46098,,ZLUOOMMZUAJVNO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678,IC50,=,2480,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010,53,3,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801,DTCT0023221,3181594,DTCC00618949,1395715,37429
CHEMBL597737,P46098,,ATCMRGMIYIPJQT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678,IC50,>,7310,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010,53,3,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801,DTCT0023221,3181600,DTCC00618115,1842781,37429
CHEMBL597843,P46098,,HIWIXUJADKOVEP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,579,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361542,DTCC00618887,446367,50968
CHEMBL597984,P46098,,KMAHQUWVTWBRDK-PMACEKPBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,59.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211382,DTCC00622380,1051063,37125
CHEMBL59834,P46098,BIMU8,AFOFVIBWSLOHFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,0.78,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14738829,DTCC01740527,2106786,68446
CHEMBL59834,P46098,BIMU8,AFOFVIBWSLOHFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,20,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14738826,DTCC01740527,2106786,68446
CHEMBL59834,P46098,BIMU8,AFOFVIBWSLOHFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,1259,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14738827,DTCC01740527,2106786,68446
CHEMBL59834,P46098,BIMU8,AFOFVIBWSLOHFR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,6918,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14738825,DTCC01740527,2106786,68446
CHEMBL598555,P46098,,YABLRALLVGHPFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678,IC50,=,3310,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010,53,3,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801,DTCT0023221,3181599,DTCC00618111,1167964,37429
CHEMBL598803,P46098,,KWVHDIHZHBHZBJ-PMACEKPBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,375,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211371,DTCC00622236,1439532,37125
CHEMBL598804,P46098,,FKNBNSUXUZHSKP-STQMWFEESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,7.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211372,DTCC00622237,1789800,37125
CHEMBL598805,P46098,,SXJUZHRNCSMYNX-PMACEKPBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,3029,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211374,DTCC00622239,1211766,37125
CHEMBL599011,P46098,,AJEBHUMZPBDLQF-STQMWFEESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,0.67,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211379,DTCC00622309,1568545,37125
CHEMBL599012,P46098,,UYPUNICVVJSXHT-KBPBESRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,71.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211380,DTCC00622310,1244760,37125
CHEMBL599760,P46098,RO-85,WLMBSKSEPQCRJV-OAHLLOKOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20045645,ACTIVITY,>,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL43694 from human recombinant 5HT3 receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting,,"Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.",Bioorg. Med. Chem. Lett.,2010,20,3,"Brotherton-Pleiss CE, Dillon MP, Ford AP, Gever JR, Carter DS, Gleason SK, Lin CJ, Moore AG, Thompson AW, Villa M, Zhai Y",,612484,DTCT0023221,3188545,DTCC00030157,1918622,37451
CHEMBL600053,P46098,,BKYSPAJPVPEZOE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19954972,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010,20,1,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603538,DTCT0023221,3163676,DTCC00609877,405425,36082
CHEMBL602850,P46098,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19954972,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,Not Determined,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010,20,1,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603538,DTCT0023221,3163677,DTCC00609826,1309981,36082
CHEMBL603052,P46098,,PKPRDSSAMMLSLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678,IC50,=,70,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010,53,3,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801,DTCT0023221,3181598,DTCC00618110,878089,37429
CHEMBL603052,P46098,,PKPRDSSAMMLSLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,IC50,=,70,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851149,DTCT0023221,11361559,DTCC00618110,900077,50968
CHEMBL603052,P46098,,PKPRDSSAMMLSLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,244,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361558,DTCC00618110,900077,50968
CHEMBL603673,P46098,,IJQKBGDDQMPHRI-STQMWFEESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,279,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211376,DTCC00622240,2049325,37125
CHEMBL604083,P46098,,XHOQYFHYEDPLTL-PMACEKPBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,749,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211378,DTCC00622308,986346,37125
CHEMBL604798,P46098,CP-810123,BSNKYWSMUAGMDO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678,IC50,=,5,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010,53,3,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801,DTCT0023221,3181595,DTCC00030113,1039298,37429
CHEMBL605562,P46098,,XQKKWUYBGYIOKW-KBPBESRZSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,5306,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211373,DTCC00622238,437627,37125
CHEMBL605772,P46098,,VZSXQQMZYQDDQE-PMACEKPBSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20146481,KI,=,0.23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5HT3A receptor expressed in HEK293 cells by scintillation counting,,Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.,J. Med. Chem.,2010,53,5,"Vernekar SK, Hallaq HY, Clarkson G, Thompson AJ, Silvestri L, Lummis SC, Lochner M",,612614,DTCT0023221,3211381,DTCC00622311,2017195,37125
CHEMBL608560,P46098,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19954972,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of 5HT3 receptor at 10 uM,Not Determined,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010,20,1,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603538,DTCT0023221,3163678,DTCC00609825,1789660,36082
CHEMBL611082,P46098,,CXJLWJAYGMWLRR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481,KI,=,13,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011,54,23,"Mazurov AA, Speake JD, Yohannes D",,851152,DTCT0023221,11361544,DTCC00618819,1094157,50968
CHEMBL611369,P46098,,MJSSERWIBBMXQD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678,IC50,=,779,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010,53,3,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801,DTCT0023221,3181592,DTCC00124272,1167975,37429
CHEMBL61946,P46098,CARAMIPHEN,OFAIGZWCDGNZGT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14740713,DTCC00208292,2107484,68446
CHEMBL62023,P46098,,MZRKHUUDDHJVHS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,0.72,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14739669,DTCC00207121,2107137,68446
CHEMBL62023,P46098,,MZRKHUUDDHJVHS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,27.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14739668,DTCC00207121,2107137,68446
CHEMBL62023,P46098,,MZRKHUUDDHJVHS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,3981,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14739667,DTCC00207121,2107137,68446
CHEMBL62023,P46098,,MZRKHUUDDHJVHS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,5523,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14739666,DTCC00207121,2107137,68446
CHEMBL62023,P46098,,MZRKHUUDDHJVHS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19119012,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents.",Bioorg. Med. Chem.,2009,17,3,"Chu W, Xu J, Zhou D, Zhang F, Jones LA, Wheeler KT, Mach RH",,515866,DTCT0023221,2694583,DTCC00207121,952786,32320
CHEMBL63054,P46098,,ZSMRRZONCYIFNB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,>,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849463,DTCC00211900,1427680,34292
CHEMBL63354,P46098,AMENTOFLAVONE,YUSWMAULDXZHPY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14753780,DTCC00216407,2103540,69275
CHEMBL63863,P46098,,LUAPLNWRHHWKLK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154,KI,=,1.43,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001,11,16,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480,DTCT0023221,1281243,DTCC00219246,1713650,4387
CHEMBL6437,P46098,MIANSERIN,UEQUQVLFIPOEMF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at SER3 receptor expressed in HEK293 cells assessed as inhibition of 10 nM octopamine-induced response by calcium imaging assay,Active,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007,450,7169,"Petrascheck M, Ye X, Buck LB",,478756,DTCT0023221,2354070,DTCC00132673,1362144,26306
CHEMBL644,P46098,TRIMIPRAMINE,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,>,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849468,DTCC00154839,973976,34292
CHEMBL65280,P46098,,QQJHRQZZCNYDMX-VPUSJEBWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,10869410,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14743043,DTCC00213993,2108262,69668
CHEMBL654,P46098,MIRTAZAPINE,RONZAEMNMFQXRA-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24035337,KI,=,2900,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]GR65630 from human 5-HT3A receptor expressed in HEK293 cells by liquid scintillation counting analysis,,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013,23,21,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988340,DTCT0023221,12618343,DTCC00155023,1301042,56006
CHEMBL66114,P46098,RS-39604,BKVIWGRFRKLFIO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,7582507,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14736053,DTCC01740814,2105854,69634
CHEMBL66692,P46098,,GALAKJYLTKKOBQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154,KI,=,0.42,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001,11,16,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480,DTCT0023221,1282499,DTCC00218537,64116,4387
CHEMBL667,P46098,ACETYLCHOLINE,OIPILFWXSMYKGL-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,EC50,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,342044,DTCC00103957,1792774,23555
CHEMBL66918,P46098,,DULFTXXWXGBQBT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154,KI,=,1.69,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001,11,16,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3480,DTCT0023221,1248997,DTCC00218476,873787,4387
CHEMBL681,P46098,ETOMIDATE,NPUKDXXFDDZOKR-LLVKDONJSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]GR65630 from 5HT3A receptor expressed in Xenopus oocyte,Not Active,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010,53,17,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675557,DTCT0023221,3545612,DTCC00156281,1343196,41410
CHEMBL681,P46098,ETOMIDATE,NPUKDXXFDDZOKR-LLVKDONJSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20704351,INHIBITION,=,1.3,%,,,,,,,,,,,,,,Inhibition of 5HT3A receptor expressed in Xenopus oocyte at 300 uM,,p-Trifluoromethyldiazirinyl-etomidate: a potent photoreactive general anesthetic derivative of etomidate that is selective for ligand-gated cationic ion channels.,J. Med. Chem.,2010,53,17,"Husain SS, Stewart D, Desai R, Hamouda AK, Li SG, Kelly E, Dostalova Z, Zhou X, Cotten JF, Raines DE, Olsen RW, Cohen JB, Forman SA, Miller KW",,675556,DTCT0023221,3545590,DTCC00156281,1343196,41410
CHEMBL68131,P46098,SB-204070,AOOSJYIINXVNHV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,KI,=,158.49,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428,DTCT0023221,2613767,DTCC01740809,694838,33265
CHEMBL68281,P46098,,DTBALPGNCWCVJP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154,EC50,=,240,NM,,,,,,,,,,,,,,Binding affinity against human 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001,11,16,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3478,DTCT0023221,1261964,DTCC00218786,257824,4387
CHEMBL68281,P46098,,DTBALPGNCWCVJP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11514154,EFFICACY,=,30,%,,,,,,,,,,,,,,Percent efficacy against 5-hydroxytryptamine 3A receptor,,5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.,Bioorg. Med. Chem. Lett.,2001,11,16,"Parihar HS, Suryanarayanan A, Ma C, Joshi P, Venkataraman P, Schulte MK, Kirschbaum KS",,3479,DTCT0023221,1261965,DTCC00218786,257824,4387
CHEMBL715,P46098,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,14642972,KI,=,417,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14757522,DTCC00160346,2111150,68458
CHEMBL715,P46098,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,=,1000,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329312,DTCT0023221,13582404,DTCC00160346,1516359,39761
CHEMBL716,P46098,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329312,DTCT0023221,13582407,DTCC00160380,1737586,39761
CHEMBL72,P46098,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,>,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849460,DTCC00137288,1104078,34292
CHEMBL726,P46098,FLUPHENAZINE,PLDUPXSUYLZYBN-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,>,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849462,DTCC00162562,1717188,34292
CHEMBL73234,P46098,CARBETAPENTANE,CFJMRBQWBDQYMK-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,7.9,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14714746,DTCC00229187,2099798,68446
CHEMBL73234,P46098,CARBETAPENTANE,CFJMRBQWBDQYMK-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,165,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14714745,DTCC00229187,2099798,68446
CHEMBL74656,P46098,REL-CISAPRIDE,DCSUBABJRXZOMT-RBBKRZOGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,1995.26,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin),,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971567,DTCT0023221,12504298,DTCC00232098,71332,55103
CHEMBL74656,P46098,REL-CISAPRIDE,DCSUBABJRXZOMT-RBBKRZOGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,1995.26,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504374,DTCC00232098,71332,55103
CHEMBL76370,P46098,TEGASEROD,IKBKZGMPCYNSLU-RGVLZGJSSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428,DTCT0023221,2613771,DTCC00232682,856773,33265
CHEMBL76370,P46098,TEGASEROD,IKBKZGMPCYNSLU-RGVLZGJSSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23756062,KI,=,2511.89,NM,,,,,,,,,,,,,,Binding affinity to human recombinant 5HT3 receptor,,"Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties.",Bioorg. Med. Chem. Lett.,2013,23,14,"McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG",,971714,DTCT0023221,12504373,DTCC00232682,848532,55103
CHEMBL773,P46098,GLYCINE,DHMQDGOQFOQNFH-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,EC50,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2126085,DTCC00168448,1539385,23555
CHEMBL78838,P46098,,IQMRECYOUIKYGG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21782429,PKI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human 5-HT3AR expressed in HEK293 cells after 24 hrs by liquid scintillation counting,Not Active,Fragment library screening reveals remarkable similarities between the G protein-coupled receptor histamine H4 and the ion channel serotonin 5-HT3A.,Bioorg. Med. Chem. Lett.,2011,21,18,"Verheij MH, de Graaf C, de Kloe GE, Nijmeijer S, Vischer HF, Smits RA, Zuiderveld OP, Hulscher S, Silvestri L, Thompson AJ, van Muijlwijk-Koezen JE, Lummis SC, Leurs R, de Esch IJ",,766545,DTCT0023221,6090025,DTCC00237145,102054,45760
CHEMBL79261,P46098,,LYXKFNHUJJDTIA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561,KI,=,1100,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14714039,DTCC00239269,2099468,68785
CHEMBL8197,P46098,,ZNRGQMMCGHDTEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,8.41,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14712502,DTCC00134926,2098709,68446
CHEMBL8197,P46098,,ZNRGQMMCGHDTEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,4332,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14712504,DTCC00134926,2098709,68446
CHEMBL8197,P46098,,ZNRGQMMCGHDTEI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14712507,DTCC00134926,2098709,68446
CHEMBL828,P46098,PHENOTHIAZINE,WJFKNYWRSNBZNX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,<=,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849465,DTCC00179549,1717190,34292
CHEMBL83954,P46098,RS-23597-190,RLSGBCUXLRMTPF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477,KI,=,1995.26,NM,,,,,,,,,,,,,,Binding affinity at 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009,17,6,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564428,DTCT0023221,2613783,DTCC01741365,1885821,33265
CHEMBL85,P46098,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,<=,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849466,DTCC00138594,1362973,34292
CHEMBL85,P46098,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity to serotonin 5-HT3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329312,DTCT0023221,13582409,DTCC00138594,1387256,39761
CHEMBL8514,P46098,BUTACLAMOL,ZZJYIKPMDIWRSN-HWBMXIPRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,944.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14711605,DTCC00135718,2098467,68446
CHEMBL8514,P46098,BUTACLAMOL,ZZJYIKPMDIWRSN-HWBMXIPRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,3464,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14711608,DTCC00135718,2098467,68446
CHEMBL8618,P46098,NAN-190,SJDOMIRMMUGQQK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9163561,KI,=,316,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14711195,DTCC00135647,2098369,68785
CHEMBL86304,P46098,MOCLOBEMIDE,YHXISWVBGDMDLQ-UHFFFAOYSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19144451,INHIBITION,<=,50,%,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of serotonin-induced inward Na+ current at >= 10 uM,,Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.,Eur. J. Med. Chem.,2009,44,6,"Kornhuber J, Terfloth L, Bleich S, Wiltfang J, Rupprecht R",,572131,DTCT0023221,2849457,DTCC00246764,812424,34292
CHEMBL93240,P46098,METITEPINE,RLJFTICUTYVZDG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at SER3 receptor expressed in HEK293 cells assessed as inhibition of 10 nM octopamine-induced response by calcium imaging assay,Active,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007,450,7169,"Petrascheck M, Ye X, Buck LB",,478756,DTCT0023221,2354071,DTCC00260212,1458837,26306
CHEMBL93240,P46098,METITEPINE,RLJFTICUTYVZDG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18033297,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at SER3 receptor expressed in HEK293 cells assessed as inhibition of 100 nM octopamine-induced response by calcium imaging assay,Active,An antidepressant that extends lifespan in adult Caenorhabditis elegans.,Nature,2007,450,7169,"Petrascheck M, Ye X, Buck LB",,478757,DTCT0023221,2354055,DTCC00260212,1458837,26306
CHEMBL93919,P46098,,NADMOKMSPBJASV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,2213824,KI,=,0.42,NM,,,,,,,,,,,,,,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.,J. Med. Chem.,1990,33,10,"Rosen T, Nagel AA, Rizzi JP, Ives JL, Daffeh JB, Ganong AH, Guarino K, Heym J, McLean S, Nowakowski JT",,3465,DTCT0023221,796811,DTCC00255816,1403478,10391
CHEMBL96,P46098,GAMMA-AMINOBUTYRIC ACID,BTCSSZJGUNDROE-UHFFFAOYSA-N,1,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904,EC50,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,Not Determined,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007,50,19,"Jensen AA, Zlotos DP, Liljefors T",,445995,DTCT0023221,2126084,DTCC00141298,698398,23555
CHEMBL98883,P46098,,LGQCVMYAEFTEFN-VUCTXSBTSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,50.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14708010,DTCC00267199,2097582,68446
CHEMBL98883,P46098,,LGQCVMYAEFTEFN-VUCTXSBTSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,1906,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14708013,DTCC00267199,2097582,68446
CHEMBL98883,P46098,,LGQCVMYAEFTEFN-VUCTXSBTSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,8246171,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14708014,DTCC00267199,2097582,68446
,P46098,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14747001,DTCC01744004,2109188,69275
,P46098,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14749638,DTCC01744004,2109188,69275
,P46098,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14751390,DTCC01744004,2110075,69159
,P46098,D-HOMOCYSTEIC ACID,VBOQYPQEPHKASR-GSVOUGTGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14755075,DTCC01745877,2104421,69159
,P46098,D-HOMOCYSTEINE SULFINIC ACID,PDNJLMZEGXHSCU-GSVOUGTGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14752977,DTCC01746621,2110340,69159
,P46098,D-HOMOCYSTEINE THIOLACTONE,KIWQWJKWBHZMDT-GSVOUGTGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14751342,DTCC01746491,2110074,69159
,P46098,DL-HOMOCYSTEIC ACID,VBOQYPQEPHKASR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14731407,DTCC01745876,2104415,69159
,P46098,EED226,DYIRSNMPIZZNBK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,28135235,IC50,=,30000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14725779,DTCC01744057,2096701,67941
,P46098,MDL 100907,HXTGXYRHXAGCFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,15999145,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14750491,DTCC01745097,2109914,69464
,P46098,PU01,WPEBMRNXFWCMHU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,490,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14712396,DTCC01744709,2098682,68163
,P46098,PU03,ZITSATWAZDKOBF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,2800,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14720093,DTCC01744876,2101991,68163
,P46098,PU04,KRBFLOBPUMORJO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14705766,DTCC01744148,2097015,68163
,P46098,PU06,IDRHDKGNUNKODU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14722190,DTCC01745080,2102510,68163
,P46098,PU07,IVHTZIIPDCREHO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14724072,DTCC01745334,2102800,68163
,P46098,PY01,WPPPKVSENOHDIG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,3400,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14712405,DTCC01744711,2098685,68163
,P46098,PY02,BWGIECJEQVGDRP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,30000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14726506,DTCC01745665,2103165,68163
,P46098,PY05,PKNNCDGLZOSLJS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14708124,DTCC01744454,2097628,68163
,P46098,SR144528,SUGVYNSRNKFXQM-ACSDJOOWSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9454810,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14754357,DTCC01745818,2103995,69395
,P46098,SURECN14521175,QLOOWOVVZLBYHU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,14709324,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14753603,DTCC01745721,2103342,69198
,P46098,TH02,YPAKIZUIDJVWEU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,14000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14719709,DTCC01744827,2101934,68163
,P46098,TH03,IULBXDZWXBXGNP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,30000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14724094,DTCC01745336,2102802,68163
,P46098,TH04,JBGBKQZMARTYMJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14721631,DTCC01745004,2102428,68163
,P46098,TH05,OIOMPFBFUIBOFU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,30000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14707513,DTCC01744398,2097466,68163
,P46098,TH06,YQZJKNSLWYSIQK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,30000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14719746,DTCC01744836,2101944,68163
,P46098,TH09,GKQNHLVTVYRVPU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14723619,DTCC01745268,2102728,68163
,P46098,TH10,FHGYGOURWHLFKB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14724448,DTCC01745401,2102876,68163
,P46098,TH11,BYOFGWKOPRCCDL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14726034,DTCC01745604,2103098,68163
,P46098,TH12,BKOSOHWFMPLYRS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14726337,DTCC01745648,2103147,68163
,P46098,TH13,HOASDGCNODVMOU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534,IC50,=,100000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14724566,DTCC01745416,2102894,68163